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ABSTRACT OF DISSERTATION 
 
 
 
THE TRANSMISSION DYNAMICS OF EQUINE HERPESVIRUS TYPE 1 (EHV-1) 
INFECTION IN OUTBREAKS CHARACTERIZED PREDOMINATELY BY 
NEUROLOGIC OR RESPIRATORY ILLNESS 
 
Formalized epidemiological field investigations were conducted to compare and 
contrast the transmission dynamics of EHV-1 neurological disease among horses 
stabled at Churchill Downs Racetrack, Louisville, Kentucky and of EHV-1 respiratory 
illness among horses stabled in the student barn at Murray State University.  
Differences were assessed by means of statistical and mathematical modeling 
techniques applied to survey and biological data collected over the course of the 
respective disease events.  
 
Regression methods applied to survey data enabled the construction of a 
statistical model to predict a date of onset of illness for horses within each equine 
cohort. Comparisons of the epidemic curves revealed that the Murray State University 
outbreak was 4.5 times longer (9 weeks versus 14 days) than the Churchill Downs 
Racetrack event.   
 
Survival analysis was used to explore the relationship between time to infection 
for each equine cohort. Horses stabled in the affected barn at Churchill Downs racetrack 
had a 3.02 times greater daily risk (p < 0.001) for contracting EHV-1 infection relative 
to horses stabled in the student barn at Murray State University. 
 
Estimates of the basic R0 number, calculated using mathematical formulae that 
incorporated the duration of the infectious period for neuropathogenic and non-
neuropathogenic strains of EHV-1, were 10.25 and 2.94 for the Churchill Downs 
racetrack and Murray State University outbreaks, respectively. The generation time for 
the Churchill Downs outbreak was 6.1 times shorter (0.39 days versus 2.38 days) than 
for the Murray State University event.  An assessment of the temporal occurrence of 
symptomatic infection is similar for each event and suggests that the appearance of 
clinical illness is constant over the course of an outbreak.  
 
A Reed-Frost model was constructed for each EHV-1 event where values of the 
transmission parameters (q, p and k) were estimated by fitting a model that most closely 
matched the observed profile of EHV-1 cases. The value of prophylactic vaccination on 
the spread of EHV-1 was assessed by making adjustments to these fitted models for 
varying levels of herd immunity. The results indicate that the prevention of EHV-1 
neurological illness requires a higher level of herd immunity than EHV-1 respiratory 
illness.  
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 1
CHAPTER ONE 
INTRODUCTION 
 
A. The research problem 
 Over the past 10-12 years, the number of reported outbreaks of equine herpesvirus 
neurologic disease or myeloencephalopathy has increased  both in Western Europe and in 
North America and, despite the lack of population-based surveillance data, many believe 
that this is due to the increased prevalence of neuropathogenic strains is increasing in the 
general horse population (Lunn et al., 2009).  While the basis for this increase can only be 
speculated, it is very probable that the severity of the clinical signs associated with 
outbreaks of herpesvirus neurologic disease increases the likelihood of reporting such 
occurrences particularly if an outbreak  involves a group of horses congregated at a 
racetrack or other type of performance venue. Conversely, respiratory illness caused by 
EHV-1 in adult horses if it occurs , often goes unreported, as there is little incentive to 
actively monitor for such cases of disease or to devote resources to an event that is 
commonplace and frequently perceived as of  little consequence. Nonetheless, there is a 
need to investigate outbreaks of EHV-1 infection where respiratory illness is the primary 
clinical feature if for no other reason than to establish a baseline for comparison with 
outbreaks of equine herpesvirus infection with more serious clinical outcomes and, perhaps, 
clarify the role that subclinical infection plays in the spread of EHV-1.   
 
 A recent consensus statement published by the American College of Veterinary 
Internal Medicine (ACVIM) identified the need for more research into the pathogenesis and 
epidemiology of EHV-1 (Lunn et al., 2009). Throughout this publication and in other recent 
reviews of EHV-1 (Pusterla, et al., 2009a) there is an absence of references to the use of 
mathematical modeling to assess the transmission characteristics of EHV-1. This may well 
reflect a scarcity of modeling expertise within the research community whose focus is the 
study of equine infectious diseases as well as a lack of appreciation of the value of disease 
modeling used for predicting the course or outcome of a disease event.  Regardless, 
mathematical modeling of this specific equine pathogen would likely increase our 
understanding of the underlying epidemiology of EHV-1 and assist in developing more 
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effective strategies for management of disease events caused by these pathogens. 
Ultimately, mathematical models that encompass the spectrum of clinical syndromes that 
can be caused by EHV-1 may assist regulatory officials in forecasting a more precise 
estimate of an end-point to an ongoing disease event. Finally, the results obtained from 
modeling occurrences of EHV-1 neurologic or respiratory disease in naturally exposed 
populations of horses would serve to complement laboratory findings and validate 
experimental data which suggest that strains of EHV-1 of a specific genotype have 
enhanced pathogenicity with respect to causing neurologic disease.   
 
B. Review of the literature 
 1. Introduction  
 Equine herpesvirus type 1 (EHV-1) is an important pathogen of equids that can 
cause respiratory disease, abortion, fatal respiratory disease in neonatal foals and, on 
occasion, sporadic outbreaks of neurological disease (Allen and Bryans, 1986).  
Epidemiological evidence suggests that foals as neonates are exposed to the virus from their 
dams and most seroconvert by six months of age, even when raised within highly 
vaccinated adult populations (Foote et al., 2006; Slater et al., 2006; Marenzoni et al., 2008).  
The clinical presentation of upper respiratory tract disease (URTD) caused by EHV-1 is 
highly variable and affected horses develop an acute rhinitis, pharyngitis and, with 
extension into the distal airways, tracheobronchitis, bronchiolitis and pneumonitis (Allen, 
2002a). Nasal discharge is frequently bilateral a consistent feature with clinical signs most 
intense and virus shedding more abundant during the first few days of infection. When 
present, fever may be slight or as high as 106°F and, in some horses, is biphasic. In 
uncomplicated cases, the nasal discharge may be minimal and will frequently go unnoticed 
by attending personnel which could potentiate the spread of the virus within a given 
population often  goes (Allen, 2002a). Respiratory disease has been reported to occur more 
commonly in younger horses and repeated exposure to the virus increases the likelihood that 
subsequent infections will be subclinical (Allen et al., 1999; Patel and Heldens, 2005; 
Henninger et al., 2007).  Virus may be recovered from the nasopharyngeal secretions or 
peripheral blood mononuclear cells (PBMC) for up to 12 days (range 4-12 days) after 
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infection (Allen 2002; Allen and Breathnach, 2006).  The duration of acquired immunity is 
short-lived and animals are at risk of re-infection within 3-6 months (Kydd et al., 2006).   
 
 Viral latency which is likely to be life-long, is a hallmark of EHV-1 infection and 
periodic reactivation of virus in latently infected horses is considered a major source of 
circulating virus (Patel and Heldens, 2005; Hussey et al., 2006). During latency, the virus is 
not in a replicative state and does not express genes coding for proteins and is unaffected by 
any of the conventional antiviral drugs that rely on viral protein targets (Field et al., 2006).  
The consequence of having a quiescent but potential source of infectious virus is that it 
may, as the result of some stressful stimulus, be reactivated with the generation of infectious 
virus capable of transmission to susceptible hosts (Borchers et al., 2006).  However, the 
contribution of reactivated latent virus to the spread or maintenance of EHV-1 in equine 
populations is not well defined, particularly in the absence of associated clinical illness, as 
horses are rarely sampled for EHV-1 unless they are displaying clinical signs.  A recent 
study of EHV-1 infection in adult horses that did not display clinical evidence of illness 
suggested that subclinical shedding of EHV-1 is infrequent and when it does occur, 
infective virus is at low level that might not pose a risk to other horses (Brown et al., 2007) 
though these observations have not been validated.   
 
 The primary sites of EHV-1 replication are the epithelial cells of upper respiratory 
tract and local lymph nodes (Patel and Heldens, 2005). The development of EHV-1 
neurological disease in horses requires a leukocyte-associated viremia with subsequent 
replication of virus in the endothelial cells lining the smaller blood vessels of the central 
nervous system (CNS) (Borchers et al., 2006; Patel and Heldens, 2005).  Studies of the 
pathogenesis of the neurological form of EHV-1 have demonstrated differences in the 
severity of illness which are correlated with the ability of the challenge strain of the virus to 
disseminate to vascular endothelial sites within the CNS (Edington et al., 1986).  Infection 
of endothelial cells is associated with the development of vasculitis and thrombosis which 
results in restricted blood flow leading to ischemic damage to the CNS (Edington et al., 
1986).  The damage to the vessels walls of the CNS can be widespread and hemorrhage is 
frequently observed on histopathological examination (Platt et al., 1980).  Although the 
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basis for a protective immune response to EHV-1 is not fully understood, evidence suggests 
that it includes both mucosal and humoral antibodies and involves the production of EHV-1 
specific cytotoxic T-Lymphocytes (CTL) (Breathnach et al., 2001; Breathnach et al., 2006; 
Coombs et al., 2006).  A more recent report by Allen (2008) found that horses with high 
concentrations of precursors of CTL were better able to control development of an EHV-1 
induced leukocyte-associated viremia and, as a result,  were less likely to develop 
neurological disease than those with a low concentration of CTL precursors. These findings 
were consistent among inoculated horses regardless of the age of the animal, their pre-
exposure serum neutralization antibodies (SN) titer for EHV-1 or the strain of the virus 
which was used as challenge inoculum. These results are in agreement with findings of 
Kydd et al., (2003) who showed a decrease in the occurrence of EHV-1 induced abortion 
among horses with high levels of CTL that were measured prior to viral challenge. More 
recently, a study by Hussey et al., (2011) comparing innate and adaptive immune responses 
of ponies challenged with a strain of EHV-1 wild type virus or an open reading frame 
(ORF) 1 and 2 deletion mutant found that ORF 1/2 genes play an important role in the 
severity of clinical outcomes and modulation of cytokine responses in infected animals. 
 
 The occurrence of  neurological disease among exposed horses is variable in 
frequency and severity of clinical signs exhibited by affected individuals. Clinical signs 
frequently include rear limb ataxia, urinary incontinence, and paresis (Kohn et al., 2006; 
Allen and Breathnach, 2006).  In general, pyrexia and depression are the most consistent 
clinical signs observed preceding the development of neurological disease (Allen and 
Breathnach, 2006; Slater et al., 2006).  
 
 Recent studies have identified a single nucleotide polymorphism (SNP) that encodes 
for the viral DNA polymerase which has been associated with an increased frequency of 
occurrence of equine herpesvirus myeloencephalopathy (EHM) (Nugent et al., 2006). The 
SNP of interest is located at nucleotide 2,254 within a highly conserved region of ORF30.  
In the case of neuropathogenic strains, this SNP encodes for G2,254 (amino acid D752) 
whereas with respect to non-neuropathogenic strains, the SNP encodes for A2,254 (amino 
acid N752) (Nugent et al., 2006).  Researchers have shown that foals exposed to a 
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neuropathogenic strain of EHV-1 develop a cell-associated viremia that is earlier in onset, 
greater in magnitude and longer in duration than that in foals inoculated with virus strains 
lacking this particular point mutation (Allen and Breathnach, 2006).  Specifically, EHV-1 
DNA can be detected by PCR analysis of PBMC in foals inoculated with neuropathogenic 
strains as early as 2 days and as late as 21 days (20-days duration of viremia) whereas for 
foals inoculated with a non-neuropathogenic strain of  EHV-1, viral DNA was not 
detectable before 4 days or after 14 days post inoculation (11-days duration of viremia). 
Furthermore, the peak magnitude of the viremia in foals inoculated with a neuropathogenic 
strain of EHV-1 isolates was 52-fold greater than in foals inoculated with abortigenic strains 
(Allen and Breathnach, 2006).  It has also been shown in natural outbreaks of EHM, that  
individual horses with neurological signs shed significantly higher levels of viral DNA, as 
determined by real-time TaqMan PCR assay, in nasopharyngeal secretions than horses 
which are only febrile or are subclinically infected (Pusterla et al., 2008).  
 
Collectively, these findings would suggest that horses stabled in close proximity to 
cases of EHV-1 neurological disease are potentially at a greater risk of exposure to the virus 
and subsequent development of EHM.  It should be pointed out, however, that the ability to 
cause neurological disease is not restricted to specific strains of EHV-1 with the afore-
mentioned SNP involving the viral polymerase gene; cases of neurological disease have 
been associated with strains of EHV-1 lacking this particular SNP (Nugent et al., 2006).  In 
fact, studies have shown that upwards of 25% of the EHV-1 isolates obtained from EHM 
cases were strains that did not have the neuropathogenic point mutation. Conversely, 
approximately 6% of horses determined to be infected with neuropathogenic strains of 
EHV-1 do not display signs of CNS disease (Goodman et al., 2007; Perkins et al., 2009). 
 
 For some outbreaks of EHM, investigators (vann Maanen et al., 2001; Henninger, et 
al., 2007) have chronicled the progression and severity of disease and the prognosis with 
respect to horses displaying neurological signs having essentially neglected to consider the 
role of subclinical cases of infection in dissemination of the virus or development of disease 
within the exposed population.  Insofar as subclinically infected horses may serve as a 
source of virus, the ability to identify horses that are shedding infective virus regardless of 
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clinical presentation is important for optimizing control strategies and in conducting contact 
tracing.  Since the introduction of allelic discrimination PCR-based assays that can 
distinguish between  neuropathogenic strains of EHV-1 with the particular SNP and non-
neuropathogenic strains of the virus lacking that point mutation (Allen 2007), investigations 
of outbreaks of EHM have focused on characterizing the genotype of the virus responsible 
for an outbreak and also identifying horses that are potentially shedding infective virus.  
While the intent of this testing is primarily to limit contact between susceptible or 
inadequately protected horses and animals shedding infectious virus, even  in the absence of 
epidemiologically derived data, it has also been used as a prognostic indicator of the 
development of CNS disease. While not an entirely inappropriate use of these testing 
modalities, it is certain that development of neurologic disease caused by EHV-1 is related 
to more than just the molecular characteristics of the virus strain involved; it should also 
include host and environmental specific factors (Allen, 2008; Lunn et al., 2009).  
 
 2. Epidemiological aspects of EHV-1 infection 
 Attempts to estimate the prevalence of EHV-1 in domestic and international equid 
populations have relied heavily on serological surveys conducted within defined 
populations (Gilkerson et al., 1999; Wood et al., 2005; Brown et al., 2007; Marenzoni et 
al., 2008).  In general, these surveys confirm that EHV-1 has a worldwide distribution 
(Matumoto et al., 1965; Allen et al., 1999) although demonstrating that seroconversion was 
common in equine populations, isolation of EHV-1 from exposed horses in the absence of 
clinical illness was rarely successful (Stierstorfer et al., 2002). To date, no study has been 
undertaken with the aim of determining population-based prevalence estimates for either 
neuropathogenic (expresses the ORF30G2,254 genotype) or non-neuropathogenic (expresses 
the ORF30A2,254 genotype) subtypes of the virus. This is despite the fact that the United 
States Department of Agriculture (USDA), Animal Health Plant Inspection Service 
(APHIS), Veterinary Services (VS) tried, for a period of time, to chronicle the occurrence of 
EHM (USDA, 2007).   From an animal health regulatory perspective, requirements for 
veterinary practitioners to report cases of EHV-1 to state animal health authorities vary 
among states.  Most state animal health agencies encourage reporting under general 
regulations (http://www.aphis.usda.gov/vs/regs/states) for reporting of communicable 
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diseases, yet few specifically designate cases of EHM caused by EHV-1 as a reportable 
disease.  With the exception of required statements of disease free status of horses intended 
for export and as a condition for states to participate in the National Animal Health 
Reporting System (NAHRS), there is no federally mandated reporting of disease conditions 
attributable to equine herpesviruses. Due to these short-comings in national reporting, it is 
not possible to establish secular trends for disease occurrence and any opinion as to an 
increase or decrease in EHV-1 disease incidence is merely speculative.   
 
 There is no evidence to indicate that currently available vaccines prevent the 
occurrence of neurological illness caused by EHV-1, as the immunity conferred by these 
vaccines does not reliably prevent infection, the development of cell-associated viremia as 
determined by quantitative real-time PCR, or the establishment of latency (Goodman et al., 
2006; Pusterla, et al., 2009b). The occurrence of EHV-1 neurologic disease among horses 
residing in highly vaccinated populations is common (Henninger et al., 2007).  It is thought 
that vaccines provide reasonable protection against respiratory disease, as evidenced by the 
lack of reports or documentation of large scale outbreaks of EHV-1 respiratory illness in 
highly vaccinated populations, though data that definitely support this conclusion is lacking 
(Slater et al., 2006; Pusterla et al., 2009a).  It is not uncommon for practitioners to 
administer antiviral agents such as acyclovir compounds to horses (personal 
communications – D. Byars) that have been exposed to or have been commingled with an 
EHV-1 neurological case; there are only limited pharmacokinetic data available to suggest 
that administration of these anti-viral drugs is of benefit in preventing the onset of clinical 
illness (Garre et al., 2007; Garre et al., 2008; Maxwell et al., 2008; Lunn et al., 2009; 
Pusterla et al., 2009a). Furthermore, the value of such therapy in preventing the spread of 
infective virus to susceptible horses or, ultimately, decreasing the occurrence of secondary 
cases has not yet been investigated. 
 
 Because neuropathogenic and non-neuropathogenic strains of EHV-1 differ in the 
quantity of virus shed in nasal secretions of infected horses and in the characteristics of the 
cell-associated viremia produced on experimental challenge, it is expected that disease 
spread and the associated transmission parameters will also vary for each EHV-1 strain. The 
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impact of specific intervention strategies on the course of an EHV-1 disease event will 
undoubtedly vary according to the viral strain responsible for the event.  
 
The goal of this research study is to analyze data collected in the course of 
investigating outbreaks of neurologic and respiratory disease attributed to neuropathogenic 
or non-neuropathogenic strains of EHV-1 that occurred among separate cohorts of horses 
housed in geographically confined locations. The hypothesis being tested is that outbreaks 
of disease caused by either neuropathogenic or non-neuropathogenic subtypes of EHV-1are 
similar with respect to their transmission dynamics regardless of the environment in which 
transmission occurs, any underlying host specific characteristics or the molecular genotype 
of the virus involved.  
 
 3. Investigation of EHV-1 disease events  
Detailed reports of the occurrence of EHV-1 neurological events are common in the 
veterinary literature and, for the most part, are comprised of clinical case reports and the 
outcome of investigations of outbreaks among horses in well-defined populations. A listing 
of some historical EHV-1 disease events are provided in Table 1.1. While not 
comprehensive, this summary illustrates that these types of events occur most commonly 
among horses located on breeding farms, at riding stables, racetracks, or at veterinary 
hospitals; locations where large numbers of horses are commingled or gathered. 
 
These events demonstrate that the recognition of CNS disease caused by EHV-1 is 
often preceded by respiratory illness or fever and suggests that these events have a seasonal 
onset with most reports occurring in the fall through spring months when animals are more 
likely to be confined in stables or barns; locations where they are maintained in close 
physical contact and share common airspace (Thomson et al., 1979; Platt et al., 1980; 
Greenwood and Simson, 1979; Friday et al., 2000; Studdert et al., 2003; Kohn et al., 2006; 
Henninger et al., 2007; Pusterla et al., 2009b; Burgess et al., 2012). 
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Table 1.1. Summary of previously reported outbreaks of EHV-1 myeloencephalopathy 
Reference Year 
of 
event 
Location Month 
(season) 
of clinical 
onset 
Number 
of  
cases 
Clinical episode 
preceding the 
recognition EHV-1
Thomson et al., 
1979 
1977 Breeding farm December 21 Respiratory illness 
Friday et al., 2000 1978 Breeding farm March 46 Fever, ataxia 
Greenwood and 
Simson, 1979 
1979 Public stud May 117 Abortion 
Platt et al., 1980 1979 Breeding farm Spring 9 Paresis 
vann Maanen et 
al., 2001 
1995 Riding school April 41 Respiratory illness 
McCartan et al., 
1995 
1995 Breeding farm May 110 Hind limb edema, 
ataxia 
Stierstorfer et al., 
2002 
1999 Riding school Autumn 5 Respiratory illness 
Studdert et al., 
2003 
2001 Breeding March 170 Ataxia 
Henninger et al., 
2007 
2003 Riding 
establishment 
January 119 Fever, depression, 
inappetence 
Kohn et al., 2006 2003 Veterinary 
clinic 
January 6 Respiratory and 
neurological 
disease 
Burgess et al., 
2012 
2008 Boarding 
facility, farm, 
veterinary 
clinic 
March - 
April 
20 Colic, fever, mild 
respiratory, 
abortion, limb 
edema 
 
 The active investigation of outbreaks of infectious disease is a systematic process of 
collecting and analyzing data with the intent of identifying and eliminating the source of 
infection (Reingold, 1998).  The process is best described as a series of steps that are 
designed to guide the field investigator and which are tailored to specific situations and 
conditions relative to a particular infectious agent and the environmental setting where in 
the outbreak is occurring (Reingold, 1998; Dwyer and Groves, 2007).  An integral part of an 
investigation is the development and use of a customized questionnaire to capture relevant 
epidemiological information with respect to time, place and person (horse).  Central to any 
outbreak investigation is the timely implementation of control measures to minimize further 
spread and, if applicable, to treat affected animals appropriately.  A necessary part of an 
investigation is to identify the population at risk and to determine the number and temporal 
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distribution of clinical cases (Reingold, 1998; Thrushfield, 2007).  For outbreaks which 
occur in animal populations, the ability to identify the sequential pattern of the onset of 
clinical illness among exposed animals is limited by the inability to query animals directly 
as to their symptomology and the need to use auxiliary diagnostic aids such as antigen 
detection or antibody determination to identify cases which are inapparent or silent 
(Thrushfield, 2007).  Even then, determination of the date that an individual animal has 
been exposed to or acquired an infection may be based solely on supposition and would 
require the use of a statistical procedure, such as linear regression methodology or survival 
analysis, to estimate with any degree of accuracy.    
 
 4. Statistical and mathematical modeling 
 Statistical and mathematical modeling offers the opportunity to assess variations in 
disease transmission and can be a useful tool for analyzing the possible consequences of 
interventions, such as immunization or anti-viral therapy, on a disease outcome (Keeling 
and Rohani, 2008).   The more common statistical methods for data analysis such as linear 
regression, logistic regression, or proportional hazards, are used to calculate risk estimates 
for parameters that relate exposure to disease in individuals.  These models assume that 
outcomes in different individuals are independent. In contrast, the assessment of disease 
transmission based on mathematical models relates individuals to each other using 
parameters that express contact rates or transmission probabilities (Koopman, 2004).  
 
a. Predictive modeling 
 Multiple linear regression models are statistical techniques employed to examine the 
association between a continuous outcome variable and a set of explanatory covariates. 
These techniques allow for reciprocal and simultaneous adjusting for all other exposure 
variables in the statistical model. The explanatory covariates can be continuous, categorical 
and may include interaction terms.  Regression models are useful in identifying and 
describing associations between exposure and outcomes but are also used to estimate the 
predicted value of a certain outcome as a function of a given set of values of the 
independent exposure variables (Szklo and Nieto, 2007).   
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 The multiple regression equation can be expressed as: 
  Yi = β0 + β1xi,1 + β2 xi,2 + ….. + βk xi,k  + εi   
where Yi is the value of the dependent variable on the ith trial, xi,k  is the value of the 
independent covariate x on the ith trial, β0 is the y intercept, βk represent the regression 
coefficients for the predictor variables and εi is the random error term.  In this model, the 
regression coefficients measure the partial contribution of each variable to the prediction of 
the response, or more precisely, the amount by which the mean response changes when the 
predictor is changed by one unit while all other predictors are unchanged (Montgomery et 
al., 2001).  The model assumes that the random errors εi, i = 1...n are independent, normally 
distributed random variables with a zero mean and constant variance σ2.  Violations of 
model assumptions are assessed through the use of statistical procedures which evaluate the 
deviations of residuals about the mean or check for the presence of multicollinearity among 
the covariates (Fernandez, 2003).   
 
 Whenever a large number of potential independent variables are being considered 
for inclusion into a regression model, it has become customary to use an automated process 
to select for a suitable subset of variables to be fitted to a model (Greenland, 1989; 
Fernandez, 2003; Sauerbrei et al., 2007).  Most statistical software packages offer a variety 
of selection methods which compare all possible variable combinations and most generate a 
statistic, such as R2 or Akaike’s information criterion (AIC), to be used to compare and 
evaluate the model.  While these automated processes allow for the inclusion and evaluation 
of a large number of potential cofounders, final variable selection resides with the 
investigator and should be based on experience and prior knowledge of the variables that 
may be important biologically (Greenland, 1989).    
 
 For occurrences of EHV-1, univariate analysis or logistic regression are the more 
common statistical procedures employed to examine the association of risk factors with 
disease outcome (Burrell et al., 1996; vann Maanen et al., 2001; Wood et al., 2005; Cohen 
et al., 2005; Henninger et al., 2007).  With the exception of studies that estimated the 
geographic spread of West Nile virus (Corrigan et al., 2006) and the spread of equine 
influenza among racehorses in training yards (de la Rua-Domenech et al., 1999), examples 
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in the veterinary literature of predictive modeling applied to equine infectious diseases are 
few in number and, of those which are available, none have been used to predict a date 
when an asymptomatic horse acquires an infection.  
 
b. Survival analysis 
 Survival analysis is a collection of statistical procedures for which the outcome of 
interest is time to the occurrence of a specified event. While the prototypical event of 
interest is death or failure, any designated experience of interest including disease incidence 
can be evaluated by this methodology (Kleinbaum, 1997; Fox, 2002).  There are many 
examples of the use of survival analysis in the veterinary literature and they include an 
examination of the temporal pattern for development of anthelmintic resistance (Suter, et 
al., 2005), the time interval for seroconversion after experimental Bovine Leukemia virus 
infection (Monti and Frankena, 2005) and estimation of risk of racehorse fatalities (Henley 
et al., 2006).  
 
 The distribution of survival times is characterized by three mathematical functions; 
the probability density function, the survival function, and the hazard function. All three 
functions are mathematically equivalent and if one is known then the others can be derived 
(Lee and Go, 1997).  The formulas for these functions are presented in the sections below 
and described by the accompanying equations.  
 
 The probability density function, also known as the unconditional failure rate, is 
defined as the limit of the probability that an individual fails in the interval t to t + Δt  per 
unit width Δt and is represented by the mathematical function 1.1. 
 
   F (t) = lim Δt        0   Pr ( t  <  T <  t + Δt )       (1.1)    
           Δt 
 
 A graph of the probability density function is called a density curve. It depicts the 
distribution of the survival times within a small interval of time and shows the proportion of 
individuals that fail at any time interval (Lee and Wang, 2003).   
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 A specific aim of survival analysis is to provide estimates of the probability of 
surviving to different times with the relationship being expressed as the survival function 
(Bull and Spiegelhalter, 1997).  The calculation of the survivor function is fundamental to 
survival analysis and represents the probability that a horse survives longer than some 
specified time (t) where (t) ranges from 0 to infinity. The survivor function, usually denoted 
by S (t), gives the probability (Pr) that a horse’s survival time (T), exceeds the specified 
time (t) (Kleinbaum, 1997) and is represented by equation 1.2. 
 
    S(t) = Pr(T > t) = 1 – Pr(t)    (1.2) 
 
 A survival curve is the graphic representation of the survival function and is useful 
to compare and contrast the survival distributions of two or more groups.  The median 
survival time, defined as the time at which the cumulative survival function is equal to 0.5, 
is commonly used as a summary statistic of the survival function and is generally the 
preferred measure of central tendency (Lee and Go, 1997).  
 
 The hazard function gives the instantaneous potential per unit time for the event to 
occur given that the individual has survived up to time (t) and is an expression of the hazard 
as it changes over time (Bull and Spiegelhalter, 1997).  It is also known as the conditional 
failure rate as the probability that the event will occur between t and t + Δt  given that the 
survival time (T) is greater than or equal to (t) (Kleinbaum, 1997).   It is represented by the 
mathematical expression given in equation 1.3. 
 
  h(t)  =  lim Δt         0    Pr [( t  <  T <  t + Δt ) / T > t]                     (1.3) 
        Δt 
 
 While survival curves express the cumulative effect of the risks faced by an 
individual, the hazard function expresses the hazard as it changes over time.  A convenient 
method for graphically depicting the hazard function is the Weibull distribution. This 
distribution takes many forms - increasing, decreasing, static or lognormal - with the shape 
of the distribution providing insights into the nature of the hazard (Kleinbaum, 1997).  
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 Since survival times must be greater than zero, their distribution is often right-
skewed and not generally assumed to be normally distributed. The Kaplan-Meier (K-M) 
procedure is a non-parametric procedure commonly used for estimating a survival function 
as it makes no assumptions about the shape of the underlying distribution of survival times 
(Bull and Spiegelhalter, 1997). The K-M procedure is a life-table technique that allows for 
the construction of a survival curve based on a series of time intervals such that only one 
event occurs at each interval with the event of interest occurring at the beginning of the 
interval (Lee and Go, 1997).  Because the K-M method uses a formula that estimates the 
survival function as the product of a series of conditional probabilities (Cox and Oakes, 
1984; Lee and Go, 1997), it is referred to as the product limit method.  This procedure 
estimates the instantaneous risk of failure at any particular time as the ratio of the number 
who became infected at time (t) to the number who are still at risk for becoming ill (Bull 
and Spiegelhalter, 1997).  Estimates of S(t) derived using this procedure provide a 
convenient method for comparing and testing whether two or more K-M curves are 
equivalent, commonly through the use of the log-rank test (Kleinbaum, 1997).   
 
 Comparisons of two or more survival curves can be done by estimating the 
distribution of survival times, examining the relationship between survival and one or more 
predictors, and comparing two or more groups with respect to the distribution of their 
respective survival times.    
 
 For observational studies of survival times of infectious diseases, the beginning of 
the period of observation coincides with the occurrence of the first case(s) and continues for 
a fixed interval (Lee and Go, 1997; Bull and Spiegelhalter, 1997).  A common feature of 
survival data is that, on occasion, a study animal (person) is removed or censored from 
observation before the event of interest occurs or prior to the termination of the study.  
Generally, censoring occurs if the horse (person) does not experience the event before the 
study ends, they are lost to follow-up, or if they withdraw from the study for a reason 
unrelated to the event of interest (Kleinbaum, 1997).  In some situations, the time that an 
event of interest occurs is not precisely known but only within a particular interval. This is 
referred to as interval-censored data and is commonly encountered when periodic 
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evaluations, usually clinical or laboratory testing, are used to assess whether the event of 
interest has occurred. The use of estimates derived from interval-censored data is rare in 
veterinary medical research as this statistical method is heavily dependent on the structure 
of the underlying data (Lindsey and Ryan, 1998; Radke, 2003) and is most often utilized in 
formalized clinical trials or longitudinal studies. Calculation of the date of disease onset 
using techniques to correct for interval censoring may not be applicable to investigation of 
disease outbreaks where diagnostic sampling is conducted only sporadically or where an 
investigation is initiated late in the disease event.     
 
 c. Mathematical modeling  
 Mathematical modeling characterizes disease transmission in terms of infection rates 
that are related to the frequency of contact between individuals and the likelihood of 
successful transmission given a contact between a susceptible and an infective host (Aron, 
2007). The population-level dynamics of disease spread is assessed most commonly through 
the estimation of a few key transmission parameters: the basic reproductive number, the 
transmission interval and the proportion of transmission that is inapparent or occurs during 
the prodromal period (Fraser et al., 2004).   
  
i. Transmission parameters 
(1) Basic reproductive number 
 For epidemic modeling, transmissibility is often expressed as the basic reproductive 
number, R0, which is defined as the mean number of secondary cases caused by each 
primary case in a population composed entirely of susceptible individuals (Anderson and 
May, 1991).  During the period that a host is infectious, a disease is transmitted to 
susceptible individuals at a rate dependent on R0 (Gani and Leach, 2001).  Conceptually, the 
basic reproductive number assumes that as one infective case is introduced into a large 
susceptible population, the initial spread would approximate a branching process (Dietz, 
1993) which, for an epidemic to expand, requires that more than one secondary case be 
generated by the primary case so that R0 > 1 (Hethcote, 2000).  The magnitude of the value 
for R0 is a useful indicator of both the risk of an epidemic and the effort needed to control 
the infection within an exposed population (Wallinga and Lipsitch, 2007). 
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For infectious disease agents, R0 is the product of the contact rate c, the duration of 
infectiousness d, and the probability that transmission will occur per contact with an 
infectious animal p, and is represented by equation 1.4 (Aron, 2007). 
 
         Number of contacts             Transmission                 Duration of  
R0 =       per unit time       x   probability per contact   x   infectiousness     = cpd (1.4) 
  
 Furthermore, the average number of contacts made by an infectious animal is the 
product of the contact rate and the duration of infectiousness while the number of new 
infections produced by one case during the infectious period is the product of the number of 
contacts in that time interval and the transmission probability per contact (Halloran, 2001). 
 
 It is readily apparent that any attempt to estimate R0 with this equation is only 
meaningful for diseases where contacts are clearly defined and can be counted. Therefore, 
attempts to determine R0 directly from individual contact parameters are restricted to a few 
vector borne diseases where estimates of the number of blood meals per unit time are 
known or to sexually transmitted diseases where estimates of the number of new partners 
per unit time or the number of contacts per partner have been determined (Dietz, 1993).  For 
infectious diseases where transmission occurs from airborne exposure or indirect contact, 
simulation modeling of disease spread is the most commonly used method to estimate the 
value for R0 in outbreaks within large populations (Ferguson et al., 2005; Roberts and 
Heesterbeek, 2007; Tildesley and Keeling, 2009; White and Pagano, 2008).  For models of 
simple immunizing infections where the incidence of disease is high, R0 can be estimated by 
equation 1.5 and transmission parameters obtained by fitting predictions of the infection or 
disease incidence obtained from a model based on observed data (Keeling and Rohani, 
2008; Vynnycky and White, 2010). 
 
      R0 = βND     (1.5) 
where β is the transmission probability or, more precisely, the per capital rate at which two 
specific individuals come into effective contact per unit time, N is the total population size 
and D is the duration of infectiousness. 
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 Alternatively, Anderson and May (1991) derived a method to calculate R0 from data 
obtained during the course of an outbreak investigation (Dietz, 1993, Galvani et al., 2003).  
This formula is based on the doubling time (i.e., the period required for the number of cases 
in an epidemic to double) of initial cases and is provided in equation 1.6 (Dietz, 1993). 
 
     R0 = 1 + D ln2 / td    (1.6)  
where D is the duration of the infectious period and td is the initial doubling time of cases.  
The parameter td is further defined (Galvani et al., 2003) by equation 1.7 where N1 and N0 
are the number of cases at time t1 and t0, respectively such that:   
 
                                     td = (t1 – t0) log (2) / log [N1 / N0]   (1.7) 
 
 As the outbreak progresses, a value for the current reproductive number – often 
referred to as the effective reproductive number - can be calculated for each time period (ti) 
and is denoted as Re. The value of Re is useful for following an outbreak over time such 
that, after the introduction of an infectious agent into a population, exposed animals will 
develop immunity and the value for the effective reproductive number, Re, will decrease. 
The outbreak will cease when the value for Re declines below the threshold value of 1.0.   
 
 Herd immunity (HI) i.e., the proportion of immune individuals which must be 
exceeded if disease incidence is to decrease, is linked quantitatively to the value of R0 and 
can be expressed algebraically as HI = 1 - 1/R0  (Fine, 1993).  Herd immunity describes the 
collective immunological status of a population and, mathematically, incorporates values of 
vaccine effectiveness and coverage into its estimate (Halloran, 2001). It serves as a target 
for disease elimination and is useful for evaluating the use of vaccines in exposed 
populations (Fine, 1993). 
 
(2) Transmission intervals 
While the serial interval is generally considered as the time period between 
infection and transmission (Fine, 2003), there is disagreement on the exact definition and 
some authors prefer the term generation time to describe this time frame. For most disease 
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outbreaks, only a proportion of cases will be directly observable (Kenah et al., 2008) and 
estimates of the transmission interval for these cases will be based on the serial interval. 
The term serial interval is therefore limited to defining the time period between successive 
clinical cases and more accurately reflects the clinical onset serial interval (Fine, 2003).  
The terminology is further complicated based on whether the transmission interval is being 
used to describe the initial phase of an epidemic or the mean value of the distribution of the 
transmission interval for the entire cohort (Wallinga and Lipsitch, 2007). Regardless, these 
intervals are based on the time period from the onset of infection in one individual and 
infection of others that a particular individual infects. Its represents the chain of 
transmission of infection in successive cases (Figure 1.1) and sets the time scale of the 
epidemic growth (Fraser et al., 2004).  Lastly, the serial interval is often confused with the 
latent period – the time before an exposed animal becomes infective – as these measures 
seem mathematically similar and it is often assumed that transmission occurs immediately 
at the end of the latent period whether or not contact between a susceptible and an infectious 
individual has occurred (Daley and Gani, 1999; Vynnycky and Fine, 2000).     
 
Figure 1.1. Diagram of the chain of disease transmission in successive cases 
  
       10  primary        20  secondary  
   exposed infection    exposed infection 
      
       generation time 
 
               time (t) 
         latent 
         period         tC    tD         
       tA            incubation   tB   serial interval   tE 
            period           
                                     
tA: Primary case is exposed to infectious agent     
tB: Clinical signs appear and primary case becomes infective 
tC: Secondary case exposed to primary case     
tD: Transmission to another susceptible 
tE: Clinical signs appear in secondary case 
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 The progress of an epidemic depends on the innate features of individuals at risk and 
the dynamics of disease transmission between members of a population (Svensson, 2007). 
The probability of transmission will differ between groups based on the environmental 
conditions under which animals reside, the population density, mixing patterns, past 
exposure history or some specific characteristic of the infectious agent.  Where possible, 
transmission intervals are best studied by directly observing the temporal pattern between 
successive cases (Mathews et al., 2007; White et al., 2009) though, to my knowledge, this 
has never been documented for infectious diseases in animal populations.   
 
Estimation of the serial interval for influenza A/H1N1 has been calculated in public 
health settings by directly monitoring household contacts with index cases for the 
occurrence of symptom onset or indirectly by simulation modeling of case reports of 
notifiable disease data (Cowling et al., 2009; White et al., 2009).  Though uncommon, 
attempts have been made to estimate transmission intervals (generation or serial interval) in 
animal populations by simulation modeling. As an example, Stegeman et al. (1999), 
proposed a generation interval of 10 days for the transmission of classical swine fever 
among breeding swine during the 1997-1998 epizootic in the Netherlands.    
 
 For epidemic models, the number of infected individuals increases exponentially in 
the early stages of an epidemic with the rate of increase equal to the Malthusian parameter r  
where a population increases over a fixed interval such that the amount of increase, absence 
of constraints, is not affected by the size of the population (Tomba et al., 2010).   
 
 Calculations of the exponential growth of a population are based on equation 1.8,  
N (t) = N0 ert       (1.8)  
where N0 = initial population, r = growth rate (Malthusian parameter), and t = time.  
 
The growth rate (r) is based on the initial doubling time and can be calculated with 
the equation 1.9 and the value for td derived from equation 1.7.  
 
     r = ln (2)/ td     (1.9) 
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For simple transmission models, there is an explicit relationship between R0 and the 
average observed initial generation time (Tg) (Wallinga and Lipsitch, 2007; Tomba et al., 
2010) such that R0 can be calculated using equation 1.10. 
 
R0 = 1 / 1 – r Tg    (1.10) 
 
 Based on this mathematical relationship, it is possible to solve for Tg when R0 and r 
are known using equation 1.11.    
 
Tg = (R0 – 1) / (r R0)    (1.11)  
 
This method of estimating Tg provides a useful measure of the generation time 
when applied to data at the beginning of the epidemic period where it is reasonable to 
assume that the whole population is susceptible (Roberts and Heesterbeek, 2007).  
 
(3) Asymptomatic transmission  
In infectious disease epidemiology, the proportion of transmission that occurs prior 
to the onset of symptoms or clinical signs – the prodromal period – or by asymptomatically 
infected animals are important factors in the dissemination of infection within a population 
(Fraser et al., 2004; Patrozou and Mermel, 2009).   
 
 Asymptomatic transmission is commonly expressed as the proportion of infection 
that occurs among susceptibles which do not display clinical signs (Nelson, 2007).  Because 
asymptomatic infection is generally considered to be immunizing, clinical attack-rates 
rarely approach 100%, even in isolated immunologically naive populations (Mathews et al., 
2007).  Ignoring asymptomatic cases in outbreak settings would underestimate morbidity 
and lead to unreliable estimates for transmission parameters.       
 
 Within the public health community, there is disagreement concerning the impact 
that shedding of influenza virus by subclinically infected individuals have on the spread of 
this disease. Observational studies in human populations and experimental studies in mice 
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would suggest that asymptomatic transmission of influenza is limited (Schulman and 
Kilbourne, 1963; Patrozou and Mermel, 2009).  For influenza A/H3N2 specifically, the 
quantity of virus shed in nasal secretions of human cases is 2-3 log10 times lower in 
asymptomatic cases of infection than in individuals who develop clinical illness (Carrat et 
al., 2008).    
 
 For occurrences of EHV-1, researchers have shown that there are no differences in 
the viral load expressed as the number of gene copies per million cells in nasopharyngeal 
secretions of febrile and subclinical horses infected with the same strain of EHV-1 (Pusterla 
et al., 2008). These findings suggest that, at least for EHV-1, subclinically infected horses 
pose a similar risk for transmission as febrile horses particularly when they are maintained 
in close physical contact, though this risk has yet to be quantified. 
 
 For veterinary practitioners, the presence or absence of clinical signs directly affects 
their ability to diagnose, treat or isolate infected animals.  It is therefore reasonable to 
assume that the lack of clinical signs in infected animals will effectively result in increased 
spread of EHV-1 within a confined population as medical or regulatory interventions are 
delayed.  As with human influenza, direct monitoring of contacts through physical 
examinations and laboratory testing offers the best opportunity to estimate transmission 
parameters and to quantify the burden that subclinically infected horses contribute to the 
spread of EHV-1.  Moreover, estimates of transmission parameters obtained through direct 
observation are inherently more accurate and less uncertain than those derived from 
epidemic models (Mathews et al., 2007). 
 
ii. Deterministic modeling 
A mathematical model is a mathematical description of the simplified dynamics of 
disease transmission and, provided that the assumptions and parameter estimates used for 
the model are realistic, serves as a useful approximation of the spread of disease within 
complex biological systems (Aron, 2007).  Mathematical models are categorized as either 
stochastic or deterministic depending on whether the model incorporates elements of 
random variation and chance (Hurd and Kaneene, 1993).  As an example, Monte Carlo 
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sampling is a stochastic technique used for complex epidemic models with the results 
expressed as confidence intervals instead of just point estimates (Martin et al., 1987). There 
is a general belief that stochastic models provide a more realistic depiction of biological 
systems than deterministic models, though in many instances, the results of a deterministic 
model will approximate the mean response of a corresponding stochastic model.  Moreover, 
deterministic models provide valuable insights into the properties of disease transmission 
when based on observational data or when used to make predictions about an event with a 
high incidence level (Martin et al., 1987; Hurd and Kaneene, 1993; de Jong, 1995; Halloran, 
2001; Keeling and Rhoni, 2008).   
 
 Transmission models are based on the Kermack-McKendrick threshold theorem 
which requires a minimum density of susceptible animals within a population to allow a 
contact-transmitted epidemic to commence (Aron, 2007; Keeling and Rhoni, 2008).  The 
formulation of epidemic models requires that individuals within a population be sub-divided 
into a range of classes or states dependent on their infection history (House and Keeling, 
2008).  A simple model of the Kermack-McKendrick type is the deterministic 
compartmental model where individuals reside in only one compartment or state at any 
given time. This model considers a population consisting of three distinct disease states; 
susceptible (S), infected (I) and immune or recovered (R).  This type of deterministic model, 
commonly referred to as an SIR model, is generally effective in describing the dynamics of 
a range of infections and, since the outcome is not subject to chance, produces the same 
result for any initial set of values and parameters (Hurd and Kaneene, 1993; Thrushfield, 
2007; House and Keeling, 2008).   
 
 The classic SIR model for closed populations without demographics (no births, 
deaths, or migration) and assuming homogeneous mixing – every pair of individuals has an 
equal probability of coming into contact with another – can be depicted schematically 
(Figure 1.2) by the following transfer diagram (Keeling and Rhoni, 2008).   
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Figure 1.2. Simple epidemic model (SIR) 
  
 
 
  
      transmission           recovery  
      of pathogen       from illness 
 
 
With respect to these three disease states, the model assumes that the rate of gain in 
the infective class is proportional to the loss in susceptibles, the rate of gain in the recovered 
class (immune) is proportional to the loss of infectives and the incubation period is 
negligible such that as a susceptible individual contracts disease they become infective 
immediately (Murray, 1989).  This process can be parameterized by a series of differential 
equations for the rates of change in the population densities of the disease states S, I and R, 
respectively, and is represented by the diagram and equations in Figure 1.3. 
 
Figure 1.3. SIR model for a closed population with differential equations for the rates 
of change for the population densities   
 
    βSI    γI 
  S      I     R 
    
     dS /dt = - βSI     (1.12)  
     dI /dt = βSI – γI    (1.13) 
     dR /dt = γI       (1.14) 
 
For epidemic modeling, the mass-action term (βSI) characterizes the rate of transfer 
of individuals from the susceptible class S to the infective class I.   The law of mass action 
can be applied to population processes and its application to disease transmission is 
analogous to the rate of a chemical reaction as a function of the initial concentrations of the 
reagents (Fine, 1993; Daley and Gani, 1999) or, for disease transmission, to the proportion 
S 
(susceptible) 
I 
(infected) 
R 
(immune) 
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of animals within each disease class at the beginning of an epidemic (Daley and Gani, 
1999).  In this context, the parameter β is a rate constant that incorporates the number of 
contacts per person per day and a probability that a contact between an infective and 
susceptible individual results in transmission of the infectious agent (Aron, 2007).  While 
the parameter γ is the recovery rate for the infective class to the recovered class, its 
reciprocal (1/γ) is the average infectious period; a parameter that provides additional insight 
into the dynamics of disease transmission (Aron, 2007).  If, for example, a therapeutic agent 
is used during an epidemic, then the recovery rate increases and the average infectious 
period is shortened, thus reducing spread to others (Aron, 2007; Keeling and Rhoni, 2008).  
By examining the rates of transfer from one class to another, the underlying concept of the 
Kermack-McKendrick threshold theorem becomes clearer such that as the rate at which the 
susceptible class become infective exceeds the rate at which the infective class is removed 
(βSI > γI) then the epidemic is permitted to grow (Daley and Gani, 1999; Keeling and 
Rhoni, 2008). 
 
 Despite its simplicity, an exact analytical expression for the dynamics of the SIR 
model is not easily understood and, for most applications, must be solved numerically 
(Keeling and Rhoni, 2008).  While individual-based transmission models in structured 
communities have been used to study the spread of smallpox and influenza in human 
populations, few threshold values relating to animal diseases are known (Thrushfield, 
2007). 
 
 The Reed-Frost model is a simple discrete-time deterministic model constructed 
within the SIR framework that is commonly used to evaluate disease spread and herd 
immunity (Abbey, 1952, Martin et al., 1987; Wahlström, et al., 1998). The Reed-Frost 
model is a chain binominal model where the expected number of cases occurring during an 
epidemic can be derived mathematically from the formula shown in equation 1.15 (Abbey, 
1952; Hurd and Kaneene, 1993). 
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     C t +1 = St (1 - qct)     (1.15) 
where         t = the time period 
    Ct+1  = the number of infectious cases in time period t + 1 
       St  = the number of susceptible individuals in time period t, 
        q  = 1− p; the probability of avoiding effective contact  
        p  = the probability of effective contact between an infective and susceptible  
 
p is calculated as    p = k ⁄ (N-1)     (1.16) 
where     k = the number of effective contacts made during time period t 
   N = the population size  
 
The Reed-Frost model assumes that the population is closed, every individual is 
equally susceptible to disease, random mixing occurs within the populations where every 
individual is equally likely to come into contact with any other individual, disease spread is 
by direct contact, an infected is a case for only one time period and immunity lasts 
indefinitely (Abbey, 1952; Carpenter, 1984; Wahlström et al., 1998).  
 
 The model equates the number of cases at any time to the number of susceptibles in 
the immediate preceding time period and the probability of contact of each individual with a 
case (Martin et al., 1987).  By applying a simple binomial probability, the expected number 
of cases can be computed for any time period (Halloran, 2001).  For discrete time Reed-
Frost models where individuals are infectious for no more than one time period, the 
transmission parameter (k) represents the number of secondary cases that arise for one 
initial infectious case and has been used as an estimate for R0 (Daley and Gani, 1999; 
Keeling and Rhoni, 2008). For the purposes of mathematical modeling, the recovered or 
immune class consists of individuals who are no longer acutely infected with a pathogen, 
who would not contribute to the infectious process and are incapable of transmitting 
infection (Vynnycky and White, 2010). 
 
 Mathematically, the Reed-Frost model is deterministic but can be made stochastic 
with the use of computer simulation or by incorporating variability into the parameters used 
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to construct the model (Hurd and Kaneene, 1993).  As an example, changing the value of 
(k) for each time period makes the model stochastic by incorporating variability into the 
probability that each contact will be adequate.  
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CHAPTER TWO 
MATERIALS AND METHODS 
 
A. Materials   
 1.  EHV-1 disease events – animals and premises  
 a. Churchill Downs Racetrack, 2005 – Investigative summary 
 On Tuesday May 17, 2005, animal health regulatory officials in Kentucky were 
notified by laboratory personnel at the University of Kentucky Veterinary Diagnostic 
Laboratory (UKVDL) of the diagnosis of EHM in a horse which had been submitted to the 
laboratory for routine necropsy.  The animal, a two-year old Thoroughbred filly was 
euthanized on May 12, 2005 and submitted to the Diagnostic center after its clinical 
condition worsened despite the institution of aggressive therapeutic measures by clinicians 
at a local equine referral hospital. The horse, a recent arrival to Churchill Downs Racetrack 
in Louisville, had a clinical onset on May 9, 2005 when she was first noted to be lethargic 
and depressed. On the morning of May 10, 2005 the horse had become recumbent and was 
unable to rise.  At that time, the horse was transported to the equine referral hospital in 
Lexington, KY where additional therapy was initiated, including placement of the affected 
animal in a sling.  EHM was suspected based on the clinical presentation and histological 
findings which demonstrated diffuse hemorrhages were noted in the gray and white matter 
and the presence of mononuclear infiltrates in the cervical spinal cord.  The diagnosis of 
EHM was confirmed with the use of a PCR assay specific for EHV-1 that was performed on 
neural tissue obtained from the horse at necropsy.  
 
 While the laboratory results were pending on this case, an additional animal residing 
in a separate training barn at Churchill Downs Racetrack presented with similar clinical 
signs as the aforementioned filly; it was reported to the state animal health regulatory 
officials.  This was a two-year old unraced Thoroughbred colt that developed a fever of 
103.5°F (39.7°C) on the morning of May 8, 2005.  According to the attending veterinarian, 
the colt was treated symptomatically but on May 13, it developed rear limb paralysis and 
became recumbent.  Due to an unfavorable prognosis for functional recovery, a decision 
was made to euthanize the animal and submit it to the UKVDL for necropsy.  As with the 
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previous case, histological findings of vasculitis and mononuclear cells in the brain 
supported a diagnosis of EHM this was confirmed through by a PCR assay specific for 
EHV-1 on lymphoid tissue obtained at necropsy.   
 
 In response to identification of two horses with EHM stabled at the racetrack, the 
Office of the Kentucky State Veterinarian initiated an epidemiological investigation at 
Churchill Downs Racetrack in Louisville, Kentucky.  An initial on-site assessment was 
conducted on May 17 and used to determine the number and location of potentially exposed 
horses.  While these two Thoroughbreds in training were both located at Churchill Downs, 
they were stabled in different barns, designated as barns six and 39, and had separate 
owners and trainers.  
 
 During the initial evaluation at Churchill Downs on May 17, a number of horses 
stabled in barn number 38, were observed exhibiting clinical signs that were compatible 
with EHV-1 illness, including hind limb ataxia and paralysis.  The horses in this barn had 
been evaluated a few days earlier by a veterinary practitioner who specializes in internal 
medicine and who had recommended that all horses housed in barn 38 be placed on a 
treatment regimen of the anti-viral agent Acyclovir beginning May 15.    
 
 Based on the recognition of two horses in separate barns with laboratory confirmed 
EHM and with the report of additional horses with clinical signs compatible with EHV-1, 
state regulatory officials and Churchill Downs Racetrack management elected to restrict the 
movement of animals into and out of three barns.  The Office of the Kentucky State 
Veterinarian, in consultation with researchers from the University of Kentucky Maxwell H. 
Gluck Equine Research Center, developed a sampling protocol designed to identify the 
presence of circulating virus among exposed horses and to provide a basis on which control 
measures for EHV-1 could be implemented.     
 
 While there were approximately 800-900 horses present on the grounds of Churchill 
Downs Racetrack when the first EHV-1 neurologic case was diagnosed, active surveillance 
efforts by veterinary practitioners and state regulatory personnel identified only three barns 
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with either a diagnosed case of EHM or laboratory evidence of acute EHV-1 infection.  Of 
these three barns, only barn 38 was ultimately determined to have more than one EHV-1 
infected horse identified throughout the entire 66 day surveillance period.  Consequently, 
further analysis of the transmission of EHV-1 within a confined population is restricted to 
the 37 horses housed in barn 38 at Churchill Downs Racetrack. 
 
 b. Murray State University, 2008 – Investigative summary 
 On April 8, 2008 Kentucky animal health regulatory officials were notified of a 
presumptive positive PCR-result specific for EHV-1 from a whole blood specimen and a 
nasal swab submitted to the UKVDL. The samples were collected from a 14-year-old 
Quarter-horse gelding that was hospitalized at an equine medical referral clinic in 
Lexington, Kentucky. The horse was admitted to the clinic after having developed hind limb 
ataxia of two days duration. 
 
 The gelding was owned by a Murray State University college student and prior to 
being admitted to the equine medical center was stabled in the student barn at the University 
farm in Murray, Kentucky. While the gelding occasionally participated at horses shows, the 
owner utilized it mainly for pleasure riding. The horse had been resident in the student barn 
since the beginning of the 2007 fall semester and had occupied the same stall for the entire 
period. Because other horses, both university and student owned, were stabled with or co-
located at the University farm with the affected gelding, an epidemiological investigation 
was initiated immediately by the Office of the Kentucky State Veterinarian.  
 
 A total of 120 horses, stabled in two barns and adjoining pastures at the Murray 
State University research farm, were resident on the facility at the time of the investigation. 
All horses were evaluated initially by regulatory personnel on April 10, at which time a 
survey questionnaire was provided to horse owners and university farm personnel with 
instructions to complete and return the following day.  Regulatory oversight, including 
movement restrictions and sampling of horses that were stabled in the student and rodeo 
barns, began on April 8 with the issuance of a state hold-order and continued for a 42-day 
period until the horses were released from quarantine on May 20, 2008.   
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 Preliminary analysis of data obtained during the investigation suggested that, among 
horses in the student barn, respiratory illness preceded the recognition of the initial 
neurological case.  Because the occurrence of neurological illness and the recognition of 
respiratory illness were confined to horses in the one student barn at Murray State 
University, analysis of data collected over the course of the investigation focused on the 
transmission of EHV-1 among the 37 horses which housed together in this barn.      
 
 2. Personnel and laboratory support 
 The investigation of each EHV-1 event was conducted under the authority of the 
Office of the Kentucky State Veterinarian and included the use of state and federal 
veterinary medical personnel, animal health technicians and regulatory enforcement staff for 
the collection and processing of blood samples.  For the EHV-1 event at Churchill Downs 
Racetrack, primary laboratory support was provided by the UKVDL and by the late Dr. 
George Allen at the Maxwell H. Gluck Equine Research Center at the University of 
Kentucky, Lexington, KY.  Samples collected over the course of the investigation at the 
Murray State University research farm were evaluated diagnostically for evidence of EHV-1 
infection at the Breathitt Veterinary Center in Hopkinsville, KY and the UKVDL.     
 
 Additional diagnostic testing to rule out other possible infectious causes of 
neurological illness of equids was conducted at the National Veterinary Services Laboratory 
(NVSL) in Ames, Iowa on samples collected from horses associated with the Churchill 
Downs Racetrack outbreak investigation. In the case of the Murray State University 
outbreak investigation, Ms. Kathy Shuck and Dr. Udeni Balasuriya at the Maxwell H. Gluck 
Equine Research Center at the University of Kentucky, Lexington, KY preformed 
diagnostic assays to rule out other infectious causes of equine viral respiratory illness. 
 
B. Methods  
 1. Regulatory protocol 
 a. Churchill Downs Racetrack, 2005 
 Regulatory management of the Churchill Downs Racetrack outbreak involved the 
institution of biosecurity measures and movement controls to limit spread, the development 
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of a surveillance and laboratory testing protocol to determine the disease status of horses 
stabled at the track and the dissemination of information about the disease event to media 
outlets and other interested stakeholders.  
 
 During the disease event, veterinary practitioners with clients at Churchill Downs 
Racetrack were required to report to Kentucky animal health regulatory authorities any 
horse stabled on the premises with a fever in excess of 101.5°F (38.6°C) or exhibiting 
clinical signs consistent with EHM.  The intent was to provide an active surveillance 
component to the investigation and to identify animals that needed further diagnostic 
evaluation.  In the case of those barns with a diagnosed case of EHM or laboratory evidence 
of EHV-1 infection, the entire population of equids housed in the barn was placed under a 
state hold-order and prevented access to the track for a 14-day period.  Following this 
isolation period, all horses within the barn were evaluated diagnostically using a PCR assay 
specific for EHV-1 (OIE terrestrial manual, chapter 2.5.7). If the remaining horses within 
the affected barns were found to be negative using this assay, they were allowed restricted 
access to the track for exercise. As a rule, this meant exercising at designated time periods 
under supervision of track personnel and avoiding any commingling with the general track 
population.  Following an observation period of seven days without additional clinical 
cases, horses within affected barns were subjected to a final round of diagnostic testing with 
the PCR assay.  Those barns without additional positive animals were released from 
regulatory oversight and allowed to train or move without further restrictions.  
 
 In the case of barn 38 where laboratory testing provided evidence of continued 
transmission of EHV-1, animals positive on the PCR assay were observed and held in an 
isolation barn and additional specimens obtained from the remaining pool of horses. A 
negative result on a PCR assay for EHV-1 was required for all barn cohorts prior to horses 
being released from restrictions. All animals determined to be infected with EHV-1 were 
required to undergo repeated testing at weekly intervals until they were negative on the PCR 
assay.   
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 Biosecurity measures employed during the outbreak included limiting access to 
affected barns to trainers, grooms and veterinary medical personnel.  To reduce the potential 
for fomite transmission, footbaths containing Environ One Stroke® were places at entry 
points and recharged as necessary.  To limit aerosol transmission, horses from non-affected 
barns and other track personnel were restricted from coming within a distance of thirty feet 
of the affected barns. Compliance was monitored and enforced by Churchill Downs 
Racetrack security and state animal health regulatory personnel. Based on recommendations 
outlined during an information sharing session on May 19, it was requested that horses 
residing on the track grounds have temperature checks regularly and any horse with an 
elevated temperature needed to be reported to state racing commission veterinarian.  If a 
horse was identified with a fever greater than 101.5°F, the practitioner involved was 
directed to collect and submit samples to test for the presence of EHV-1 by PCR assay.   
 
 While regulatory restrictions were removed from all horses at Churchill Downs on 
June 1, 2005, monitoring of horses for clinical evidence of EHM was continued by private 
practitioners and by veterinarians employed by the Kentucky Racing Commission. The 
observational period for the event lasted 66 days and encompassed the entire racing meet 
which ended on July 10, 2005. 
 
 b. Murray State University, 2008 
 All horses located at the University’s agricultural research complex in Murray were 
placed under a verbal state hold-order on April 8 to prevent the movement from the 
premises until an on-site assessment could be conducted by regulatory personnel.  The 
movement restrictions were initially applied to all horses stabled in barns and pastures 
located on the research farm and to horses stalled within the Agricultural Exposition Center, 
including bucking stock and other university-owned horses.  Informational meetings were 
held on two separate occasions to provide updates of the investigation to horse owners and 
to encourage compliance with regulatory restrictions.  University employees and faculty 
members with duties and responsibilities at the research farm and students with horses 
stabled on the premises were advised to limit contact between horses while exercising, to 
avoid the use of shared equipment, and to disinfect hands and equipment frequently.    
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 Daily health monitoring of horses was conducted by a university veterinarian and 
compliance with movement restrictions monitored by farm staff and state agricultural 
employees. To determine whether there was any spread of EHV-1 from the farm, all horses 
sold or moved from the premises within the three-month period prior to April 8, 2008 were 
identified, traced and evaluated for evidence of clinical illness.   
 
 Following a 30-day period without additional cases of neurologic illness and a 21-
day interval after identification of the last PCR positive specimen, movement restrictions 
placed on horses in the student barn were lifted by state regulatory officials on May 8, 2008, 
two days before the end of the spring semester.   
 
 2. Data collection  
 a. Survey questionnaire 
 Customized questionnaires were developed for each outbreak investigation and used 
to obtain information specific to each animal including ownership, management, travel, past 
performance and medical history (Appendices A & B). For the Churchill Downs 
investigation, the questionnaire was administered to the assistant trainer by regulatory 
personnel and completed by reviewing treatment and billing records maintained on the 
premises for each horse.  The questionnaire utilized for the Murray State University 
investigation was designed to be self-administered and intended to be completed by each 
horse owner.  Both questionnaires were a combination of closed and open-ended questions 
and included space for written comments. 
 
 The intent of administering the questionnaires, in addition to obtaining basic 
demographic information such as breed, age and gender, was to document the date of 
disease onset of clinical cases, to identify potential risks factors for EHV-1 infection, and to 
collect data from individual animals that would allow for the statistical and mathematical 
exploration of diagnostic disease data.   
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       b. Biological sampling 
 i. Churchill Downs Racetrack, 2005 
 Unclotted blood in EDTA anticoagulant and clotted blood for serum harvest were 
obtained via jugular venipuncture from 35 of the 37 horses stabled in barn 38 on May 21, 
2005.  Two of the 37 horses were not available for sampling on this date as they had been 
transported to a referral equine hospital due to the development of CNS disease.  Blood 
samples which had been collected from these two animals just prior to May 21 by the 
attending veterinarian at Churchill Downs Racetrack were retrieved and included with the 
35 samples for diagnostic evaluation.    
 
 In order to rule out other infectious causes of equine CNS disease, the nine animals 
with neurological illness were evaluated for exposure to other infectious agents.  
Convalescent serum samples were obtained from these nine animals and submitted to the 
National Veterinary Services Laboratory (NVSL) in Ames, IA to test for the presence of 
antibodies to West Nile Virus (WNV), Venezuelan Equine Encephalomyelitis virus (VEE), 
Eastern Equine Encephalitis virus (EEE) and Western Equine Encephalomyelitis virus 
(WEE).  With reference to the two affected horses which were euthanized and considered 
presumptive cases of EHM, specimens of brain tissue were submitted to the state public 
health laboratory for rabies determination.   
 
 To document the cessation of viral shedding among affected animals, blood samples 
were collected at weekly intervals and evaluated by PCR assay. In order to contain financial 
costs of the investigation and to decrease the burden on laboratory personnel of performing 
multiple assays, the presence of EHV-1 specific DNA was limited to PCR testing of the 
samples of whole blood. Though not a requirement of the regulatory protocol, virus 
isolation was also attempted from peripheral blood mononuclear cells (PBMC) obtained 
from unclotted venous blood samples collected from horses on May 21, 2005.  In addition, 
serum neutralization (SN) antibody titers for EHV-1 were determined on blood samples 
collected at weekly intervals throughout the disease outbreak as a means of documenting 
recent exposure among the cohort of horses.  
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 ii. Murray State University, 2008 
 On April 14, 2008, nasal swabs, unclotted and clotted blood samples were collected 
from 36 of the 37 horses stabled in the student barn at Murray State University by state and 
federal regulatory personnel; the index horse was located off-site at the veterinary referral 
hospital at the time of the initial site visit and was not available for additional sampling. All 
of the horses were visually inspected for evidence of clinical illness at the time of specimen 
collection.  Nasal swab specimens for virus isolation were collected from each horse by 
placing a sterile 6” Dacron swab against the mucosal surface of the ventral meatus of one 
nostril.  Swabs were placed in individual tubes containing Brain Heart Infusion (BHI) broth 
for transport to the Breathitt Veterinary Center.  Swabs were maintained on wet-ice and 
delivered to the laboratory within four hours of specimen collection. BHI broth was used as 
transport medium because it was readily available, supplied to all Foreign Animal Disease 
Diagnosticians (FADD) as an all-purpose transport medium, and on the recommendation of 
NVSL and with the concurrence of Dr. Allen.  
 
 Blood specimens were collected from 36 horses located in the student barn on April 
22 for EHV-1 SN titer and PCR determination and on May 5 for PCR testing for EHV-1. 
 
 c. Laboratory techniques for EHV-1 determination 
 The presence of equine herpesvirus DNA was looked for in PBMC obtained from 
horses associated with each disease event through the use of a commercial kit designed to 
extract genomic DNA from blood leukocytes and, for the 37 horses at Churchill Downs  
including the index horse at Murray State University, conducted according to methods 
described by Allen and Breathnach, (2006) or, for the 36 remaining horses at Murray State 
University, through the use a standardized DNA extraction protocol (Breathitt Veterinary 
Center Laboratory DNA SOP 0011, 2008).  All samples were examined for both EHV-1 
and EHV-4 using a multiplex PCR assay designed to target the glycoprotein H (gH) gene of 
EHV-1 and the glycoprotein B (gB) gene of EHV-4 (Varrasso et al., 2001).  The 
determination of the genotype of the EHV-1 strain associated with EHM cases for each 
outbreak were based on an allelic discrimination PCR assay which used primers specifically 
designed to differentiate between a DNA polymerase gene expressing the G2, 254 genotype at 
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ORF 30 (neuropathogenic strain) versus one that expressing the A2,254 genotype at ORF 30 
(non-neuropathogenic strain).  The type-specific assay used to identify the strain of EHV-1 
circulating among horses at both locations was based on a sequence capture –nested PCR 
testing protocol (Allen, 2006). 
 
 Virus isolation was attempted from PBMC samples collected from horses at 
Churchill Downs on May 21, 2005 and from nasal swabs collected on April 14, 2008 from 
horses at Murray State University according to the methods of Allen, 2006 (OIE terrestrial 
manual, chapter 2.5.7).   
 
 Sera was harvested from all blood specimens collected from horses in each disease 
occurrence, either Churchill Downs or Murray State University, and checked for antibodies 
to EHV-1 to the Serum Neutralization (SN) test protocol (OIE terrestrial manual, chapter 
2.5.7).   
 
 d. Analytical procedures 
 i. Data management  
 Data were abstracted from questionnaires and laboratory reports and entered into an 
Excel® spreadsheet (Microsoft Corporation, Redmond, WA, USA) for storage and 
management. Data were analyzed using SAS for Windows, version 9.0 (SAS Institute, 
Cary, NC, USA), Epi Info version 5.0 (CDC, Atlanta GA, USA) and R, a language and 
environment for statistical computing and graphics (R Development Core Team 2009).   
 
 Data obtained during the two outbreak investigations was used primarily to facilitate 
regulatory compliance with testing protocols and the observance of isolation periods. 
Secondarily, the information was used to estimate through the use of statistical modeling, 
the date of disease onset for subclinically infected animals.  
 
 A uniform definition for a clinical case of EHV-1 or for a horse subclinically 
infected with EHV-1 was utilized for both outbreak investigations.  A clinical case of   
EHV-1 was defined as any equid residing at Churchill Downs Racetrack, Louisville, 
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Kentucky between May 9 and July 10, 2005 or which resided in the student barn at Murray 
State University research farm between January 1 and May 10, 2008 which displayed 
clinical signs consistent with EHV-1.  Diagnosis of a presenting clinical case of EHV-1 was 
confirmed by either a positive PCR test for EHV-1, or a serum neutralization (SN) titer to 
EHV-1 of  >1:256 on at least one serum sample or a fourfold or greater increase in titer 
between paired samples collected during the course of the investigation.  The use of a SN 
titer > 1:256 in a single sample when coupled with clinical illness is considered indicative 
of recent exposure and has been used by others investigators to identify cases of EHV-1 
(Friday et al., 2000). 
 
 An inapparent or subclinically infected horse is defined as any equid residing at 
Churchill Downs Racetrack between May 9 and July 10, 2005 or which resided in the 
student barn at Murray State University research farm between January 1 and May 10, 2008 
which did not display clinical signs consistent with infection with EHV-1 but which had 
either a positive PCR test for EHV-1 or SN titer to EHV-1 of  >1:256 on at least one serum 
sample or a fourfold or greater increase in titer between paired samples collected during the 
course of the investigation. For epidemiological and modeling building purposes, clinical 
and subclinical cases were collectively considered infected and designated as a case of 
EHV-1.   
 
The designation of a case of EHV-1 with a SN titer > 1:256 in a single sample in a 
horse that had not been vaccinated or that been vaccinated > 6 months prior against equine 
herpesvirus was based on the studies which have shown that protective immunity conferred 
by EHV-1 vaccination is short lived (Kydd et al., 2006).  For this study, the determination 
of a case of EHV-1 is a population based designation used for epidemiological purposes and 
is not intended as a basis for individual animal diagnosis. A broad but uniform case 
definition allows for inclusion of an expanded number of cases linked by a common cause 
and is consistent with the intent and purpose of case definitions in public health 
investigations such that not all cases of disease need to be laboratory confirmed (Sacks, 
1985; CDC, 1990; Heymann, 2004).  For each disease event, a case was excluded if an 
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alternative laboratory diagnosis was a more likely cause of the signs exhibited by clinically 
affected animals. 
 
 Horses were considered to be clinically affected with EHV-1 if they had a fever 
greater than 101.5°F or other signs characteristic of EHV-1 infection (ataxia, depression, 
paralysis, decreased tail tone, urinary incontinence, and respiratory disease).  A fever 
(elevated temperature) was defined as a rectal temperature equal to or greater than 101.5°F 
on at least one occurrence during the disease event.  The designation of 101.5°F as a 
threshold temperature for a fever is consistent with other investigators (Friday et al., 2000; 
Goehring et al., 2006; Marenzoni et al., 2008; Wilsterman et al., 2011) who used 38.5°C 
(101.3°F) as the diagnostic criteria for defining an elevated temperature for horses infected 
with EHV-1.  For horses with CNS disease, a grading system developed by the American 
Association of Equine Practitioners was used to assess lameness (AAEP, 2011).  The AAEP 
lameness scale ranges from 0 to 5, with 0 being no perceptible lameness and horses 
classified as a 5 are most severely affected. Specifically, Grade 1, Grade 2 and Grade 3 
exhibited, respectively, mild, moderate or severe ataxia, paresis and/or gait deficits which 
worsened with manual manipulation. Horses which stumble or fall at normal gaits are Grade 
4 and recumbent horses are Grade 5.  The date of onset of clinical signs was defined as the 
first day when the horse was reported with at least one of the listed signs: fever, cough, 
nasal discharge, ataxia, paresis, etc. 
 
 Simple descriptive and categorical statistical approaches were used to examine the 
characteristics of the two cohorts under investigation and to calculate the frequency, range 
and severity of clinical signs by age, gender, and breed.  Univariate associations between 
categorical variables and illness were determined using chi-square analysis for trend and, 
for a comparison of age structure between cohorts, by the use of a t-test, assuming unequal 
variance (Welch, 1947; Ruxton, 2006).  
 
 ii. Multivariate linear regression methods 
 Multivariate linear regression methods were applied to data obtained in the course of 
each outbreak investigation. The date of clinical onset for horses with overt clinical signs 
 39
was obtained directly from completed questionnaires and, for those subclinically affected, 
the date of onset determined by the use of linear regression methods applied to survey and 
laboratory data.  For horses with a known onset date, the date was recoded to the 
corresponding Julian calendar date and treated as a continuous outcome variable.  A 
forward step-wise automated variable selection process was used to select, depending on the 
specific disease event, from a set of five to ten possible explanatory variables for inclusion 
into the regression models.  Final model selection was based on identifying a significant 
regression model (p < 0.05) with the lowest calculated AIC value of the models being 
evaluated (Sauerbrei et al., 2007).  For the Churchill Downs event, variables evaluated for 
inclusion in the model included age, breed, gender, stall number, assigned groom, state of 
origin and results of laboratory testing. Data elements used for model building for the 
Murray State University event included variables that described horses with respect to 
individual characteristics, time, place and contact between co-located horses.  Co-variates 
used in the model included stall number, age, breed, gender, laboratory results, vaccination 
history, geographic origins, length of time at current location, recent travel and training 
associations with other horses residing within the facility.  A listing and description of the 
variables used for regression analysis whereby the date of onset of EHV-1 illness was 
estimated are provided in Table 2.1. 
 
An over-all model fit for each of the regression models built for the separate events 
was evaluated using residual analysis which included a visual inspection of diagnostic plots 
of residuals. Multicollinearity (overly high correlation among independent variables) was  
evaluated by calculating a variance inflation factor (VIF) for pair-wise comparisons of the 
variables selected for inclusion into the model.  Multicollinearity was not considered to be 
significant for VIF values < 4.0 for any pair-wise comparison. Diagnostic evaluation of the 
regression models was undertaken for the purpose of determining whether the data met the 
assumptions of normal distributed data and whether linear regression methods were an 
appropriate statistical procedure for analyzing the data. To assess the sensitivity of the 
regression models for observed dates of illness onset, consecutive iterations of the final 
models were run after removing a single observation (horse) from the analysis.  Models  
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Table 2.1. Description of variables used for regression analysis whereby date of illness 
onset was estimated. 
 
Variable 
 
Designation  
 
Definition 
  
Churchill Downs   
Groom Continuous (1-10) Numerical designation of groom responsible for 
daily husbandry duties 
Age Continuous (2-11) Year of age of horse 
Gender   1- male (intact/geldings) 
  2- female 
Gender of horse 
Stall Continuous (1-37) Stall number where horses is stabled 
 
State Categorical (1-5) State of origin for each horse 
1- Arkansas/New York 2- Florida, 3- Louisiana,   
4- Texas, 5- Kentucky 
Date  Julian calendar date Date horses arrived in Kentucky 
 
NS No – 0   Yes – 1 Development of CNS  
 
PCR Negative – 0     
Positive – 1 
Result of PCR testing on any sample collected 
during course of investigation 
   
Murray State University   
Stall Continuous (1-37) Stall number where horses is stabled 
   
Area Categorical (1-3) Location in barn with respect to occupying an 
interior, exterior, or outer facing stall 
Breed Categorical (1-3) 1-Quarterhorse 
2-Thoroughbred 
3- Other (Arab, Paint, Appaloosa, Tennessee 
Walker, Sport horse) 
Gender  1- male (intact/geldings) 
 2- female 
Gender of horse 
Age Continuous (.17-22) Year of age of horse 
 
PCR Negative – 0 
Positive – 1 
Result of PCR testing on any sample collected 
during course of investigation 
 
EverVAC No – 0     Yes – 1 Has horse ever been vaccinated for EHV-1 
RecVAC No – 0     Yes – 1 Has horse been vaccinated for EHV-1 recently        
(within year but > 6 months ago)    
  
FreqAssist 1- minimal 
2- medium 
3- frequent 
Frequency that owner provided assistance to 
other horses owners for care and feeding 
 41
were evaluated for their level of significance based on the absence of a single animal with a 
documented date of illness onset.  If the removal of an individual horse produced a majority 
of non-significant models, then the predicted date of illness onset was used for further 
analysis including survival and mathematical modeling instead of the observed date of 
illness onset.  Both outbreaks were treated similarly with respect to the use of a date of 
illness onset such that, if one outbreak utilized the predicted date, then the other outbreak 
used the predicted date.  Estimates obtained for the predicted date of illness onset through 
regression modeling were rounded to the nearest whole day.    
 
 iii. Survival analysis 
 Survival for horses within each cohort was estimated by K-M methods using the 
predicted date of illness onset derived through regression methods.  Life-tables were 
constructed using K-M methods for each disease event based on the predicted date of 
disease onset with dates being recoded as a time interval starting with the first case as day 
one. The probability of escaping infection was displayed graphically as a survival curve and 
the median survival function calculated for each separate disease event.  
 
 Survival curves were compared between  outbreaks with respect to the duration and 
magnitude of the outbreak and their median survival times. The log-rank test was used to 
compare the time to infection  (survival time) for each equine cohort. The two-sided 
probability value was set to 0.05 
 
 iv. Mathematical modeling  
 An estimate for R0 was obtained for each disease event location using the methods 
described by Anderson and May (1991).  There are relatively few published estimates for 
the duration of viral shedding for EHV-1 based on virus isolation(Allen et al., 1999; Allen, 
2002b; Allen and Bryans –unpublished data, 1986; Goodman et al., 2006; Allen and 
Breathnach, 2006; Pusterla et al., 2010; Goehring et al., 2010; Burgess et al., 2012) as most 
researchers have focused on determining the duration and magnitude of viremia caused by 
herpesviruses instead of quantifying the amount of infective virus shed in respiratory 
secretions of infected animals. This avenue of research is not unexpected since elimination 
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of the viremia induced by EHV-1 is key to preventing clinical cases and essential to the 
identification and development of candidate efficacious vaccines. In general, mature horses 
have a shorter duration of viremia and shed EHV-1 for shorter periods of time than young 
naïve horses, regardless of whether the strain expresses the ORF30G2,254 genotype or the 
ORF30 A2,254 genotype (Allen and Bryans –unpublished data, 1986; Goodman et al., 2006; 
Allen, 2008).  Subsequently, a value of four days was used as the duration of viral shedding 
for the Churchill Downs event where neurologic disease predominated and seven days for 
the Murray State University event where respiratory illness was the predominant clinical 
sign. These values were then used to calculate the R0 and the effective reproductive number 
(Re) for the respective outbreaks.  
 
For each disease event, the effective reproductive number (Re) was calculated for 
each incident case and graphically displayed as a curve. Estimates for Re, the generation 
time, and the proportion and temporal pattern of asymptomatic infection occurring within 
each cohort were calculated using methods described earlier (see Appendices E through H).  
 
Because the prodromal period for EHV-1 is relatively short and estimated to be 
between 12-24 hours (Ostlund, 1992), analysis of EHV-1 outbreak data obtained for this 
study is limited to quantifying asymptomatic spread within the equine cohorts under 
investigation. Therefore, further analysis of outbreak data obtained from this study is 
limited to quantifying asymptomatic infection only and the evaluation of disease spread that 
occurs specifically within the prodromal period will not be undertaken.      
 
A simple deterministic Reed-Frost chain binomial (state transition) model was 
constructed for each outbreak using methods described elsewhere (Carpenter, 1984).  The 
models were created using a spreadsheet matrix in Excel® and consisted of three states: 
susceptible (S), infectious (I) and recovered (R) and one probability: probability of effective 
contact (p).  For the purposes of mathematical modeling, the recovered or immune class 
consists of individuals who are no longer acutely infected with a pathogen, who would not 
contribute to the infectious process and are incapable of transmitting infection (Vynnycky 
and White, 2010).  For the final Reed-Frost models, the value for (k) - the number of 
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effective contacts made by an individual during the time period (t) used to calculate (p) - 
was used to optimize the fit between the predicted and observed incidence in each disease 
event by using the Solver add-in for the Excel® spreadsheet (Wahlström, et al., 1998).  
 
 A baseline or initial Herd Immunity (HI) level was calculated for each event 
(Appendix I) using the methods described by Fine (1993), with the values interpreted as the 
cohort-level immunity threshold needed for disease elimination.  To evaluate the effects of 
prophylactic vaccination on the duration and the cumulative number of EHV-1 cases that 
occurred in each outbreak, different levels of herd immunity were incorporated into the 
Reed-Frost model for each disease event by decreasing the probability of an adequate 
contact (1-qct) by an amount equal to the corresponding increase in herd immunity. 
Consequently, individual models for each outbreak and their corresponding epidemic curves 
were constructed by increasing the herd immunity level above the initial baseline by 10%, 
25%, 50%, 75% and 90%.  Since we are assuming that vaccine is given to every horse, the 
results from the models are, in essence, a reflection of vaccine efficacy.  
 
A single graphic plot was used to visually compare and contrast the epidemic curves 
for the various levels of herd immunity within each equine cohort.   
 
 A summary of the software code used for this study is provided in Appendix J. 
 
 
 
 
 
 
 
 
 
 
Copyright © Barry Jay Meade 2012  
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CHAPTER THREE 
RESULTS 
 
A. Descriptive comparisons of outbreaks 
 A total of 37 horses, considered at risk of acquiring EHV-1 infection, were stabled 
in barn 38 at Churchill Downs Racetrack during the EHV-1 event. None of the horses in this 
barn had been vaccinated against equine herpesvirus 1 or 4 during the six-month period 
preceding the recognition of the first cases of CNS disease in this cohort.  Of the 37 horses 
located within this barn, 34 (91.9%) met the case definition for being infected with EHV-1 
(Appendices C and D).   
 
 Of the 37 horses stabled in the student barn at the Murray State University research 
farm, 35 were considered at risk for infection. Two of the 37 horses at Murray State 
University were not considered at risk as they had been immunized immediately prior to the 
beginning of the EHV-1 incident. Their exclusion from the analysis is supported by their 
lack of clinical signs and because neither of these two horses was PCR positive on repetitive 
sampling or demonstrated a change in antibody titer over the course of the investigation. Of 
the 35 horses considered at risk for infection, 30 (85.7%) met the definition of an EHV-1 
case (Appendices C and D). 
 
 A summary of the diagnostic testing and occurrence of clinical illness for the two 
disease outbreaks is presented in Table 3.1 and is inclusive of horses on both premises that 
were determined to be at risk of acquiring EHV-1.  For horses at Churchill Downs, all PCR 
tests were conducted using methods described by Allen and Breathnach (2006), and, for 
those which were positive, are reflective of the occurrence an EHV-1 strain that expresses 
G2,254 genotype at ORF 30 (neuropathogenic variant).  For Murray State University, only the 
index horse was tested using these methods with remaining horses at Murray State 
University being tested using methods which could distinguish between EHV-1 and EHV-4 
only.     
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Table 3.1.  Comparison of diagnostic testing and clinical presentation for each 
separate EHV-1 disease event – Churchill Downs Racetrack, 2005 and Murray State 
University, 2008 
  Horses with specific signs and/or laboratory 
result by outbreak location 
Assay/clinical feature (s)  Churchill Downs Murray State University 
  Number (%) Number (%) 
    
PCR  positive  9/37 (24.3) 16/35 (45.7) 
Serologic positivea  30/37 (81.1) 15/35 (42.8) 
Fever (>101.5°F)  15/37 (40.5) 0 
Respiratory illness  0 18/35 (48.6) 
Neurological illness  9/37 (24.3) 3/35 (8.6) 
Fever w/ positive PCR   7/15 (46.7) 0 
Fever w/ positive serology  14/15 (93.3) 0 
Fever w/ neurological illnessb  7/15 (46.7) 0 
Respiratory illness w/ neurological illness  0 1/18 (5.5) 
Respiratory illness w/ positive PCR  0 11/18 (61.1) 
Respiratory illness w/ positive serology  0 5/18 (27.8) 
Fever or PCR positive  17/37 (45.9) 16/35 (45.7) 
Fever or serologically positive  34/37 (91.9) 15/35 (42.9) 
Fever or neurological illness  17/37 (45.9) 3/35 (8.6) 
Respiratory illness or neurological illness  9/37 (24.3) 20/35 (57.1) 
Respiratory illness or PCR positive  9/37 (24.3) 30/35 (85.7) 
Respiratory illness or serologic positive 30/37 (81.1) 26/35 (78.8) 
aSerological positive is defined as an SN titer to EHV-1 of >1:256 on at least one serum 
sample or a fourfold change (increase or decrease) in titer on paired samples  
bOdds ratio (Fisher exact) 8.75; 95% CI (1.22, 97.3), p-value = 0.017 
 
 Of the 15 horses at Churchill Downs Racetrack that developed fever, only one 
animal did not demonstrate a significant change in antibody titer even though this horse was 
diagnosed with neurological illness. All nine PCR positive horses were also serologically 
positive; seven (78%) had fevers but only four (44%) of the nine PCR positive animals with 
fever were diagnosed with neurological illness.  The odds for developing EHM were 8.75 
times greater for febrile horses compared to afebrile horses. In reference to the nine horses 
which presented with neurologic illness, all were negative for WNV, EEE, and WEE based 
on testing conducted at NVSL.  The rapid onset of illness, presence of clinical disease in 
older horses and the occurrence of multiple cases on a given premise suggest that protozoal 
myeloencephalitis or non-infectious causes of neurologic disease such cervical stenotic 
myelopathy, cervical instability, or trauma were not responsible for these outbreaks. Rabies 
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had been ruled out based on negative results on brain specimens collected from the two 
index cases at Churchill Downs and recovery of the affected horses. Of these nine 
neurological horses, seven were judged to have mild ataxia (grade I), one exhibited a 
moderate ataxia (grade III) and one had a severe gait deficit (grade IV).  Overall, 34 animals 
had at least two of the clinical or diagnostic consistent with cases of EHV-1 cases.   
 
 Of the 18 horses stabled at Murray State University with owner-reported signs of 
respiratory illness, eleven (61.1%) were PCR positive and 5 (27.8%) demonstrated either a 
fourfold or greater increase in SN titer or had a SN titer >1:256 between paired sera on at 
least one blood specimen collected over the course of the investigation.  Of the eleven PCR 
positive horses with respiratory illness, only two (18.2%) were also serologically positive.  
Of the three animals with neurological signs, only one was reported to have had respiratory 
illness and two were PCR positive.  For the 18 horses with respiratory illness, a date for 
onset of clinical signs was provided by the owner for 16 (89.9%) horses.  Clinically, horses 
were described most commonly by their owners as having a mild to moderate serous nasal 
discharge of greater than two-day duration.  Five of the horses developed a cough but none 
were reported to have a decrease in appetite.  Seventy-eight percent (14/18) of the horses 
with respiratory illness were also positive on PCR or were classified as positive for EHV-1 
in the SN test. To rule out EAV as a possible cause of respiratory illness for horses within 
this equine cohort, serum samples were tested for the presence of antibodies to EAV in the 
SN test.  Of the blood specimens collected during the course of the investigation, serum 
samples collected at the beginning of the investigation were available for testing from 16 of 
the 18 horses with respiratory illness; all were negative to EAV.  To rule out Equine 
Influenza (EI) as a cause of the respiratory illness, these same 16 samples were also tested 
using a recently developed PCR assay; all were negative to EI.  Four animals with 
respiratory illness did not have an SN titer to EHV-1 of >1:256 on at least one serum 
sample or have a fourfold or greater increase in titer between paired samples and were not 
PCR positive.  However, they were included as cases of EHV-1 based on the demonstration 
of respiratory illness which occurred within the time interval of interest, were stabled in 
association with other EHV-1 positive cases, lacked a history of recent immunization 
against EHV-1 (no vaccine > 6 months) and were negative for EAV antibodies and EI 
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nucleic acid.  Overall, 30 animals met the definition for a case of EHV-1.  A comparison of 
case-animals by breed, age and gender by outbreak location is presented in Table 3.2. In 
general, the horses at Churchill Downs Racetrack and Murray State University student barn 
were similar with respect to breed and gender but the horses located in the student barn at 
Murray State University were significantly older (p < 0.001), double the ages of the horses 
at Churchill Downs Racetrack.  Gender was not associated with an increased risk of EHV-1 
infection for Churchill Downs Racetrack (odds ratio, 1.78; 95% CI 0.8, 11.34) or the 
Murray State University facility (odds ratio, 1.76; 95% CI 0.04, 5.25) or for both events 
combined (odds ratio 1.21; 95% CI 0.2, 7.07).    
 
Table 3.2.  Characteristics of case and non-case horses – Churchill Downs Racetrack, 
2005 and Murray State University, 2008 
 Outbreak location 
Characteristics Churchill Downsb Murray State Universityc 
 Cases Non-cases Total   Cases Non-cases Total 
Breed       
   Thoroughbred 33 3    36   22 1 23 
   Quarter-horse 1 0      1   3 3 6 
   Other  0 0      0   5 1 6 
   Total 34 3    37   30 5 35 
       
Mean age (years)a 3.8 2.7   3.7    7.7 9.6 7.5 
       
Genderd       
   Male (colt/gelding) 18 2    20    17 2 19 
   Female (mare/filly) 16 1    17    13 3 16 
   Total 34 3    37    30 5 35 
       
a Welch two-tailed t-test for groups with unequal sample size and unequal variance. t = 4.15 
with 43 df; 95% CI (1.935, 5.585), p-value < 0.001 
b Odds ratio (Fisher exact) 1.78; 95% CI (0.8, 111.34), p-value = 1.0  
c Odds ratio (Fisher exact) 1.96; 95% CI (0.19, 26.23), p-value = .642  
d Odds ratio (Fisher exact) 1.21; 95% CI (0.2, 7.07), p-value = 1.0  
 
A summary of a few standard epidemiological measures of disease occurrence for 
the two outbreaks are presented in Table 3.3.  An overall attack rate of 91.9% and 85.7% for 
the occurrence of EHV-1 infection was calculated for the Churchill Downs and Murray 
State University outbreaks, respectively. Though the attack rate among horses at Churchill  
 48
Table 3.3.  Measures of disease occurrence – comparisons between EHV-1 outbreaks 
at Churchill Downs Racetrack, 2005 and Murray State University, 2008  
 Outbreak location 
Epidemiologic measure of interest Churchill Downs Murray State 
University 
   
aAttack rate 
(%) 
Number of EHV-1  
case horses          
Number horses on premises 
 
34/37 (91.9) 
 
30/35  (85.7) 
   
b Clinical 
attack rate 
(%) 
Number horses with EHV-1    
compatible illness 
Number of case horses  
 
17/34 (50.0) 
 
20/30 (66.7) 
   
Case-fatality rate (%) 0c 0 
    
dAge and clinical sign-specific morbidity 
(fever, CNS or respiratory illness) 
e Odds ratio  
(relative to baseline) 
f Odds ratio  
(relative to baseline) 
            < 2 yrs of age 1.0 1.0 
               3 yrs of age 0.34 0.11 
               4-5 yrs of age 0.19 0.44 
            > 6 yrs of age 0.0 0.22 
   
a Odds ratio 1.73; 95% CI (0.57, 5.33), p-value =  0.28  
b Odds ratio 2.19; 95% CI (0.71, 6.79), p-value = 0.12
c The index cases at Churchill Downs which were euthanized due to complications of EHM 
did not reside in barn 38 and were not included in totals for data analysis.  
d Morbidity based on the occurrence of fever in horses at Churchill Downs and respiratory 
illness in horses at Murray State University 
e Chi-square for linear trend 4.94; p-value = 0.026 
f Chi-square for linear trend 0.724, p-value = 0.395 
 
Downs was greater than for those at Murray State University, these indices did not differ 
statistically (p-value = 0.84).  Of the 35 horses stabled in the student barn at Murray State 
University which were at risk of acquiring EHV-1 infection, a larger proportion were 
symptomatic (57.4% versus 44.1%) compared with the horses stabled at Churchill Downs 
Racetrack.  None of the horses within the defined cohorts, stabled in barn 38 at Churchill 
Downs Racetrack or the student barn at Murray State University, died during their 
respective disease events and no horses at Churchill Downs Racetrack developed respiratory 
illness. The two horses at Churchill Downs that were the first to be diagnosed with EHM 
and, subsequently euthanized, were not housed in barn 38 and therefore were excluded as 
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members of the cohort of animals used for statistical or mathematical modeling. The 
significance of these two horses to the study is that they served as sentinels for the events to 
follow; although they were seronegative for EHV-1 at the time of clinical onset, they were 
positive to EHV-1 by PCR.   
 
For horses at Churchill Downs Racetrack, there was an age related trend (Chi-square 
for linear trend 4.94; p-value = 0.026) for the occurrence of fever in so far as older horses 
were found to be less likely to develop fever following exposure to the particular strain of 
EHV-1 circulating within the population than were younger horses.   
 
 Conversely, there was no age related difference in the occurrence of respiratory 
illness among horses at Murray State University (Chi-square for linear trend 0.724, p-value 
= 0.395).  Of the three horses at Murray State University with neurological signs, one was a 
14-year-old gelding with a severe gait deficit (grade III), one was a 14-year-old gelding with 
stiff rear limb gait (grade I) and the other animal was a 3-year-old filly with mild ataxia 
(grade I). The neurological status for these three horses was determined by a veterinarian 
and only the 14-year-old gelding with the grade I lameness was noted to have an underlying 
medical condition – a sole abscess – at the time that CNS signs were observed; this animal 
also exhibited respiratory signs.         
 
B. Statistical modeling – determination of the date of illness onset for subclinical cases 
 1. Churchill Downs Racetrack, 2005 
 a. Exploratory data analysis    
 Summary statistics for three continuous covariates, abstracted from completed 
survey questionnaires used to obtain information on individual horses stabled at Churchill 
Downs Racetrack, are presented in Table 3.4.  Overall, 10 grooms provided care for 37 
horses whose age distribution is skewed toward younger animals.  
 
With respect to the 17 horses at Churchill Downs with a documented date of onset of 
clinical signs, either fever or neurological, a summary listing for the continuous covariates 
is presented in Table 3.5.  For these horses, the distribution of stall numbers is similar to the 
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values in Table 3.4 but the numerical values for groom designation and the age of horses 
have a smaller range. An examination of the data for the presence of outliers did not reveal 
any data values 1.5 times the interquartile range above the 3rd or below the 1st quartile.  
 
Table 3.4. Summary statistics of three continuous variables for all horses stabled in 
barn 38 – Churchill Downs Racetrack, 2005     
Measure Stall Number Groom Age 
Minimum 1 1 2.0 
1st Quartile 10 2 2.0 
Median 19 8 3.0 
Mean 19 4.7 3.7 
3rd  Quartile 28 7 4.0 
Maximum 37 10 11.0 
 
In the case of the 17 horses that developed fever and/or neurological signs, the first 
clinical case was recognized on May 5 and the last on May 13, an interval of eight days. 
 
Table 3.5. Summary statistics for response variable and three potential continuous 
predictor covariates for symptomatic horses, fever or CNS – Churchill Downs 
Racetrack, 2005     
Measure  Julian calendar date of  
the onset of clinical cases 
(actual date) 
Stall 
Number 
Groom Age 
Minimum  125.0 (5/5/05) 1.0 1.0 2.0 
1st Quartile  127.0 (5/7/05) 9.5 2.5 2.0 
Median  128.0 (5/8/05) 15.0 4.0 3.0 
Mean  128.6 (5/8/05) 16.7 3.1 3.1 
3rd  Quartile   130.5 (5/10/05) 24.5 4.0 3.5 
Maximum   133.0 (5/13/05)  36.0 4.0 6.0 
 
b. Multivariate linear regression  
 With respect to the Churchill Downs outbreak, the step-wise model selection process 
identified a multiple linear regression model with the lowest AIC value that included only 
groom and age as variables in the final model.   The automated model selection process 
originally included the variable stall in a model with the lowest AIC value. However, the 
VIF value for the pairwise comparison for the variables stall and groom exceeded 2.5, 
suggesting that multicollinearity – the occurrence of highly correlated variables – would be 
an issue should both stall and groom be included in the final model. This was remedied by 
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dropping the variable stall from the final model. Table 3.6 depicts the covariates in the final 
regression model with corresponding estimates and significance levels of their partial 
contributions to the model. Overall, this model was considered statistically significant with 
a p-value of 0.0262.  
 
Table 3.6.  Main effects model for date of illness onset – Churchill Downs Racetrack, 
2005  
Covariates Model 
parameter 
Beta 
estimate 
Std. dev. 
 
95% Confidence intervals 
Intercept Β0 124.733 1.9889 (120.467, 128.999) 
Groom Β1 0.03553 0.2392 (-0.478, 0.549) 
Age Β2 1.3354** 0.4319 (0.409, 2.262) 
Significance levels  >0.001***,  >0.01**,  > 0.05*  
Residual standard error: 2.481 on 14 degrees of freedom 
Multiple R-Squared: 0.4057, Adjusted R-squared: 0.321  
F-statistic: 4.779 on 2 and 14 df, p-value: 0.02617  
 
Graphic plots of the diagnostic plots for the final regression model are displayed in 
Figure 3.1.  For the plot of the model residuals, the points appear to be randomly 
distributed, supporting the assumptions of a zero mean and constant variance. The normal 
probability plot of the quantiles has a reasonable linear pattern with a slight departure from 
the fitted line at the tails of the plotted line which indicates more variance than would be 
expected in a completely normal distribution.  The histogram of the residuals is slightly 
skewed to the right. Visually, the pattern of the plotted points in the plot of the model 
residuals appear randomly distributed and would support an assumption of normal data.  
The VIF estimate for the pair-wise comparison between the variables groom and age was 
1.104.  Any departure from normality identified by the diagnostic plots is likely due to 
sparse data and would not prohibit the use of the final model for predictive modeling. 
  
 52
Figure 3.1. Plot of main effects model and diagnostic plots for final regression model – 
Churchill Downs Racetrack, 2005     
 
 
.    
 
An epidemic curve based on the predicted date of illness onset for all 34 cases of 
EHV-1 is presented in Figure 3.2.  With respect to the Churchill Downs Racetrack outbreak, 
the first EHV-1 case occurred on May 5 and the last on May 18: a period of 14 days.  The 
outbreak peaked at ten cases on May 6, eleven days before initiation of the regulatory 
response on May 17, 2005.     
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Figure 3.2.  Distribution of the number of cases of EHV-1 by date of illness onset, 
Churchill Downs Racetrack, 2005 
 
 
 The dates of disease onset for the EHV-1 cases which occurred on May 14 and May 
18 were determined by regression methods as these horses were subclinically infected. 
Although these horses did not have neurological signs, they met the case definition based on 
a positive PCR result on samples of PBMC.  Of note, the attending veterinarian initiated a 
14-day course of treatment with Acyclovir® beginning May 15 for all 37 horses stabled in 
barn 38 at Churchill Downs Racetrack.  Based on the estimated dates for disease onset, this 
therapy would have begun when only five horses in the cohort had not yet been exposed to 
EHV-1, of which two would eventually become EHV-1 cases.       
 
 2. Murray State University, 2008    
a. Exploratory data analysis  
Summary statistics for the continuous covariates abstracted from the survey 
questionnaires for the 35 horses considered at risk of acquiring EHV-1 are presented in 
Table 3.7.  Overall, the horses stabled in the student barn at Murray State University ranged 
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in age from 2 months to 22 years with an average age of 7.9 years.  With respect to the 18 
horses in the student barn at Murray State University with a documented date for the onset 
of respiratory signs or neurological illness, a summary of three continuous and four 
categorical covariates used in model building are presented in Table 3.8.  With the 
exception of a 22 year-old asymptomatic gelding, the horses at Murray State University 
with a defined date of illness onset are similar in age to the entire cohort.   An examination 
of the data for the presence of outliers did not reveal any data values 1.5 times the 
interquartile range above the 3rd or below the 1st quartile. 
 
Table 3.7. Summary statistics of two continuous variables for 35 horses at risk for 
EHV-1 infection stabled in the student barn – Murray State University, 2008   
Measure Stall number Age 
Minimum 2 .17 (2 months) 
1st Quartile 9.5 3.5 
Median 18 7.0 
Mean 18 7.9 
3rd  Quartile 26.5 12.5 
Maximum 60 22.0 
  
 
Table 3.8. Summary statistics for response variable and five potential predictor 
covariates for the 18 horses with a documented date for illness onset – Murray State 
University, 2008    
Measure Julian calendar date 
of onset  
of clinical cases 
(actual date) 
Stall Area Age Breed FreqAssit Gender 
Minimum 41.0 (3/2/05) 2 1.0 1.0 1.0 1.0 1.0 
1st Quartile 75.5 (3/24/05) 33.8 1.0 3.0 1.0 1.0 1.0 
Median 90.5 (4/5/05) 45 2.0 4.5 1.0 2.0 1.5 
Mean 89.6 (4/4/05) 39.7 1.8 6.9 1.6 2.1 1.5 
3rd  Quartile 105.0 (4/15/05) 53.5 2.0 12.0 2.0 3.0 2.0 
Maximum 128.0 (5/8/05)  60 3.0 15.0 3.0 3.0 2.0 
 
b. Multivariate linear regression  
 Similarly to the model selection process used for the Churchill Downs data, the 
initial model for the Murray State University outbreak started as a simple linear model with 
the variable stall included as the only covariate. Through the course of adding and 
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subtracting variables, the step-wise model selection process for multiple linear regression 
modeling identified several statistical models with low or comparable AIC values for 
consideration.  Diagnostic plots and VIF values were compared for these candidate models 
and a final model selected based on the overall data fit and on a visual examination of 
diagnostic plots.  The covariates for the final regression model with corresponding estimates 
and significance levels of their partial contributions to the model are shown in Table 3.9. 
Overall, this model had a p-value < 0.01.  
 
Table 3.9. Main effects model for date of illness onset – Murray State University, 2008 
Covariates Model 
parameter 
Beta 
 estimate 
Std. dev. 95% Confidence intervals 
Intercept Β0 180.3171*** 22.0990 (95.822, 210.491) 
Stall Β1 -0.5006 0.2618 (-1.359, 0.0669) 
Area Β2 -16.5779* 6.6816 (-31.418, 0.526) 
Breed Β3 -10.5956* 4.1244 (-18.214, 2.678) 
FreqAssist Β4 -11.8510* 4.0510 (-39.970, 0.332) 
Significance levels:  >0.001***,  >0.01**,  > 0.05*  
Residual standard error: 14.17 on 13 degrees of freedom 
Multiple R-Squared: 0.6652, Adjusted R-squared: 0.5621  
F-statistic:6.456 on 4 and 13 df, p-value: 0.004341  
 
Graphic plots of the main effects model and the accompanying diagnostic plots are 
displayed in Figure 3.3.  On examination, the plotted residuals appear to be randomly 
distributed and support the assumptions of a zero means and constant variance. Visually, the 
normal probability plot of the quantiles (Q-Q plot) and the histogram of the residuals 
suggest that the data approximate a normal distribution, though the tail of the Q-Q plot and 
the histogram of the residuals suggest that the data is skewed to the left.  The VIF estimates 
for all pair-wise comparisons of variables in the final model ranged between 1.0315 and 
2.1709 indicating a lack of multicollinearity among the variables. As with the Churchill 
Downs model, deviations from normalcy are likely due to sparse data and would not 
preclude the use of this model for predictive modeling.   
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Figure 3.3. Plot of main effects model and diagnostic plots for final regression model – 
Murray State University, 2008 
  
 
The epidemic curve for the 30 EHV-1 infected horses stabled at Murray State 
University is depicted in Figure 3.4. It shows that the outbreak began the week of March 1, 
2008 and lasted 9 weeks with the last cases occurring the week of April 26, 2008.  The 
curve demonstrates a biphasic peak in the number of cases with the beginning of the second 
peak occurring the week of April 5, 2008; a time period that corresponds to the initiation of 
the official regulatory response.  
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Figure 3.4.  Distribution of the number of cases of EHV-1 by week of illness onset, 
Murray State University, 2008 
 
 
 
C. Survival analysis 
 1. Churchill Downs Racetrack, 2005 
 A life table was constructed and used to estimate the survival distribution of horses 
stabled at Churchill Downs (Table 3.10). The S (ti) column gives the estimated survival 
function for the listed time intervals; these values are plotted in Figure 3.5.  None of the 37 
horses located in barn 38 at Churchill Downs Racetrack were lost to follow-up or censored 
prior to the end of the observational period.  From the K-M survival curve shown in Figure 
3.5, the estimated median time for horses to become an EHV-1 case was 3.1 days.  In total, 
three horses (8.1%) within this cohort escaped infection. 
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Table 3.10. Life table for horses located at Churchill Downs Racetrack, 2005a 
 Survival parameters 
Interval 
(ti) 
(n´i) (di) wi + li S(ti) 
1.0 37 1 0 0.9730 
1.3 36 1 0 0.9459 
1.4 35 1 0 0.9189 
1.7 34 1 0 0.8919 
1.8 33 2 0 0.8378 
2.0 31 1 0 0.8108 
2.1 30 3 0 0.7297 
2.2 27 2 0 0.6757 
2.3 25 1 0 0.6486 
2.5 24 2 0 0.5946 
2.9 22 3 0 0.5135 
3.1 19 1 0 0.4865 
3.4 18 1 0 0.4595 
3.6 17 2 0 0.4054 
3.9 15 2 0 0.3514 
4.0 13 1 0 0.3243 
5.1 12 1 0 0.2973 
5.2 11 1 0 0.2703 
5.3 10 1 0 0.2432 
5.5 9 1 0 0.2162 
6.5 8 2 0 0.1622 
6.9 6 1 0 0.1351 
10.8 5 1 0 0.1081 
13.4 4 1 0 0.0811 
14.0 3 3 0 0 
a Symbols: n´i, number of horses not infected  at beginning of interval; di, number of 
horses infected during interval;  wi + li ,number horses lost to follow-up during event;  
S(ti), cumulative proportion that avoided infection to end of interval 
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Figure 3.5. Kaplan-Meier plot for time to infection for horses located at 
Churchill Downs Racetrack, 2005 
 
Time to Infection (days) 
 
 2. Murray State University, 2008  
A life table was constructed and used to estimate the survival distribution of horses 
stabled at Murray State University (Table 3.11). The S (ti) column gives the estimated 
survival function for the listed time intervals; these values are plotted in Figure 3.6.   
 
With respect to the Murray State University outbreak, none of the 35 horses located 
in the student barn and considered at risk of EHV-1 infection were lost to follow-up or 
censored prior to the end of the observational period.  The K-M survival curve shown in 
Figure 3.6 provides an estimate of 29.8 days for the median survival time for EHV-1 
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infected horses. Ultimately, a total of five horses (14.3%) did not get exposed to EHV-1 and 
become infected over the course of the outbreak.   
 
Table 3.11. Life table for horses located at Murray State University, 2008a 
 Survival parameters 
Interval 
(ti) 
(n´i) (di) wi + li S(ti) 
1.0 35 1 0 0.971 
3.4 34 1 0 0.943 
12.6 33 1 0 0.914 
13.1 32 1 0 0.886 
14.2 31 1 0 0.857 
14.7 30 1 0 0.829 
15.2 28 2 0 0.800 
16.2 28 1 0 0.771 
23.1 27 1 0 0.743 
23.6 26 1 0 0.714 
23.7 25 1 0 0.686 
23.9 24 1 0 0.657 
24.7 23 1 0 0.629 
26.7 22 1 0 0.600 
28.8 21 1 0 0.571 
29.0 20 1 0 0.543 
29.8 19 1 0 0.514 
33.5 18 1 0 0.486 
35.3 17 1 0 0.457 
35.8 16 1 0 0.429 
36.3 15 1 0 0.400 
37.1 14 1 0 0.371 
37.4 13 1 0 0.343 
41.8 12 1 0 0.314 
41.9 11 1 0 0.286 
43.9 10 1 0 0.257 
52.1 9 1 0 0.229 
53.1 8 1 0 0.200 
55.9 7 1 0 0.171 
62.0 6 1 0 0.143 
63.0 5 0 0 0 
a Symbols: n´i, number of horses alive at beginning of interval; di, number of horses 
infected during interval;  wi + li ,number horses lost to follow-up during event;  S(ti),  
cumulative proportion surviving to end of interval 
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Median survival = 51 days 
Figure 3.6. Kaplan-Meier plot for time to infection for horses located at Murray State 
University, 2008  
 
Time to Infection (days) 
 
3. Comparison of survival between outbreak locations  
 The K-M survival curves estimated from the Churchill Downs and Murray State 
University data are displayed in Figure 3.7.  This graph, which incorporates both outbreak 
investigations, illustrates a survivor function for the Churchill Downs horses that 
consistently lies below the survivor function for the Murray State University horses.   
 
The log-rank statistic for the comparison of survival between equine cohorts is 20.6 
(p-value < 0.001) indicating that these groups have significantly different K-M survival 
patterns.  Horses stabled in the affected barn at Churchill Downs are at a 3.02 times greater 
risk for EHV-1 infection (p < 0.001) per day relative to horses stabled in the student barn at 
Murray State University (Table 3.12).  
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Figure 3.7.  Kaplan-Meier plots for horses during an EHV-1 event, Churchill Downs 
Racetrack versus Murray State University 
 
Time to Infection (Days) 
 
 
Table 3.12. Comparison of survival by location of disease event  
 
Location 
Number of 
events 
(Observed) 
Number of 
events 
(Expected) 
 
(O – E)2 /Ea 
Median 
time to infection 
in days 
 (95% CI)   
     
Churchill Downs 37 20.6 13.11 3.13  (2.3, 4.0) 
     
Murray State 
University 
35 51.4 5.25 29.8  (23.6, 36.3) 
     
aLog-rank test = 20.6 with 1 df, p-value <0.001; CI = Confidence interval. 
Hazard ratio (Infection ratio) = 3.02 with 71 df; 95% CI (1.84, 4.95), p-value < 0.001 
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D. Mathematical modeling 
 1. Comparison of transmission parameters  
Estimates of the basic R0 number, generational time, and the proportion of 
asymptomatic infection occurring within each cohort are presented in Table 3.13.   Using a 
mathematical formula that incorporates the duration of the infectious period for different 
EHV-1 neuropathogenic genotypes and the doubling time of initial cases, estimates of R0 
were 10.25 and 2.94 for the Churchill Downs and Murray State University outbreaks, 
respectively (appendix E).  Calculations of the generation time (Tg), based on estimates of 
R0 for each disease event, are 0.39 days for Churchill Downs EHV-1 cases and 2.38 days 
for Murray State University EHV-1 cases. Overall, the generation time for the Churchill 
Downs outbreak was 6.1 times shorter than the Murray State University event. 
 
Table 3.13. Comparison of transmission parameters between EHV-1 outbreaks  
  Outbreak location 
Transmission Parameter  Churchill Downs Murray State University 
    
aBasic reproductive number (R0)  10.25 2.94 
    
bGeneration time (Tg)  0.39 days 2.38 days 
    
c,dAsymptomatic transmission (θ)  17/34 (50.0%) 10/30 (33.3%) 
  e Odds ratio  
(relative to baseline) 
f Odds ratio  
(relative to baseline) 
1st Quartile  1.0 1.0 
2nd Quartile  1.2 .80 
3rd Quartile  3.2 .33 
4th Quartile  2.4  .29 
    
aAppendix E 
bAppendix G 
c Trend analysis for the proportion of asymptomatic infection occurring within each quartile
d Odds ratio 2.0; 95% CI (0.65, 6.27), p-value = 0.178
e Chi-square for linear trend 1.94; p-value = 0.163 
f Chi-square for linear trend 1.72, p-value = 0.190 
 
 
The ratio of symptomatic to asymptomatic infection for case-horses were different in 
magnitude for horses located at Churchill Downs (1:1) versus those located at Murray State 
University (2:1), though the difference was not statistically significant (Odds ratio = 1.82; 
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95% CI 0.73, 5.51).  A combined ratio of symptomatic to asymptomatic EHV-1 infection of 
(1.4:1) was calculated for both events without an observable trend for the occurrence of 
clinical cases.  
 
Figure 3.8 depicts the proportion of symptomatic to asymptomatic EHV-1 cases 
over the course of the outbreak for horses stabled at Churchill Downs Racetrack and, 
visually, appears that more asymptomatic cases occur later in the outbreak.  Based on a 
comparison of the quantiles of the occurrence of EHV-1 cases, the proportion of 
symptomatic to asymptomatically infected horses did not demonstrate a temporal 
association with the appearance of clinical signs (Chi-square for linear trend 1.94; p-value = 
0.163); suggesting that the occurrence of symptomatic infection within this population is 
constant over the course of the outbreak. 
 
Figure 3.8. Comparison of symptomatic and asymptomatic infection for Churchill 
Downs EHV-1 disease event, 2005
 
 
 
With respect to horses stabled at Murray State University (Figure 3.9), there does 
not appear to be a trend in the occurrence of asymptomatic illness, such that, as the outbreak 
progressed the proportion of horses which did not exhibit respiratory signs illness did not 
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demonstrate a temporal trend (Chi-square for linear trend 1.72, p-value = 0.190).  These 
results are similar to the Churchill Downs event and suggest that the occurrence of EHV-1 
disease in the form of respiratory illness is constant over the course of an outbreak.   
 
Figure 3.9. Comparison of symptomatic and asymptomatic infection for Murray State 
University EHV-1 disease event, 2008 
 
 
Overall, these transmission indices suggest that the EHV-1 outbreak at the Churchill 
Downs Racetrack produced a 3.6 (10.25 versus 2.94) times greater number of secondary 
cases per initial primary case, had a much shorter average generation interval between 
successive cases, with a larger proportion of asymptomatic infections than the Murray State 
University event. 
 
 2. The effective reproductive number, Re 
 a. Churchill Downs Racetrack, 2005 
 Estimates of the effective reproductive number for the Churchill Downs Racetrack 
event and a graph of this value as it changes over the course of the outbreak are presented in 
Table 3.14 and Figure 3.10.  The effective reproductive number decreases rapidly between 
the first and third day of the outbreak, then declines gradually over the remainder of the 
0
1
2
3
4
5
6
7
1 2 3 4 5 6 7 8 9 10
N
um
be
r 
of
  E
H
V
-1
 c
as
es
Week of EHV-1 onset
Asymptomatic infection
Symptomatic infection
 66
observation period.  Graphically, the effective reproductive number is shown to fall below 
the threshold value of one until after the 14th day of observation.     
 
Table 3.14.  Estimates of the effective reproductive number (Re) for Churchill Downs 
Racetrack EHV-1 event, 2005   
 
Time 
Number of 
susceptible 
horses 
Number 
of  
cases 
Cumulative 
cases 
Doubling 
time 
(days) 
Growth 
rate 
Effective 
reproductive number 
(Re) 
1 37 1 1 0 0 0 
1.3 36 1 2 0.29 2.324 10.25 
1.4 35 1 3 0.63 1.105 5.39 
1.7 34 1 4 1.01 0.685 3.72 
1.8 33 2 6 1.21 0.571 3.27 
2.0 31 1 7 0.99 0.699 3.78 
2.1 30 3 10 1.58 0.441 2.76 
2.2 27 2 12 1.12 0.362 3.46 
2.3 25 1 13 1.56 0.319 2.78 
2.5 24 2 15 1.92 0.346 2.44 
2.9 22 3 18 2.18 0.3 2.27 
3.1 19 1 19 2.01 0.346 2.38 
3.4 18 1 20 2.73 0.254 2.01 
3.6 17 2 22 2.83 0.245 1.98 
3.9 15 2 24 2.90 0.239 1.95 
4.0 13 1 25 2.99 0.233 1.93 
5.1 12 1 26 4.28 0.163 1.65 
5.2 11 1 27 4.21 0.165 1.66 
5.3 10 1 28 4.25 0.164 1.65 
5.5 9 1 29 4.49 0.155 1.62 
6.5 8 2 31 5.40 0.129 1.51 
6.9 6 1 32 5.35 0.130 1.52 
10.8 5 1 33 9.44 0.074 1.29 
13.4 4 1 34 11.30 0.061 1.24 
14.0 3 3 37 11.36 0.061 1.24 
15.0 3 0 37 0 0 0 
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Figure 3.10. Estimates for the parameter Re (effective reproductive number) for EHV-1 
infection occurring in the population of horses stabled at Churchill Downs Racetrack, 
2005  
 
 
 
 b. Murray State University, 2008 
Estimates of the effective reproductive number for the disease event in the Murray 
State University student barn as it changes over the course of the outbreak are presented in 
Table 3.15.  The effective reproductive number for the Murray State University outbreak 
shows a sharp decline over the first two weeks of the disease event and then gradually 
approaches a steady or endemic state for the remainder of the observational period.  The 
outbreak terminates after day 62 when the effective reproductive number fell below 1.0.  
 
The temporal pattern for the effective reproductive number (Re) is displayed in 
Figure 3.11 and is calculated as each incident case occurs. Graphically, the Re is shown to 
decrease sharply for the first 16 days before beginning a gradual reduction that remains only 
marginally above the threshold level of 1.0 for the last 28 days of the outbreak. 
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Table 3.15.  Estimates of the effective reproductive number (Re) for Murray State 
University EHV-1 event, 2008  
Time Number of 
susceptible 
horses 
Number 
of  
cases 
Cumulative 
cases 
Doubling 
time 
(days) 
Growth 
rate 
Effective 
reproductive number
(Re) 
1.0 35 1 1 0 0 0 
3.5 34 1 2 2.49 0.278 2.94 
12.6 33 1 3 10.39 0.067 1.47 
13.1 32 1 4  6.79 0.103 1.71 
14.2 31 1 5 8.56 0.081 1.57 
14.7 30 1 6 9.20 0.076 1.53 
15.2 28 2 7 9.96 0.069 1.49 
16.2 27 1 8 11.13 0.062 1.44 
23.1 26 1 9 18.03 0.039 1.27 
23.6 25 1 10 16.67 0.042 1.29 
23.7 24 1 11 16.87 0.041 1.29 
23.9 23 1 12 17.32 0.040 1.28 
24.7 22 1 13 18.21 0.038 1.27 
26.7 21 1 14 20.19 0.034 1.24 
28.8 20 1 15 21.93 0.032 1.22 
29.0 19 1 16 21.83 0.031 1.22 
29.8 18 1 17 26.35 0.026 1.21 
33.5 17 1 18 27.37 0.025 1.18 
35.3 16 1 19 27.61 0.025 1.18 
35.8 15 1 20 28.13 0.025 1.18 
36.3 14 1 21 28.92 0.024 1.17 
37.3 13 1 22 29.19 0.021 1.17 
41.8 12 1 23 33.64 0.021 1.14 
41.9 11 1 24 32.90 0.019 1.15 
43.9 10 1 25 34.99 0.016 1.14 
52.1 9 1 26 43.31 0.016 1.11 
53.1 8 1 27 42.29 0.015 1.11 
55.9 7 1 28 45.03 0.014 1.11 
61.9 6 1 29 50.57 0.014 1.09 
62.0 5 0 30 0 0 0 
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Figure 3.11. Estimates for the parameter Re (effective reproductive number) for EHV-1 
infection occurring in the population of horses stabled in the student barn at Murray 
State University, 2008 
 
 
 
 3. Deterministic modeling (SIR)   
 a. Reed-Frost models 
 i. Churchill Downs Racetrack, 2005 
Using methods described previously (Carpenter, 1984; Wahlström et al., 1998) a 
simple Reed-Frost model was constructed for the Churchill Downs Racetrack event.  The 
estimated distribution of the three disease states S, I and R and the transmission probabilities 
are presented in Table 3.16.  For this model, the number of effective contacts made during a 
time period (k) was determined by optimizing the number of observed cases with the 
expected number of cases by minimizing the value of the chi-square (Figure 3.12).  The 
probability of transmission (1 – qct) and the probability of avoiding effective contact (qct) 
are 0.936 and 0.06, respectively. 
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Table 3.16. Reed-Frost model for Churchill Downs Racetrack EHV-1 outbreak   
Time  
interval 
(t) 
Number  of 
cases  
(Ct) 
Number of 
susceptibles  
(St) 
Number of 
immunes 
(It) 
Total 
population 
N 
 
 
k 
 
 
qct  
 
 
(1 – qct) 
0 0 37 0 37 2.3 0.063 0.936 
1 1 36 0 37 2.3 0.063 0.936 
2 2 34 1 37 2.3 0.063 0.936 
3 5 29 3 37 2.3 0.063 0.936 
4 8 21 8 37 2.3 0.063 0.936 
5 9 13 18 37 2.3 0.063 0.936 
6 5 7 27 37 2.3 0.063 0.936 
7 2 5 30 37 2.3 0.063 0.936 
8 1 4 32 37 2.3 0.063 0.936 
9 0 4 33 37 2.3 0.063 0.936 
 
 
Figure 3.12.  Optimization of the fit of the observed and expected EHV-1 cases for 
horses located at Churchill Downs Racetrack, 2005 
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Estimates of the daily number of susceptible, infected (cases), and immune horses as 
they occurred over the course of the outbreak are shown in Figure 3.13.  The proportion of 
the horses that are infectious (cases) at any one time period approaches 25% of the total 
population on day five.  
 
Figure 3.13.  Reed-Frost model of EHV-1 outbreak among horses located at  
Churchill Downs Racetrack, 2005 
 
 
 ii. Murray State University, 2008 
The estimated distribution of the three disease states S, I and R and the transmission 
probabilities for the Murray State University event are shown in Table 3.17.  This model 
was treated similarly to the Churchill Downs model where the number of effective contacts 
made during a time period (k) was determined by optimizing the number of observed cases 
with the expected number by minimizing the chi-square value (Figure 3.14).  The 
probability of transmission (1 – qct) and the probability of avoiding effective contact (qct) 
are 0.953 and 0.057, respectively. 
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Table 3.17. Reed-Frost model for Murray State University EHV-1 outbreak   
Time  
interval 
(t) 
Number  of 
cases  
(Ct) 
Number of 
susceptibles  
(St) 
Number of 
immunes 
(It) 
Total 
population 
N 
 
 
k 
 
 
qct 
 
 
(1 – qct) 
0 0 35 0 35 2.04 0.059 0.941 
1 1 34 0 35 2.04 0.059 0.941 
2 2 32 1 35 2.04 0.059 0.941 
3 2 30 3 35 2.04 0.059 0.941 
4 3 27 5 35 2.04 0.059 0.941 
5 4 23 8 35 2.04 0.059 0.941 
6 4 19 12 35 2.04 0.059 0.941 
7 3 16 16 35 2.04 0.059 0.941 
8 2 13 20 35 2.04 0.059 0.941 
9 1 12 22 35 2.04 0.059 0.941 
10 1 11 23 35 2.04 0.059 0.941 
11 1 11 24 35 2.04 0.059 0.941 
12 0 11 24 35 2.04 0.059 0.941 
13 0 10 25 35 2.04 0.059 0.941 
 
 
Figure 3.14.  Optimization of the fit of the observed and expected EHV-1 cases for 
horses located at Murray State University, 2008
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 Estimates of the daily number of susceptible, infected (cases), and immune horses 
which occurred over the course of the outbreak are shown in Figure 3.15.  The proportion of 
the horses that are infectious (cases) at any one time period never exceeds 14% of the total 
population. 
 
Figure 3.15.  Reed-Frost model of the EHV-1 outbreak among horses located at 
Murray State University, 2008 
 
 
 
b. Evaluation of herd immunity (HI)  
 The minimum proportion of an equine population that needs to be effectively 
immunized in order to reduce the magnitude and duration of transmission of EHV-1 was 
estimated for the horses at Churchill Downs Racetrack and Murray State University student 
barn.  Based on the estimates of R0 calculated at the beginning of the two outbreaks (see 
Appendix F) and the duration of the infectious period for specific genotype of EHV-1 
(neuropathogenic versus non-neuropathogenic), values for herd immunity were calculated 
for each disease event.  For the Churchill Downs event, a threshold level of herd immunity 
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the horses at Murray State University need to be immunized with a fully protective vaccine 
to achieve a level of herd immunity that will reduce the transmission of the respiratory form 
of EHV-1 associated with this disease event.    
 
While these results are useful to compare the value of progression of disease among 
cohorts of horses affected with different genotypes of EHV-1, the calculations also illustrate 
a basic tenet of disease eradication and vaccine coverage, namely that, larger values of R0 
require a larger fraction of the population be immunized to eliminate transmission. 
 
Comparisons of various levels of prophylactic vaccination and, by extension, herd 
immunity, on the duration and magnitude of the Churchill Downs and the Murray State 
University outbreaks are presented in Figures 3.16 and 3.17.  
 
Figure 3.16.  Comparisons of increasing levels of herd immunity on the transmission of 
EHV-1 among horses located at Churchill Downs Racetrack, 2005  
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Figure 3.17.  Comparisons of increasing levels of herd immunity on the transmission of 
EHV-1 among horses located at Murray State University, 2008 
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For horses stabled at Churchill Downs, an increase in herd immunity above baseline 
(no vaccine) to 25% produced only a modest reduction in the total number of infected 
horses and the R0 value for this event from 9.45 to 7.07 (Table 3.18).  For outbreaks of 
EMH, the herd immunity level has to be above 90% in order to reduce R0 below 1.0 and 
effectively prevent transmission. By comparison, a herd immunity level below 50% would 
only marginally decrease R0 and the number of susceptible horses but not to a level that 
would prevent the occurrence or spread of EHV-1 within an EHM event.    
 
For horses stabled at Murray State University, an increase in the herd immunity 
level to 75% drastically reduced the total number of susceptible horses in this population 
and the transmission parameter R0 below the threshold value of one.  A herd immunity level 
of 90% is needed to prevent the transmission of EHV-1 within the Churchill Downs cohort. 
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Table 3.18. Comparison of the effects of varying levels of herd immunity on the 
burden and transmission of illness for each equine cohort  
Herd 
immunity  
level 
Outbreak 
location 
Probability of 
adequate 
contact per day 
(1-qct) 
Attack 
rate 
(%) 
Cases 
averted 
(%) 
aR0 
      
  Initial (No vaccine)     
Churchill Downs 0.0639 33/37 (89.2) 0 9.45 
Murray State 0.0086 30/35 (85.7) 0 2.09 
      
  10%      
Churchill Downs 0.0575 31/37 (83.8) 2 (6.1) 8.51 
Murray State 0.0077 28/35 (80.0) 2 (6.7) 1.89 
      
  25%      
Churchill Downs 0.0478 28/37 (75.6) 5 (15.2) 7.07 
Murray State 0.0064 23/35 (65.7) 7 (23.3) 1.57 
      
  50%      
Churchill Downs 0.0319 15/37 (40.5) 18 (54.5) 4.72 
Murray State 0.0042 9/35 (25.7) 21 (70.0) 1.03 
      
  75%      
Churchill Downs 0.0159 2/37 (5.4) 31 (93.9) 2.35 
Murray State 0.0021 2/35 (5.7) 33 (93.3) 0.51 
      
  90%      
Churchill Downs 0.0064 1/37 (2.7) 32 (96.9) 0.95 
Murray State 0.0009 1/35 (2.9) 34 (96.7) 0.22 
     
a Calculation of R0 is based on fitted data and the formula R0 = βND where β is the probability of adequate 
contact, D is the duration of infectiousness and N is the total population size. Values of 4 days and 7 days were 
used as the duration of infectiousness for Churchill Downs and Murray State University, respectively.  
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CHAPTER FOUR 
DISCUSSION  
    
The time and place of the onset of clinical illness as well as the type, frequency and 
timing of contact between cases and those still at risk are among the key observations upon 
which infectious disease research and control decisions depend (Fine, 2003).  Accordingly, 
the important features of this observational study are the use of statistical and mathematical  
modeling to estimate a date of illness onset for horses which are subclinically infected with 
EHV-1, estimation of the daily risk of acquiring EHV-1 infection for each disease event, the 
calculation and comparison of transmission parameters between equine cohorts, and 
examination of the impact of immunization on the theoretical spread of EHV-1 within 
cohorts exposed to herpesviruses with dramatically different transmission kinetics.   
 
The use of regression methods applied to survey data allowed for the construction of 
a statistical model to predict a date of illness onset for horses within each of the separate 
equine cohorts.  To my knowledge, this is the first study to use statistical modeling to 
estimate a date that inapparently or subclinically infected horses would have acquired a 
communicable/contagious disease.  The estimates of illness onset derived from this analysis 
allow for construction of an epidemic curve and an examination of the temporal pattern of 
occurrence of EHV-1 cases.  Visually, the epidemic curves for the outbreaks appear 
markedly different in the duration of infectious disease events. The curve for the Churchill 
Downs outbreak depicts an outbreak of very short duration which, for the most part, was 
over before any regulatory action was taken.  By comparison, the Murray State University 
epidemic curve shows that EHV-1 cases occurred over an extended interval with this 
outbreak lasting 4.5 times longer (9 weeks versus 14 days) than the Churchill Downs event.   
 
Confining animals increases the population density and effectively facilitates the 
spread of disease (Wahlström et al., 1998). The secondary peak in EHV-1 cases among 
horses at Murray State University during the week of April 5th is likely the result of the stop 
movement order issued by the Office of the Kentucky State Veterinarian. This regulatory 
action increased the contact between susceptible and infectious horses and facilitated the 
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spread of disease within this cohort.  For EHV-1 respiratory disease events of this type, 
simply preventing horses from freely moving off an affected premise is an effective 
intervention strategy which allows virus to cycle throughout the entire population until all 
horses are no longer communicable nor represent a risk to the general horse population. It is 
likely that this regulatory action imposed by the Office of the Kentucky State Veterinarian 
shortened the epidemic period of the outbreak by hastening the spread of virus within the 
cohort. 
 
The reason for the prolonged nature of the Murray State University event is 
speculative; it may be due in part to the quantity of virus shed in respiratory secretions by 
infectious horses such that smaller doses of virus require multiple interactions between an 
infected horse and a susceptible horse before an effective contact occurs.  Since these 
investigations were conducted primarily for regulatory purposes and with a need to limit 
costs, sampling was not conducted in a manner that allowed us to measure the magnitude or 
duration of nasal shedding of EHV-1 for horses within each equine cohort. However, 
researchers (Allen, 2002b; Kydd et al., 2006; Coombs et al., 2006) have shown that 
immunologically conditioned horses, exposed through natural infection or immunization, 
shed smaller amounts of virus in nasal secretions than younger horses which, theoretically, 
have had fewer past exposures to EHV-1.  Since horses at Murray State University were 
significantly older than the horses at Churchill Downs Racetrack, it seems likely that based 
on age alone, horses at Murray State University would be shedding smaller amounts of 
infectious virus. Ultimately, the lower volume of circulating virus would decrease the 
probability of an effective contact and lengthen the interval between cases.  
 
In this study, survival analysis was used to explore the relationship of time to 
infection for each equine cohort and to estimate the relative hazard (risk) of becoming an 
EHV-1 case.  The results highlight the dramatic differences in the survival function for 
horses located at the different venues and imply that, for an event characterized principally 
by the occurrence of neurological disease, there is a three times greater hazard (risk) per day 
for EHV-1 infection and a 9.5 times shorter median survival time compared to an event 
characterized principally by EHV-1 respiratory illness. In as much as these events were 
 79
investigated independently, it is not possible to construct a Cox proportional hazard model 
to examine or compare common risk factors across outbreaks.  While other researchers have 
examined animal-level risk factors for the development of neurologic disease (Allen, 2008; 
Burgess et al., 2012), studies designed to quantify the contribution of environmental and 
management factors to the occurrence of EHV-1 have yet to be undertaken.     
 
While the PCR assay has been used previously to identify the neuropathogenic 
subtype of EHV-1 circulating among horses in confined populations (Henninger et al., 
2007; Pusterla et al., 2009b), this study is the first to use this laboratory technique to 
characterize an equine disease event by the viral subtype circulating among comingled 
horses with the intent of developing mathematical models to quantify the transmission of 
EHV-1 in an outbreak setting.  For this study, the designation of an outbreak by its 
neuropathogenic subtype is based on the results of a type-specific EHV-1 PCR assay and is 
restricted solely to the calculation of the values for R0 and Re for each cohort. All other 
mathematical or statistical analyses were conducted independent of this laboratory 
distinction. While a positive PCR result is not predictive for EHM and generally 
overestimates the duration of viral shedding (Goodman et al., 2006; Goehring et al., 2010), 
this laboratory technique offers a rapid method to detect potentially infectious horses and 
can identify an end-point for the period of communicability. In the absence of newer 
diagnostic methods, it is likely that the volume of PCR testing for EHV-1 will increase as it 
gains wider clinical acceptance among veterinary practitioners. Therefore, it is incumbent 
upon us to compare and contrast outbreaks, not purely for purely theoretical reasons but 
rather to gain an appreciation of the transmission dynamics of different EHV-1 subtypes.   
 
The basic reproductive number - R0 is one of the most useful concepts in 
mathematical modeling of infectious diseases. Its threshold property provides criteria for 
developing policies to eliminate an infection from a population and it can forecast the 
magnitude of the effort required to achieve eradication. A variety of mathematical equations 
have been used to calculate R0 (Dietz, 1993), with the mathematical approach used by 
researchers based on the type, quantity and quality of data available for analysis.  For this 
observational study, estimates of R0 were obtained using two independent methods: from an 
 80
equation based on the initial rate of growth of the epidemic and with the aid of transmission 
parameters obtained by fitting a Reed-Frost model to the observed profile of EHV-1 cases.  
Based on the initial rate of growth, R0 was estimated to be 10.25 and 2.94, for Churchill 
Downs and Murray State, respectively.  By comparison, transmission parameters obtained 
from a Reed-Frost model estimated an R0 of 9.45 for Churchill Downs and 2.09 for Murray 
State University.  Overall, the estimates are comparable in magnitude and direction across 
outbreaks regardless of the method employed.  These findings illustrate the highly 
transmissible nature of the virus responsible for the Churchill Downs outbreak versus the 
Murray State University outbreak where, by comparison, the virus was moderately 
transmissible.  For reference, in human populations, published estimates of R0 for Smallpox 
and Influenza range from 3.5-6 and 3-4 respectively, while the range for Chickenpox is 10-
12 and Measles is 16-18 (Keeling and Rohani, 2008).  For equine populations, R0 for equine 
influenza has been estimated to be 10-18 (Glass et al., 2002) based on data obtained from an 
outbreak in New York in 1963 and 2-5 for horses located at a racetrack in Japan (Satou and 
Nishiura, 2006).  
 
There is a paucity of published studies defining the duration of viral shedding for 
EHV-1, particularly for neuropathogenic variants, for horses older than 2-years of age and 
for viral shedding which occurring in natural settings. At first glance, it appears that the 
estimates of 4 days for Churchill Downs and 7 days for Murray State University for the 
duration of viral shedding used to calculate R0 run counter to what would be expected 
intuitively based on studies which use PCR to measure the duration of viremia or quantify 
the number of viral DNA copies shed in nasal secretions of clinically affected horses. 
However, viremia is not the same immunologically as viral shedding and PCR is not a 
substitute for virus isolation as the presence of viral DNA estimated by PCR does not equate 
to infectious virus; estimates derived from the use of PCR methods generally overestimate 
the duration compared to those obtained by viral isolation. Furthermore, prior to the 
outbreak of EHM in Finley, Ohio (Henninger et al., 2007) and subsequent spread to the 
Ohio State University School of Veterinary Medicine (Kohn et al., 2006), conventional 
wisdom suggested that EHV-1 infected horses displaying neurologic signs were not 
communicable. Due to the compact nature of the epidemic curve, the short survival function 
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and the lack of respiratory illness among horses at Churchill Downs, we are certain that, on 
average, the duration of viral shedding was truncated for this population compared to horses 
at Murray State.  Moreover, the values for the duration of viral shedding used in this study 
are based on an outbreak investigation and an EHV-1 challenge study with an age 
appropriate cohort (Goodman et al., 2006; Burgess et al., 2012) or knowledge of EHV-1 
shedding patterns gained through years of research with EHV-1 (personal communications 
– G. Allen).  
 
 By measuring the Re (effective reproductive rate), it is possible to assess over time 
the effectiveness of the management strategies used to control an outbreak as well as 
quantify the transmission potential of Re at a specific point in time. Since the institution of a 
stop movement order (quarantine) occurred toward the end of the Churchill Downs 
outbreak, we were essentially able to observe the changes to Re at the cohort-level over the 
natural course of infection. For this disease event, Re was initially 10.25 which fell to 1.24 
by the second week of the outbreak. Because regulatory interventions were not initiated 
until late in the event, it appears that the outbreak was brought under control independent of 
movement restrictions or other bio-security measures placed on the premises by regulatory 
personnel.  By the fourth day of the event, there had been an 81% reduction in Re, although 
Re did not fall below the threshold value of 1.0 until the very end of the outbreak and only 
when three horses were still susceptible. Since Re remained above 1.24 for over ten days, 
there was the potential for exposing additional horses at the racetrack to infected members 
of this cohort, mainly through interactions with subclinical cases, as the horses which were 
not clinically ill were freely moving around the grounds of the racetrack for training and 
racing. The occurrence of asymptomatic spread is supported by the recognition of two 
horses that had only recently arrived at Churchill Downs and were not affiliated with barn 
38, but contracted EHV-1 and developed neurologic illness while the disease event was 
unfolding.  It is likely that these horses were exposed upon arrival at the track and not in-
transit as they did not share a common conveyance. If this is the case, then the subclinical 
horses from barn 38 were communicable during the time they were mixing with other 
horses on the grounds of the racetrack.  
 82
With respect to Murray State University, Re decreased from 2.94 to 1.44 within the 
first 16 days of the outbreak but remained above the threshold value of one for the last 46 
days. Furthermore, transmission of EHV-1 continued to occur throughout the outbreak as 
positive PCR results were documented late in the EHV-1 event.  Though one must use 
caution when using mathematical models to explain complicated biological processes, it 
appears that the transmission of the respiratory form of EHV-1 among horses at Murray 
State University reached an endemic state where there was a lack of sustained transmission 
and the occurrence of cases was at a low predictable rate. For the last 28 days of the 
outbreak, the value of Re was just marginally above the threshold value of one.  While the 
transmission potential was low, if more susceptible horses were added periodically to the 
existing population at Murray State or if infectious horses traveled to other venues where 
susceptible horses were located, additional cases of EHV-1 respiratory illness could have 
occurred and the cycle of EHV-1 infection continued indefinitely, albeit at a very low level.     
 
 The generation time is the mean time between the infection of a horse and the 
subsequent infection that this horse causes. The estimates derived from this study do not 
represent the time to the first occurrence of a secondary case but the average time to 
infection for all horses within a cohort.  Conceptually, the generation time incorporates the 
incubation period and the period of infectiousness into its calculation. For the horses located 
at Murray State University, the generation time between successive cases was estimated to 
be 2.38 days, a period that was 6.1 times longer than the estimate of 0.39 days for Churchill 
Downs cases. If one assumes that contact between horses occurs randomly and the 
frequency of contact is constant over the course of the outbreak, then the short generation 
interval for Churchill Downs implies that the average incubation period is also less than 
0.39 days (9.4 hours).  For those agents which have been studied, the length of an 
incubation period is inversely correlated with the infective dose, the severity of disease 
(Field and Hill, 1975; Aaby, 1992; Glynn and Bradley, 1992) and mode of transmission 
(Fine, 2003). For EHV-1, an abbreviated incubation period suggests that horses at Churchill 
Downs were exposed through direct contact to a large amount of circulating virus; 
conditions that would increase the probability that a contact between an infected and 
susceptible animal would be effective in transmitting virus.  
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Conversely, if horses at Murray State were exposed to smaller amounts of virus then 
the efficiency of transmission (1- qct) is reduced and the interval between cases is 
prolonged.  This reduction in efficiency may reflect that transmission is not occurring 
through direct spread but by the indirect sharing of equipment or carried from stall to stall 
by individuals who exchange tasks or perform common chores. Alternatively, if the 
incubation period for horses at Murray State was prolonged, assuming the infectious period 
is constant throughout the event, then the time interval between successive cases would also 
increase and the generation time would be longer. In general, the results demonstrate that 
the generation interval and its component indices can vary based on the clinical phenotype 
of an outbreak caused by the same etiologic agent; an observation that has been 
demonstrated for outbreaks of Ebola (Chowell et al., 2004).  While this index provides a 
quantitative measurement that can be used for comparison of different EHV-1 outbreaks, 
the generation interval is not a constant of nature but is dependent upon the interactions of 
the host, agent and environment where transmission is occurring. 
 
Although veterinary practitioners and researchers who study equine infectious 
diseases have long recognized variability in the clinical signs observed in horses infected 
with EHV-1, the identification of strains of EHV-1 that are associated with the development 
of neurological illness is a relatively recent finding (Nugent et al., 2006).  Furthermore, the 
relationship of animal-level risk factors on the development of EHM caused by a particular 
neuropathogenic strain of EHV-1 has only recently been examined (Allen, 2008).  While the 
molecular and immunological characteristics of neuropathogenic strains provide a plausible 
explanation for the occurrence of CNS disease, the relationship of this genetic marker to the 
development of neurological disease is far from clear-cut as it cannot account for all 
occurrences of EHM.  For cases of EHM that are attributed to strains that are designated as 
non-neuropathogenic (expresses A2,254 genotype at ORF 30),  it seems logical that the 
occurrence of neurological disease would be precipitated by some underlying medical 
condition.  While the first recognized case at Murray State was a 14-year old gelding with a 
sole abscess, it is unlikely that a medical condition this commonplace would pre-dispose a 
horse to EHM, especially since other researchers (Carr et al., 2011) have failed to find an 
association with hospitalized colic cases and the development of EHM.  Regardless, since it 
 84
has been estimated that 25% of EHM cases are caused by non-neuropathogenic strains, it is 
equally important to investigate these occurrences and characterize the clinical and 
immunological profile of such cases in order to identify risk factors for illness among 
affected animals.  
 
Field studies of the respiratory form of EHV-1 are difficult to conduct due to the 
ubiquitous nature of EHV-1 respiratory illness in the general equine population.  If the 14-
year old gelding which displayed gait deficits and other CNS signs at Murray State 
University had not been transferred to an equine referral hospital for treatment, it is unlikely 
that a respiratory event attributed to EHV-1 would have come to the attention of (or that an 
investigation would have been initiated by) state animal health regulatory officials.  In 
general, serological surveys of equine populations for the presence of antibodies to EHV-1, 
even in the presence of clinical illness, provide only limited epidemiological information as 
these surveys cannot identify the temporal pattern of disease occurrence or quantify the risk 
for becoming infected.  In order to accurately describe the sequence of events associated 
with an EHV-1 outbreak, it is necessary to conduct a formalized investigation and use a 
structured questionnaire to obtain animal specific information.  For example, the studies by 
Bell et al., (2006) or Brown et al., (2007) were able to identify the occurrence of various 
equine herpesviruses among mares and their foals but not an association with clinical 
illness, the sequential pattern of illness onset or an estimation of the risk for acquiring 
infection.  The Murray State University event is the first of its kind to be formally 
investigated as an outbreak of EHV-1 respiratory illness and not merely to estimate the 
prevalence of herpesviruses among a narrowly defined cohort of horses.     
 
Although virus was not successfully isolated from horses associated with either 
disease event, the laboratory and clinical findings collectively provide strong evidence in 
support of the outbreaks being caused by EHV-1.  These findings include: 1) the 
demonstration of SN titers to EHV-1 that were  >1:256 on at least one serum sample or 
showed a fourfold increase in antibody titer between paired samples collected from horses 
during the investigation; 2) the identification of multiple horses within each cohort with 
PCR positive results to EHV-1; 3) the recognition of EHV-1 compatible clinical illness in 
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greater than 50% of case-horses; 4) the confirmation that horses considered at-risk for 
infection had not been immunized against EHV-1 for a minimum of 6 months preceding the 
event; 5) the negative laboratory findings for other potential causes of illness which appear 
clinically similar to illness caused by EHV-1; and 6) the lack of compatibility with  non-
infectious causes of neurologic disease.   
 
The failure to isolate virus or demonstrate a four-fold or greater increase in titer for 
every EHV-1 infected horse is not unexpected and has been reported by other investigators 
(Greenwood and Simson 1979; Friday et al., 2000; Pusterla, et al., 2008). Peak viral 
shedding occurs during the first few days after onset of nasal discharge and coincides with 
the febrile phase (Allen, 2002b). Consequently, isolation of EHV-1 is most successful when 
attempted during the febrile stage of illness (Allen and Bryans, 1986).  For these 
investigations, the inability to isolate virus or show a two-fold change in titer for every 
horse is likely due to the fact that viral shedding had ceased or antibody titers had already 
peaked in infected horses prior to sample collection.  Regardless, in an outbreak setting not 
all cases of disease can or need to be laboratory confirmed (Sacks, 1985). As an example, in 
a recent outbreak of E. coli O157:H7 in North Carolina, only 44% of case-patients were 
laboratory confirmed (CDC, 2011) with the majority being included as cases based solely 
on clinical presentation.  Similarly, in an outbreak of Equine Influenza among racehorses in 
Japan (Yamanka et al., 2008) only 19.4% (188/969) of infected horses had a corresponding 
positive laboratory test result; the other horses were considered infected based on the 
demonstration of fever alone.  
 
The reliability of owner or trainer-reported illness occurring in animals has been 
assessed for a variety of veterinary medical conditions (Catley et al., 2001; Hamlin and 
Hopkins, 2003) and, in human health, for self-reported illness (Steele, 1982; Finger et al., 
1994). In general, the criteria used by lay-persons and their ability to recognize signs or 
symptoms of disease in animal or human populations are similar to those of veterinarians 
and physicians. Overall, a self or third-party report for a case of clinical illness correlates 
well with supporting laboratory evidence though recall is affected by time since disease 
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onset. For chickenpox in children, an accurate recall by caregivers has been demonstrated 
for periods of up to 4-5 years (Finger et al., 1994). 
 
For the Murray State event, the occurrence of illness was queried for only a 6 month 
period prior to the investigation with students being asked only to identify the occurrence of 
clinical signs and not potential etiologic agents.  Considering the frequency of contact with 
and the personal attachment of Murray State University students to their horses, it is 
reasonable to expect that these owners would recognize respiratory signs in their horses, 
though there are limits to the length of time that a person can accurately remember details of 
a specific event. The results would be subject to a form of recall bias; that is, owners are 
more likely to remember events that occurred recently than those which occurred weeks or 
months ago.  A bias of this nature likely underestimates the number of clinically affected 
horses and suggests that potentially more horses at Murray State University actually 
developed respiratory illness than were documented from the survey questionnaire. 
 
The recognition of respiratory illness among older horses at Murray State University 
is in contrast to the Churchill Downs event and other investigations of EHM where 
respiratory signs are rarely observed (Thomson et al., 1979; Friday et al., 2000; vann 
Maanen et al., 2001) or, when present, are restricted to foals or horses less than 2 years of 
age (Greenwood and Simson, 1979; McCartan et al., 1995; Studdert et al., 2003; Henninger 
et al., 2007).  In accordance with these investigations, the absence of respiratory signs in 
neurologically affected horses at Churchill Downs may be related to the exposure dose or 
genetic makeup of the virus associated with the event where, following exposure to a large 
viral dose or a neuropathogenic EHV-1 strain with the requisite SNP, replication of the 
virus and rapid dissemination to the CNS modifies or precludes the expression of 
respiratory signs in adult horses exposed in natural settings.  It follows that since EHV-1 is 
transmitted mainly through exposure to respiratory secretions, discounting for the moment 
spread through abortion, the lack of a respiratory component in neurologically affected 
horses has to markedly impact (i.e. shorten) the duration of viral shedding in these types of 
disease scenarios.   
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Similar to other EHM outbreak investigations (Goehring et al., 2006; Henninger et 
al., 2007), pyrexia was the most common clinical feature observed among affected horses at 
Churchill Downs and, while 78% (7/9) of the neurologic cases presented with a fever, only  
46.7 % (7/15) of the horses with an elevated temperature displayed neurologic signs. The 
results suggest that the risk for developing EHM was 8.75 times greater for febrile horses 
compared to afebrile horses. While the presence of fever in horses infected with EHV-1 has 
been described previously, this study demonstrates a clear age-related trend for the 
development of fever. For horses stabled at Churchill Downs which were 4-5 years of age, 
the risk of developing fever was 5.3 times less than for 2-year-old horses.  
 
In contrast to previous reports of EHM events (Goehring et al., 2006; Barbic et al., 
2012) which found an increased risk to mares for the development of neurologic disease, 
more intact males and geldings at Churchill Downs developed neurologic disease than 
females; though this difference was not statistically significant. In comparison to some 
outbreaks investigations (Goehring et al., 2006; Henninger et al., 2007) which found an 
association with age and the development of EHM, the present study did not find an 
association and is more similar in this respect to the investigation by Burgess et al. (2012). 
However, the lack of an association may be a reflection of the narrow range in ages for 
horses at Churchill Downs  (Interquartile Range = 2 years of age)  such that, if there is truly 
an age associated risk for the development of EHM, our sample size was not sufficiently 
large enough to detect a statistical difference.   
 
The recognition of EHV-1 respiratory disease at Murray State University beginning 
in February 2008 is in agreement with the observations of Matsumura et al., 1992 who 
found that in Japan the occurrence of EHV-1 respiratory disease in racehorses occurred 
almost exclusively during December through February. These researchers suggest that the 
occurrence of respiratory EHV-1 is seasonal, age-related and facilitated by the year round 
operation of racetracks in Japan.  Regardless, seasonality leads to the maintenance of 
recurrent epidemics of infectious diseases. If there is a seasonal component to the 
occurrence of EHV-1 in the US, then strategies exist which can exploit this epidemiologic 
feature. For example, EHV-1 immunizations can be targeted toward young racehorses in 
 88
training during the winter and late spring, much in the same way boosters for EHV-1 are 
recommended for brood mares at 5, 7 and 9 months of gestation to prevent abortion.  
Currently, immunizations for equine herpesviruses in adult horses are only recommended 
annually with a 6-month revaccination for performance horses without regard to the timing 
of boosters (AAEP, 2012).    
 
Using a Reed-Frost model that most closely matched the observed profile of cases 
for each disease event, we explored the impact of altering herd immunity levels on the 
theoretical transmission and final outbreak size within each cohort. While mathematical 
models can simultaneously incorporate various levels of vaccine efficacy and coverage for 
analysis, for simplicity, we set vaccine coverage at 100% such that every horse was 
expected to be given a vaccine.  The results suggest that with each incremental increase in 
herd immunity, there was a corresponding decrease in the number of EHV-1 cases and the 
value for R0 at each location. For increases in herd immunity levels above 75% and 95%, 
the model predicts that there would be a substantial reduction in the incidence and 
transmission of respiratory and neurological illness, respectively.  Based on these models, a 
herd immunity level of 95% would provide protection against both the respiratory and 
neurologic form of EHV-1; this level could potentially serve as a useful target for vaccine 
development.  
 
Given the high degree of transmissibility and the severity of clinical illness 
associated with the occurrence of EHV-1 neurologic illness, even a moderate increase in 
herd immunity would reduce morbidity and decrease spread. Because herd immunity 
confers protection to animals that are not immunized and can decrease morbidity even with 
the use of an imperfect vaccine, animal health regulators may want to consider some 
targeted prevention strategy such as requiring racehorses be immunized prior to admission 
to a performance venue. As an example, a 50% increase in the herd immunity level would 
reduce the number of cases by 54% and 70% among horses at Churchill Downs and Murray 
State, respectively.  Since we are assuming that every horse is immunized, this theoretical 
reduction in morbidity is based solely on a vaccine that is 50% efficacious (only 50 percent 
of vaccinated horses would develop protective immunity).   
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The equine populations at Churchill Downs Racetrack and Murray State University 
student barn differed in their age structure, intended use and principal clinical features; yet 
the clinical attack rates and the proportion of the respective populations which developed 
either an elevated SN titer and/or were PCR positive were similar between cohorts and are 
in agreement with others (Allen, 2002b; Kydd et al., 2006; Coombs et al., 2006) who 
suggest that re-exposure to EHV-1 and immunological boosting is a common occurrence in 
most horse populations.  Notwithstanding the differences in composition between the two 
equine cohorts, horses located at Churchill Downs are typical of a stable of thoroughbreds 
in training; likewise, the horses at Murray State University are representative of horses kept 
primarily for recreational purposes.  Accordingly and despite the uncertainties inherent to 
observational studies, the findings of this study can be generalized to other equine 
populations in similar settings that are managed under comparable husbandry conditions.   
For racehorses in training, the findings would be generalized to a population of horses that 
have multiple or absentee owners, are maintained under a uniform medical 
monitoring/treatment protocol, trained similarly, and consume identical feed rations.  For 
horses kept for recreational purposes, the findings would be applicable to a stable of horse 
with individual owners where horses are older, consume different feed rations and are used 
for a variety of purposes (shows, trail riding, rodeo competition, pleasure, etc.).  
 
Due to limitations of the study, it was not possible to conclusively identify a specific 
strain of EHV-1 as the cause of each clinical case or rule out the possibility of co-infection 
with multiple strains of EHV-1 for each disease event, though clinical and laboratory 
evidence suggests that different and distinct viral strains were circulating among comingled 
horses at each venue.  Likewise, it was not possible to identify the index case or the source 
of EHV-1, whether introduced by direct spread or resulted from latently reactivated virus, in 
one or both events.  Therefore, the sequential pattern for the occurrence of EHV-1 cases and 
the results derived from the statistical analysis lend themselves best to comparisons of 
outbreaks which differ by the principal clinical features of the event and not by viral 
subtype.  
 
 90
From an epidemiological perspective, an accurate determination of the duration of 
viral shedding of infectious virus is of greater importance to animal health regulators than 
determining whether a horse is viremic or simply positive in the PCR test. Unnecessarily 
restricting the movement of horses in commercial settings after they are no longer infectious 
exacts an economic cost to producers in lost opportunity.  To address issues of 
communicability, future EHV-1 research should focus on quantifying and comparing the 
magnitude and duration of nasal shedding of infective virus for various genetic variants of 
EHV-1, for a range of ages for infected horses and for both symptomatic and asymptomatic 
affected horses exposed in natural settings.  
 
Despite the increased use of PCR-based allelic discrimination testing for EHV-1, 
there appears to be a lack of uniformity or standardization of these methods between 
laboratories. Since these tests are not marketed commercially as a complete assay, there is 
no federal oversight for the production and distribution of the individual components or an 
attestation of their reliability. The USDA-APHIS-NVSL should consider production of a 
check panel to validate test results and international organizations, such as the World 
Organization of Animal Health (OIE), should promote the use of a standard laboratory 
protocol by incorporating this testing in the OIE Manual of Diagnostic Tests and Vaccines 
for Terrestrial Animals. 
 
The modeling results for this study need to be validated by other researchers under a 
range of conditions and settings.  Stochastic modeling techniques, such as Monte Carlo 
methods, should be considered for future transmission models to calculate more realistic 
parameters estimates. Network analysis should be used to examine the underlying 
relationships and the patterns of association between horse owners, whether social or 
economic, that contributes to the spread of EHV-1.  
 
 
 
 
Copyright © Barry Jay Meade 2012  
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APPENDIX A: 
Questionnaire for EHV-1 disease event Churchill Downs Racetrack, 2005 
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Owner/Animal Information 
 
Date of interview: ________________     
 
Animal Name: _______________________     Age: ______       
 
(Year of Birth)  _________        Sex:_____  
 
Animal Location  
Trainer: _________________       Barn:  _____  Stall: _____ 
 
How long has animal resided at this location?  ____________     
 
 
Travel/Training History 
 
Is a Health Certificate available for review? Circle (Y or N)      
 
 
 
Recently purchased/claimed? Circle (Y or N)?  If yes, how long ago and from whom: 
 
 
 
 
Prior to arriving at Churchill, where has this horse resided? (Last 2 months).  
 
 
 
 
Training history (last three weeks) - Was the animal working normal, off, etc.?     
 
 
 
 
     
Describe most recent training history 
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Clinical/Medical History 
    
Has this animal had a fever of greater than 101.5o since December 1, 2005?  
Circle (Y or N).   If yes, explain: 
 
 
 
 
Other signs/symptoms (type/date/duration): Any coughing, off-feed, lameness, weak in rear, 
stumbling, dropping feed. 
 
 
 
Has this horse been vaccinated against Herpes (Rhino) - within last six months? 
Circle (Y or N) 
 
 
If Yes, date (if known) __________________    
 
Give approximate if exact date unknown. ________________ 
 
Has this animal been administered any medications or vaccinations in the past 4 weeks 
(other than race day medications)? Circle (Y or N)     
If yes, describe: 
 
 
 
 
Has this animal been examined by a veterinarian for any reason in the past 4 weeks 
(Scoped, X-rays, lameness exam)?  Circle (Y or N).  If yes, describe: 
 
 
 
 
 
Are you aware of other animals with a diagnosis of EHV-1 that this horse could have been 
exposed other than at Churchill?  Circle (Y or N).  If yes, where and when. 
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APPENDIX B: 
Questionnaire for EHV-1 disease event Murray State University, 2008 
  
 95
Owner/Animal Information 
 
Owner: ________________________________    Today’s Date _______ 
 
Barn/Stable Identification (Number or Name): ________________________________ 
 
Name (Identification of Animal): ____________________________________________  
 
Age: ________     (Year of Birth) _______    Sex: _____ 
 
 
Stall Number (or location): _____________     Breed ___________________________ 
 
 
How long has this animal resided at this location?  _____________________________ 
 
 
Prior to arrival at the Equine Center at Murray, where had this horse resided? (Last 6 
months)  
 
______________________________________________________________________ 
 
______________________________________________________________________ 
 
______________________________________________________________________ 
 
 
Was this horse purchased within the past year? : Circle (Yes or No); If Yes, how long ago 
and from whom 
______________________________________________________________________ 
 
______________________________________________________________________                                 
 
 
What do you consider to be the primary use of this animal? Circle one. 
 1–Pleasure 
 2–Lessons/school 
 3–Showing/competition (not betting) 
 4–Breeding 
 5–Racing 
 6–Farm or ranch work 
 7–Other (specify: ________________) 
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Clinical/Medical History 
 
Has this animal had any of the following signs/symptoms since March 1, 2008? 
(Approximately 45 days ago)   
 
Since March  1, 2008        If YES, Date when signs            
                        first appeared (Onset) 
 
Fever (>101.5o F)    Yes     No 
 
Changes in eating habits   Yes     No 
(Off feed, dropping feed) 
 
Lameness     Yes     No 
(including stumbling, weakness in rear limbs) 
 
Reduced/ Loss of Tail Tone    Yes     No 
 
Dribbling Urine    Yes     No 
 
Colic      Yes     No 
 
Abortion     Yes     No 
 
Respiratory illness    
(Including coughing,  
running/snotty/crusty noses)   Yes     No  
 
Has this animal been examined by a veterinarian for any reason in the past 6 weeks       
(Scoped, X-rays, lameness exam)?   
 
Circle (Yes or No); If Yes, describe: 
 
 
 
 
 
 
 
Has this ever horse been vaccinated against Herpes (Rhino); Circle (Yes or No) 
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Has this horse been vaccinated against Herpes (Rhino) - within last six months? Circle (Yes 
or No);  
 
 
If Yes,  Date (if known) __________________  Give approximate if exact date unknown.  
[use chart if needed] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Has this animal been administered any medications or treatments in the past 6 weeks? Circle 
(Yes or No);  
If Yes, describe: 
[use charts if needed] 
 
 
 
 
 
 
 
 
 
 
Husbandry Practices 
 
Describe husbandry practices that are routinely done for this animal [i.e., maintained in 
barn/ put on pasture/ housed at night/fed hay grain, clean stalls daily]  
 
 
 
 
 
  
Vaccines types Yes/No  
 
Date Vaccinated 
Fluvacc Innovator   
Pnuemabort K   
Equivac   
Prestige   
Prodigy   
Calvenza   
Rhinomune   
Medication type Yes/No  
 
Date of 
treatment  
Antivirals   
NSAIDS (Bute)   
Corticosteroids   
Antibiotics    
Other (specify)   
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Have you helped or assisted other horse owners at this or other facilities with the care and 
feeding of their horses?  Circle (Yes or No).  
 
 
If Yes, describe: [i.e., feeding, exercising, and approximate frequency (daily, weekly, 
occasionally)].  
 
 
 
 
Please identify by stall number, those stalls which you have had access to within the past 
month (30 days). 
 
 
 
 
Do you share grooming tools or other items with other horse owners? Circle (Yes or No); If 
Yes, describe: 
 
 
 
 
 
Travel/Training History 
 
Has this animal been moved from this location for any reason in the past 3 months?                 
Circle (Yes or No); If Yes, describe:  
[i.e., shows, trail rides, competition, pleasure, hospital/vet clinic and approximate dates] 
 
 
 
 
 
 
Has your horse(s) shared a trailer ride with another horse from this facility?  Circle (Yes or 
No); If Yes, describe: 
 
 
 
 
If used for competition, has this animal performed to your expectations? Circle (Yes or No); 
If No, Describe issue with performance  
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Describe the locations [i.e., outside corral near barn which houses rodeo horses, indoor 
arena, etc.,] and activities [exercising, training, shows] which you and your horse(s)  have 
participated in while on the Murray State University equine center property. 
 
 
 
 
 
 
 
 
 
Additional comments:  Use the area below for any additional information that was not 
covered in the questions above and which you feel is important to this disease event. 
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APPENDIX C: 
Summary of clinical and laboratory data for each horse associated with the EHV-1 
disease events at Churchill Downs Racetrack in 2005 and  
Murray State University in 2008 
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Churchill Downs, 2005 
a Grading system for CNS disease based on AAEP lameness scale; b Samples collected 5/13/05; c Samples collected 5/21/05; d Samples collected 6/1/05; e Samples collected 6/7/05; f Samples 
collected 6/13/05;  NT = Not tested; g Transferred to equine referral hospital in Lexington, KY;  hNS = Not specified; i Number of horses which demonstrate an initial titer > 1:256. 
 
Animal Stall Presence of 
neurologic 
signs 
Assessment of 
presenting 
neurologic signsa 
Fever EHV-1b 
serology 
test results 
EHV-1c 
serology 
test results  
EHV-1d 
serology 
test results  
EHV-1e
serology 
test results 
EHV-1f
serology 
test results 
Date of 
illness 
Onset 
PCR test results 
(date positive 
sample collected) 
Pimm’sO’Clock  1 No  Yes NT Pos 1:512 Pos 1:1024 Pos 1:2048 Pos 1:512 5/6/2005 Positive (6/1/05) 
GottaSecret  2 No  Yes NT Pos 1:1024 Pos 1:1024 Pos 1:1024 Pos 1:256 5/7/2005 Positive (6/1/05) 
DiaAlegre 3 No  No NT Pos 1:128 Pos 1:256 Pos 1:256 NT  Negative 
KingofCapers 4 Yes Grade 1 Yes Pos 1:256 Pos 1:512 Pos 1:512 Pos 1:2048 NT 5/6/2005 Negative 
Majestically  5 No  No NT Pos 1:256 Pos 1:128 Pos 1:1024 NT  Negative 
PrinessPegasus  6 No  No NT Pos 1:256 Pos 1:1024 Pos 1:1024 NT  Negative 
Dances  7 No  Yes NT Pos 1:128 Pos 1:1024 Pos 1:256 Pos 1:512 5/10/2005 Positive (6/1/05) 
ClassFive  8 No  No NT Pos 1:64 Pos 1:64 Pos 1:128 NT  Negative 
RedPiano  9 No  No NT Pos 1:1024 Pos 1:256 Pos 1:512 NT  Negative 
Dynarein 10 No  No NT Pos 1:128 Pos 1:256 Pos 1:512 NT  Negative 
MoAppeal 11 No  No NT Pos 1:32 Pos 1:64 Pos 1:64 NT  Negative 
LunarGal 12 Yes Grade 1 Yes NT Pos 1:512 Pos 1:256 Pos 1:512 NT 5/7/2005 Positive (6/1/05) 
CastingPearls 13 No  Yes NT Pos 1:512 Pos 1:2048 Pos 1:1024 NT 5/5/2005 Negative 
WhiteHotCat 14 No  Yes NT Pos 1:512 Pos 1:1024 Pos 1:512 NT 5/8/2005 Negative 
DancingLeibling 15 No  Yes NT Pos 1:512 Pos 1:1024 Pos 1:1024 NT 5/13/2005 Negative 
DukeofDestiny 16 Yes Grade 1 Yes Pos 1:256 Pos 1:128 Pos 1:4096 Pos 1:256 NT 5/8/2005 Positive (5/14/05) 
SisterSwank 17 No  No NT Pos 1:128 Pos 1:512 Pos 1:512 NT  Negative 
GrandSteal 18 No  No NT Pos 1:512 Pos 1:512 Pos 1:512 NT  Negative 
BwanaCharlie 19 No  No NT NT Pos 1:256 Pos 1:1024 NT  Negative 
Warleighg 20 Yes Grade 4 Yes Pos 1:256 NT NT NT NT 5/12/2005 Negative 
SongDancer 21 Yes Grade 1 No Pos 1:128 Pos 1:64 Pos 1:64 Pos 1:256 NT 5/12/2005 Negative 
LadyTak 22 Yes Grade 2 Yes Pos 1:256 Pos 1:512 Pos 1:512 Pos 1:1024 NT 5/8/2005 Positive (6/1/05) 
Summerly 23 Yes Grade 1 No Pos 1:512 Pos 1:512 Pos 1:512 Pos 1:512 NT 5/14/2005 Positive (6/1/05) 
SeductivelySmooth 24 No  No NT Pos 1:512 Pos 1:512 Pos 1:512 NT  Negative 
Megascape 25 No  No NT Pos 1:256 Pos 1:128 Pos 1:256 NT  Negative 
YaddoCat 26 No  Yes NT Pos 1:512 Pos 1:512 Pos 1:1024 NT NSh Positive (6/1/05) 
LunarPalg 27 Yes Grade 1 Yes NT Pos 1:256 NT Pos 1:1024 NT 5/11/2005 Negative 
EndsofStorm 28 No  Yes NT Pos 1:128 Pos 1:256 Pos 1:1024 NT 5/10/2005 Positive (6/1/05) 
Effectual 29 No  No NT Pos 1:256 Pos 1:512 Pos 1:64 NT  Negative 
Souris 30 No  No NT Pos 1:256 Pos 1:128 Pos 1:512 NT  Negative 
SantanaSprings  31 No  No NT Pos 164 Pos 1:64 Pos 1:64 NT  Negative 
Razor 32 No  No NT Pos 1:512 Pos 1:512 Pos 1:1024 NT  Negative 
MtnGeneral 33 No  No NT Pos 1:256 Pos 1:512 Pos 1:256 NT  Negative 
Hotense 34 No  Yes NT Pos 1:128 Pos 1:2048 Pos 1:1024 NT 5/12/2005 Negative 
MyExtolledhonor 35 No  No NT Pos 1:512 Pos 1:256 Pos 1:256 NT  Negative 
DocO’Dynamite 36 Yes Grade 1 Yes NT Pos 1:512 Pos 1:512 Pos 1:256 NT 5/7/2005 Negative 
Poncho 37 No  No NT Pos 1:256 Pos 1:256 Pos 1:512 NT  Negative 
Number positive findings 9  16 5i 22i 6i 1i  17 9 
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Murray State University, 2008 
Animal Stall Presence 
of 
neurologic 
signs 
Description of presenting 
neurologic signs 
Presence 
of 
respiratory 
signs 
Description of presenting  
respiratory signs and 
accompanying comments 
EHV-1a 
serology 
test results  
EHV-1b 
serology 
test results  
Date of 
illness 
Onset 
PCR test results 
(date positive 
sample collected) 
Claire 2 No  Yes Runny/crusty nose NTc NT 3/23/08 Positive (4/9/08) 
Tinker 3 No  No  >1:256 NT  Positive (4/22/08) 
Martini 4 No  No  NT Neg 1:4  Negative 
Rocket 5 Yes Rear limb ataxia Yes Coughing, runny/crusty nose NT NT 4/15/08 Positive (4/9/08) 
Sheeza 6 No  Yes Runny/crusty nose Pos 1:32 NT 4/10/08 Positive (4/9/08) 
Cool 7 No  No  Pos 1:64 Pos 1:64  Negative 
Eddied 8 No  No  Pos 1:64 Pos 1:128  Negative 
Dina 32 No  Yes Runny/crusty nose >1:256 NT 3/15/08 Positive (4/9/08) 
Fergie 33 No  Yes Sinus infection, guttural pouches 
flushed 
Pos 1:128 Pos 1:128 4/18/08 Negative 
Chip 34 No  No  Pos 1:128 >1:256  Negative 
Buckye 35 No  No  Pos 1:128 Pos 1:128  Negative 
Bailey 36 No  Yes Runny/crusty nose Pos 1:128 NT 3/8/08 Positive (4/9/08) 
Dancer 37 No  Yes Runny/crusty nose Pos 1:64 NT 4/24/08 Positive (4/9/08) 
Rusty 38 No  Yes Coughing, runny/crusty nose Pos 1:64 NT 2/10/08 Positive (4/9/08) 
Henry 39 Yes Dribbling urine, ataxiaf.  No  NT NT 5/7/08 Positive (4/9/08) 
Myrtle 40 No  No  >1:256 Pos 1:128  Negative 
Never 41 No  No  Pos 1:128 >1:256  Negative 
Mystic 42 No  No  Pos 1:64 NT  Positive (4/22/08) 
Dixie 43 No  No  Pos 1:128 >1:256  Negative 
Zip 44 No  Yes Runny nose. Tx w/antibiotics Pos 1:32 Pos 1:128 NSg Negative 
Sparten 45 No  No  >1:256 NT  Positive (4/9/08) 
Calli 46 No  Yes Coughing, runny/crusty nose > 1:256 >1:256 3/17/08 Negative 
Hershey 47 No  Yes Runny/crusty nose. Tx w/antibiotics Pos 1:128 Pos 1:64 3/13/08 Negative 
Stella 48 No  No  > 1:256 Pos 1:128  Negative 
Booger 49 No  No  Pos 1:64 Pos 1:32  Negative 
Major 50 No  No  >1:256 NT  Positive (4/9/08) 
Indy 51 No  Yes Runny/crusty nose >1:256 NT 4/14/08 Positive (4/9/08) 
Sugar 52 No  Yes Runny/crusty nose Pos 1:64 NT 3/26/08 Negative 
Omaha 53 No  Yes Runny nose/ lacrimation Pos1:128 NT 3/31/08 Positive (4/9/08) 
Squirt 54 No  Yes Coughing, runny/crusty nose Pos 1:32 NT 4/14/08 Negative 
Tucker 55 No  Yes Coughing, runny nose Pos 1:64 NT NSg Positive (4/9/08) 
Lightening 56 No  No  >1:256 Pos 1:128  Negative 
Kiddo 57 No  Yes Runny/crusty nose >1:256 Pos 1:128 3/1/08 Negative 
Zoey 58 Yes  Painful, stiff rear limb gait No  >1:256 >1:256 3/30/08 Negative 
Crimson 59a No  No  Pos 1:128 Pos 1:128  Negative 
Cupid 59b No  No  Neg 1:4 Neg 1:4  Negative 
Sobe 60 No  Yes Runny/crusty nose Pos 1:64 NT 4/7/08 Positive (4/9/08) 
Positive findings 3   18  11h 6I 18 17 
a Samples collected 4/9/08; b Samples collected 4/22/08; c NT = Not tested; d Vaccinated 1/16/08, not considered at risk for infection; e Vaccinated 2/3/08, not considered at risk for infection; 
 f Transferred to equine referral hospital in Lexington, KY; g Not specified; h Number of horses with a titer > 1:256;  I Total includes one horse with a four-fold change in titer “Zip”   
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APPENDIX D: 
Data elements used for model building with the predicted dates of disease onset for 
each horse associated with the EHV-1 disease events at Churchill Downs Racetrack in 
2005 and Murray State University in 2008 
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Churchill Downs, 2005 
Animal Groom Age Gender Datea Stall State NSb PCRc Serological 
positived 
Fevere Case Actual 
onset datef 
Predicted 
onset dateg 
Pimm’sO’Clock  1 2 1 108 1 2 0 1 1 1 1 126 127.84 
GottaSecret  1 2 1 108 2 1 0 1 1 1 1 127 127.84 
DiaAlegre 1 4 1 123 3 4 0 0 1 0 1 ------ 129.11 
KingofCapers 1 2 1 96 4 4 1 0 1 1 1 126 126.65 
Majestically  1 3 2 125 5 4 0 0 1 0 1 ------ 127.87 
PrinessPegasus  1 3 2 87 6 4 0 0 1 0 1 ------ 127.87 
Dances  2 3 1 74 7 3 0 1 1 1 1 130 128.03 
ClassFive  2 3 1 101 8 2 0 0 0 0 0 ----- ------- 
RedPiano  2 4 2 87 9 3 0 0 1 0 1 ----- 129.26 
Dynarein 2 4 1 87 10 2 0 0 1 0 1 ----- 129.26 
MoAppeal 3 2 2 87 11 2 0 0 0 0 0 ------ ------ 
LunarGal 3 2 2 87 12 3 1 1 1 1 1 127 126.95 
CastingPearls 3 3 2 87 13 4 0 0 1 1 1 125 128.18 
WhiteHotCat 3 3 2 87 14 4 0 0 1 1 1 128 128.18 
DancingLeibling 4 4 2 104 15 4 0 0 1 1 1 133 129.56 
DukeofDestiny 4 2 1 97 16 3 1 1 1 1 1 128 127.09 
SisterSwank 4 4 2 87 17 5 0 0 1 0 1 ------ 129.56 
GrandSteal 4 5 1 128 18 2 0 0 1 0 1 ------ 130.79 
BwanaCharlie 5 4 1 88 19 3 0 0 1 0 1  129.71 
Warleigh 5 6 1 104 20 3 1 1 1 1 1 132 132.18 
SongDancer 5 6 1 131 21 3 1 0 0 0 1 132 132.17 
LadyTak 5 5 2 88 22 3 1 0 1 1 1 128 130.94 
Summerly 6 3 2 87 23 4 1 0 1 0 1 134 128.63 
SeductivelySmooth 6 3 2 87 24 3 0 0 1 0 1 ----- 128.63 
Megascape 6 3 2 1 25 5 0 0 1 0 1 ----- 128.63 
YaddoCat 6 2 2 87 26 3 0 1 1 1 1 ----- 127.39 
LunarPal 7 3 1 87 27 5 1 1 0 1 1 131 128.78 
EndsofStorm 7 2 1 91 28 3 0 0 1 1 1 130 127.54 
Effectual 7 2 2 87 29 3 0 0 1 0 1 ----- 127.54 
Souris 7 5 2 87 30 1 0 1 1 0 1 ----- 131.24 
SantanaSprings  8 3 1 108 31 3 0 0 0 0 0 ----- ----- 
Razor 8 2 1 87 32 3 0 1 1 0 1 ----- 127.69 
MtnGeneral 8 6 1 91 33 2 0 0 1 0 1 ----- 132.63 
Hotense 8 5 2 104 34 3 0 0 1 1 1 132 131.00 
MyExtolledhonor 9 9 1 101 35 5 0 0 1 0 1 ------ 136.47 
DocO’Dynamite 9 2 1 104 36 3 1 0 1 1 1 127 127.84 
Poncho 10 11 1 87 37 3 0 0 1 0 1 ----- 139.08 
aDate of arrival in Kentucky ; bDeveloped Neurological illness; cPCR positive; d Either single EHV-1 titer > 256 or four-fold change in titer; eTemp > 101.5°;  f,gJulian calendar date for onset  
of clinical illness. Binominal responses coded as No = 0, Yes = 1. 
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Murray State University, 2008 
Animal Stall Area Breed Gender Age Ever 
VACb 
Rec 
VACc 
Freq 
Assistd 
PCRa NS Serological 
positive 
Respiratory 
illness 
Case Actual 
onset datee 
Predicted 
onset date 
Claire 2 3 1 2 3 0 0 3 1 0 0 1 1 83 83.43 
Tinker 3 3 1 2 10 1 0 3 1 0 1 0 1 ----- 82.93 
Martini 4 3 1 2 6 1 1 1 0 0 0 0 0 ----- ----- 
Rocket 5 3 2 1 14 0 0 1 1 1 0 1 1 106 95.04 
Sheza 6 3 1 2 7 0 0 2 1 0 0 1 1 101 93.28 
Cool 7 3 1 1 22 0 0 3 0 0 0 0 0 ----- ----- 
Eddie 8 3 3 1 11 1 1 2 0 0 0 0 0 ----- ----- 
Dina 32 2 1 2 4 1 0 2 1 0 1 1 1 75 96.84 
Fergie 33 1 1 2 1 1 1 2 0 0 0 1 1 109 112.92 
Chip 34 2 1 1 3 1 1 3 0 0 1 0 1 ----- 111.91 
Bucky 35 1 1 2 18 1 1 2 0 0 0 0 0 ----- ----- 
Bailey 36 2 2 1 15 1 1 3 1 0 0 1 1 68 72.39 
Dancer 37 1 3 2 2 1 1 1 1 0 0 1 1 115 101.58 
Rusty 38 2 3 1 4 0 0 3 1 0 0 1 1 41 60.79 
Henry 39 1 1 1 14 0 0 1 1 1 0 0 1 128 121.77 
Myrtle 40 2 3 2 19 1 0 1 0 0 1 0 1 ----- 83.49 
Never 41 1 2 1 15 1 0 3 0 0 1 0 1 ----- 86.47 
Mystic 42 2 1 2 3 1 0 1 1 0 0 0 1 ----- 103.69 
Dixie 43 1 1 2 5 1 0 3 0 0 1 0 1 ----- 96.06 
Zip 44 1 1 1 13 1 0 3 0 0 1 1 1 ----- 95.56 
Sparten 45 1 2 1 5 1 0 3 1 0 1 0 1 ----- 84.47 
Calli 46 2 1 2 7 0 0 1 0 0 1 1 1 77 101.69 
Hershey 47 1 3 1 12 0 0 3 1 0 0 1 1 73 72.87 
Stella 48 2 2 2 5 1 0 1 0 0 1 0 1 ----- 83.72 
Booger 49 1 3 1 10 1 0 2 0 0 0 0 0 ----- ----- 
Major 50 2 1 1 13 1 0 3 1 0 1 0 1 ----- 75.98 
Indy 51 1 1 2 4 1 1 1 1 0 1 1 1 105 115.76 
Sugar 52 2 1 1 5 1 1 3 0 0 0 1 1 86 74.98 
Omaha 53 2 1 1 13 1 1 3 1 0 0 1 1 91 74.48 
Squirt 54 2 1 2 1 1 1 1 0 0 0 1 1 105 73.98 
Tucker 55 2 1 1 8 1 0 1 1 0 0 1 1 ----- 97.18 
Lightening 56 1 1 1 7 1 0 3 0 0 1 0 1 ----- 89.55 
Kiddo 57 2 3 1 3 1 1 2 0 0 1 1 1 61 63.14 
Zoey 58 1 1 2 3 0 0 3 0 1 1 0 1 90 88.55 
Crimson 59a 2 1 2 10 1 1 2 0 0 0 0 0 ----- ----- 
Cupid 59b 2 2 2 .17 0 0 2 0 0 0 0 0 ----- ----- 
Sobe 60 1 2 1 12 1 1 2 1 0 0 1 1 98 88.81 
aPolymerase Chain Reaction; bEver been vaccinated against EHV-1; cRecently vaccinated against EHV-1;dFrequncey that owner provided assistance to other horses owners for care and 
 feeding; eJulian calendar date for onset of clinical illness; Binominal responses coded as No = 0, Yes = 1. 
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APPENDIX E: 
Calculation of the initial doubling time of EHV-1 cases for each EHV-1 disease event 
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A. Churchill Downs  Racetrack  
 
   td = (t1 – t0) log (2) / log [N1 / N0]  (see equation 1.6) 
  
   where  t0    =   1 day 
    t1    =   1.3 days 
    N0   =  1 
    N1  =  2 
 
    
   td = (1.3 – 1.0) log (2) / log [2 / 1] 
 
   td = (0.3) 0.30103 / 0.30103 
 
   td = 0.09031 / 0.301 
 
          td = 0.2999 
 
 
B. Murray State University Student Barn 
 
   td = (t1 – t0) log (2) / log [N1 / N0]  (see equation 1.6) 
  
   where  t0    =   1 day 
    t1    =   3.5 days 
    N0   =  1 
    N1  =  2 
 
    
   td = (3.5 – 1.0) log (2) / log [2 / 1] 
 
   td =  (2.5) 0.30103 / 0.30103 
 
   td = 0.7225/ 0.30103 
 
          td = 2.4999 
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APPENDIX F: 
Calculation of the basic reproductive number (R0) for each EHV-1 disease event 
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  A. Churchill Downs  
 
   R0 = 1 + D ln2 / td    (equation 1.5) 
  
   where  td     =   0.2999    (see Appendix E) 
    D    =   4 days    Goodman et al., 2006 
     
   R0 = 1 + (4.0) (0.69315) / 0.2999 
 
   R0 = 1 + 2.7726 / 0.2999 
   
   R0 = 1 + 9.245 
 
   R0 = 10.25 
 
   
  B. Murray State University 
 
   R0 = 1 + D ln2 / td    (equation 1.5) 
  
   where  td     =   2.4999    (see Appendix E) 
    D    =   7 days    Allen, 2002a 
personal communications – G. Allen 
  
   R0 = 1 + (7.0) (0.69315) / 2.4999 
 
   R0 = 1 + 4.8528 / 2.4999   
    
R0 = 1 + 1.9409 
 
   R0 = 2.94 
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APPENDIX G: 
Calculation of the exponential growth rate – r for each EHV-1 disease event 
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  A. Churchill Downs Racetrack 
    
r = ln (2)/ td    (equation 1.8) 
 
    where td = 0.2999   (see Appendix E) 
 
     r = (0.69315) / 0.2999 
 
     r = 2.311 
   
  B. Murray State University Student Barn 
 
    r = ln (2)/ td    (equation 1.8) 
    
    where td = 2.4999   (see Appendix E) 
    
     r = (0.69315) / 2.4999 
 
     r = 0.2773 
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APPENDIX H: 
Calculation of the generation interval of EHV-1 cases for disease event location 
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  A. Churchill Downs Racetrack 
    
Tg = (R0 – 1) / (r R0)   (equation 1.10) 
  
    where r = 2.317   (see Appendix E) 
     
     R0 = 10.25   (see Appendix F)  
 
      
Tg = (10.25 -1) / [(2.311) (10.25)] 
 
     Tg = 9.25 / 23.749 
      
     Tg = 0.390 days 
   
  B. Murray State University Student Barn 
 
    Tg = (R0 – 1) / (r R0)   (equation 1.10) 
    
    where r = 0.2773   (see Appendix E) 
     
     R0 = 2.9419   (see Appendix F)  
 
      
Tg = (R0 – 1) / (r R0)  
 
     Tg = (2.9419 -1) / [(0.2773) (2.9419)] 
 
     Tg = 1.9419 / 0.81579 
      
     Tg = 2.38 days 
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APPENDIX I: 
Calculation of the minimum value for Herd Immunity (HI) needed to eliminate the 
spread of EHV-1 by each event location 
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  A. Churchill Downs Racetrack 
    
Herd Immunity (HI) = 1 – 1/R0 
  
    where R0 = 10.25   (see Appendix D)  
 
     HI = 1 – 1/10.25  
 
     HI = 1 – 0.0976 
      
     HI = 90.24% 
   
  B. Murray State University Student Barn 
 
Herd Immunity (HI) = 1 – 1/R0 
  
    where R0 = 2.9419   (see Appendix D)  
 
     HI = 1 – 1/2.9419  
 
     HI = 1 – 0.3399 
      
     HI = 66.0% 
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APPENDIX J: 
R and SAS Code  
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I. R code 
 
_____________________ Date of Onset Data – Churchill Downs___________________ 
 
Obs <-c(4,13,1,2,12,36,14,16,22,7,28,27,20,34,15,21,23) 
Stall <-c(4,13,1,2,12,36,14,16,22,7,28,27,20,34,15,21,23) 
Gender <-c(2,1,2,2,1,2,1,2,1,2,2,2,2,1,1,2,1) 
Age <-c(2,3,2,2,2,2,3,2,5,3,2,3,6,5,4,6,3) 
Groom <-c(1,3,9,9,3,9,3,4,5,2,7,7,5,8,4,5,3) 
State <-c(2,1,4,4,4,4,4,2,3,2,2,3,4,4,4,5,3) 
Date <-c(96,87,77,108,87,104,77,97,88,74,91,87,104,104,104,131,87) 
NS <-c(1,0,0,0,1,1,0,1,1,0,0,1,1,0,0,1,1) 
Time <-c(125,125,126,127,127,127,128,128,128,130,130,131,132,132,133,134,134) 
PCR <-c(0,0,1,1,1,0,0,1,1,1,1,0,0,0,0,0,1) 
Side <-c(1,1,1,1,1,2,1,1,2,1,2,2,2,2,1,2,2) 
Quarter <-c(1,2,1,1,2,4,2,2,3,1,4,3,3,4,2,3,3) 
  
 
___________________________ EDA – Churchill Downs _________________________ 
 
summary (Obs) 
summary (Stall) 
summary (Gender) 
summary (Age) 
summary (Groom) 
summary (State) 
summary (Date) 
summary (NS 
summary (Time) 
summary (PCR) 
summary (Side) 
summary (Quarter) 
 
_______________________________Call in Library ______________________________  
 
library (MASS) 
library (survival) 
 
_____________________________ Model Building ______________________________ 
library (MASS) 
MLRfit.9 <-lm(Time~Groom) 
summary (MLRfit.9) 
 
Stepwise.fit <- stepAIC(MLRfit.7, scope = list(upper= ~Groom + Age + Gender + Stall  
+ State + Date + NS + PCR + Groom:Age + Stall:Age + Groom:Stall, 
lower = MLRfit.9), direction = "both")  
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___________________________ Final Model - CD_______________________________ 
 
MLRfit.7 <- lm(Time ~ Groom + Age) 
summary (MLRfit.7) 
 
plot(fitted(MLRfit.7),Time,xlim=c(125,135), ylim=c(120,140), xlab ="Fitted Model", 
ylab ="Date of Fever Onset",main ="Outbreak of Neurologic Equine Herpes (EHV-1)\n 
Churchill Downs - 2005") 
abline(0,1) 
 
predict.lm (MLRfit.7, interval = "confidence") 
predict.lm (MLRfit.7, interval = "prediction") 
 
 
______________________ Diagnostics for Final Model - CD _______________________ 
 
par(mfrow = c(2,2)) 
 
plot(fitted(MLRfit.7),Time,xlim=c(125,135), ylim=c(120,140), xlab ="Fitted Model", 
ylab ="Date of Illness Onset",main ="") 
abline(0,1) 
 
plot (fitted(MLRfit.7),resid(MLRfit.7),xlab = "Fitted Values", 
ylab ="Residuals",main="") 
 
lines(lowess(fitted(MLRfit.7),resid(MLRfit.7))) 
qqnorm(resid(MLRfit.7),main="") 
qqline(resid(MLRfit.7)) 
hist(resid(MLRfit.7),xlab ="Residuals",main="") 
 
plot(fitted(MLRfit.7),Time,xlim=c(125,135), ylim=c(120,140), xlab ="Fitted Model", 
ylab ="Date of Fever Onset",main ="Churchill Downs - 2005") 
abline(0,1) 
 
___________________ Point Estimates - Final Churchill Model _____________________ 
 
newdata3 = list (Groom =c(1), Age=c(4)) 
predict.lm(MLRfit.7, newdata3, interval ="confidence") 
 
newdata5 = list (Groom =c(1), Age=c(3)) 
predict.lm(MLRfit.7, newdata5, interval ="confidence") 
 
newdata6 = list (Groom = c(1), Age=c(3)) 
predict.lm(MLRfit.7, newdata6, interval ="confidence") 
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newdata8 = list (Groom = c(2), Age=c(3)) 
predict.lm(MLRfit.7, newdata8, interval ="confidence") 
 
newdata9 = list (Groom = c(2), Age=c(4)) 
predict.lm(MLRfit.7, newdata9, interval ="confidence") 
 
newdata10 = list (Groom = c(2), Age=c(4)) 
predict.lm(MLRfit.7, newdata10, interval ="confidence") 
 
newdata11 = list (Groom = c(3), Age=c(2)) 
predict.lm(MLRfit.7, newdata11, interval ="confidence") 
 
newdata17 = list (Groom = c(4), Age=c(4)) 
predict.lm(MLRfit.7, newdata17, interval ="confidence") 
 
newdata18 = list (Groom = c(4), Age=c(5)) 
predict.lm(MLRfit.7, newdata18, interval ="confidence") 
 
newdata19 = list (Groom = c(5), Age=c(4)) 
predict.lm(MLRfit.7, newdata19, interval ="confidence") 
 
newdata24 = list (Groom = c(6), Age=c(3)) 
predict.lm(MLRfit.7, newdata24, interval ="confidence") 
 
newdata25 = list (Groom = c(6), Age=c(3)) 
predict.lm(MLRfit.7, newdata25, interval ="confidence") 
 
newdata26 = list (Groom = c(6), Age=c(2)) 
predict.lm(MLRfit.7, newdata26, interval ="confidence") 
 
newdata29 = list (Groom = c(7), Age=c(2)) 
predict.lm(MLRfit.7, newdata29, interval ="confidence") 
 
newdata30 = list (Groom = c(7), Age=c(5)) 
predict.lm(MLRfit.7, newdata30, interval ="confidence") 
 
newdata31 = list (Groom = c(8), Age=c(3)) 
predict.lm(MLRfit.7, newdata31, interval ="confidence") 
 
newdata32 = list (Groom = c(8), Age=c(2)) 
predict.lm(MLRfit.7, newdata32, interval ="confidence") 
 
newdata33 = list (Groom = c(8), Age=c(6)) 
predict.lm(MLRfit.7, newdata33, interval ="confidence") 
 
newdata35 = list (Groom = c(9), Age=c(9)) 
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predict.lm(MLRfit.7, newdata35, interval ="confidence") 
 
newdata37 = list (Groom = c(10), Age=c(11)) 
predict.lm(MLRfit.7, newdata37, interval ="confidence") 
 
_________________ Date of Onset Data – Murray State University _________________ 
 
Obs <-c(1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18) 
Stall <-c(02,05,06,32,33,36,37,39,44,46,47,51,52,54,55,57,58,60) 
Area <-c(3,3,3,2,1,2,1,2,1,2,1,1,2,2,2,2,1,1) 
Breed <-c(1,2,1,1,1,2,3,3,1,1,3,1,1,1,1,3,1,2) 
Gender <-c(2,1,2,2,2,1,2,1,1,2,1,2,1,1,2,1,2,1) 
Age <-c(3,14,7,4,1,15,2,4,14,7,12,4,5,13,1,3,3,12) 
PCR <-c(1,1,1,1,0,1,1,1,1,0,1,1,0,1,0,0,0,1) 
EverVac <-c(0,0,0,1,1,1,1,0,0,0,0,1,1,1,1,1,0,1) 
RecVac <-c(0,0,0,0,1,1,1,0,0,0,0,1,1,1,1,1,0,1) 
FreqAssist <-c(3,1,2,2,2,3,1,3,1,1,3,1,3,3,1,2,3,2) 
Time <-c(83,106,101,75,109,68,115,41,128,77,73,105,86,91,105,61,90,98) 
 
________________________  EDA – Murray State University ______________________ 
 
summary (Obs) 
summary (Stall) 
summary (Location) 
summary (Section) 
summary (Area) 
summary (Breed) 
summary (Gender) 
summary (Age) 
summary (PCR) 
summary (EverVac) 
summary (RecVac) 
summary (FreqAssist) 
summary (Time) 
 
_______________________________Call in Library ______________________________ 
 
library (MASS) 
 
_______________________ Model Building – Murray State University _______________ 
 
library (MASS) 
MLRfit.4 <-lm(Time~Stall) 
summary (MLRfit.4) 
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StepwiseForward.fit <- stepAIC(MLRfit.4, scope = list(upper= ~Stall + Location + 
+Section + Area + Breed + Gender + Age + PCR + + EverVac + RecVac + FreqAssist,  
lower = MLRfit.4), direction = "both")  
 
 
___________________  Final Model - Murray State University ______________________ 
 
MLRfit.5 <- lm(Time ~ Stall + Area + Breed + FreqAssit) 
summary (MLRfit.5) 
 
plot(fitted(MLRfit.5),Time,xlim=c(40,140), ylim=c(40,140), xlab ="Fitted Model", 
ylab ="Date of Disease Onset",main ="Outbreak of Equine Herpes (EHV-1)\n Murray State 
University - 2008") 
abline(0,1) 
 
 
predict.lm (MLRfit.5, interval = "confidence") 
predict.lm (MLRfit.5, interval = "prediction") 
 
 
_______________Diagnostics for Final Model - Murray State University_______________ 
 
par(mfrow = c(2,2)) 
 
plot(fitted(MLRfit.5), Time,xlim=c(60,120),ylim=c(60,120), xlab ="Fitted model", 
ylab ="Date of illness onset", main="") 
abline(0,1) 
 
plot(fitted(MLRfit.5),Time,xlim=c(40,140), ylim=c(40,140), xlab ="Fitted Model", 
ylab ="Date of Disease Onset",main ="") abline(0,1) 
 
plot (fitted(MLRfit.5),resid(MLRfit.5),xlab = "Fitted Values", 
ylab ="Residuals",main="") 
 
lines(lowess(fitted(MLRfit.5),resid(MLRfit.5))) 
qqnorm(resid(MLRfit.5),main="") 
qqline(resid(MLRfit.5)) 
hist(resid(MLRfit.5),xlab ="Residuals",main="") 
 
 
 
____________ Point Estimates - Final Murray State University Model _________________ 
 
newdata1 = list (Stall =c(2), Area =c(3), Breed =c(1), FreqAssit = c(3)) 
predict.lm(MLRfit.5, newdata1, interval ="confidence") 
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newdata2 = list (Stall =c(3), Area =c(3), Breed =c(1), FreqAssit = c(3)) 
predict.lm(MLRfit.5, newdata2, interval ="confidence") 
 
newdata3 = list (Stall =c(5), Area =c(3), Breed =c(2), FreqAssit = c(1)) 
predict.lm(MLRfit.5, newdata3, interval ="confidence") 
 
newdata4 = list (Stall =c(6), Area =c(3), Breed =c(1), FreqAssit =c(2)) 
predict.lm(MLRfit.5, newdata4, interval ="confidence") 
 
newdata5 = list (Stall =c(32), Area =c(2), Breed =c(1), FreqAssit= c(2)) 
predict.lm(MLRfit.5, newdata5, interval ="confidence") 
 
newdata6 = list (Stall =c(33), Area =c(1), Breed =c(1), FreqAssit = c(2)) 
predict.lm(MLRfit.5, newdata6, interval ="confidence") 
 
newdata7 = list (Stall =c(34), Area =c(2), Breed =c(1), FreqAssit= c(3)) 
predict.lm(MLRfit.5, newdata7, interval ="confidence") 
 
newdata8 = list (Stall =c(36), Area =c(2), Breed =c(2), FreqAssit= c(3)) 
predict.lm(MLRfit.5, newdata8, interval ="confidence") 
 
newdata9 = list (Stall =c(37), Area =c(1), Breed =c(3), FreqAssit = c(1)) 
predict.lm(MLRfit.5, newdata9, interval ="confidence") 
 
newdata10 = list (Stall =c(38), Area =c(2), Breed =c(3), FreqAssit = c(3)) 
predict.lm(MLRfit.5, newdata10, interval ="confidence") 
 
newdata11 = list (Stall =c(39), Area =c(1), Breed =c(1), FreqAssit = c(1)) 
predict.lm(MLRfit.5, newdata11, interval ="confidence") 
 
newdata13 = list (Stall =c(40), Area =c(2), Breed =c(3), FreqAssit= c(1)) 
predict.lm(MLRfit.5, newdata1, interval ="confidence") 
 
newdata14 = list (Stall =c(41), Area =c(1), Breed =c(2), FreqAssit = c(3)) 
predict.lm(MLRfit.5, newdata14, interval ="confidence") 
 
newdata15 = list (Stall =c(42), Area =c(2), Breed =c(1), FreqAssit =c(1)) 
predict.lm(MLRfit.5, newdata15, interval ="confidence") 
 
newdata16 = list (Stall =c(43), Area =c(1), Breed =c(1), FreqAssit = c(3)) 
predict.lm(MLRfit.5, newdata16, interval ="confidence") 
 
newdata17 = list (Stall =c(44), Area =c(1), Breed =c(1), FreqAssit = c(3)) 
predict.lm(MLRfit.5, newdata17, interval ="confidence") 
 
newdata19 = list (Stall =c(45), Area =c(1), Breed =c(2), FreqAssit = c(3)) 
 123 
 
predict.lm(MLRfit.5, newdata19, interval ="confidence") 
 
newdata20 = list (Stall =c(46), Area =c(2), Breed =c(1), FreqAssit = c(1)) 
predict.lm(MLRfit.5, newdata20, interval ="confidence") 
 
newdata21 = list (Stall =c(47), Area =c(1), Breed =c(3), FreqAssit = c(3)) 
predict.lm(MLRfit.5, newdata21, interval ="confidence") 
 
newdata22 = list (Stall =c(48), Area =c(2), Breed =c(2), FreqAssit = c(1)) 
predict.lm(MLRfit.5, newdata22, interval ="confidence") 
 
newdata23 = list (Stall =c(50), Area =c(2), Breed =c(1), FreqAssit = c(3)) 
predict.lm(MLRfit.5, newdata23, interval ="confidence") 
 
newdata24 = list (Stall =c(51), Area =c(1), Breed =c(1), FreqAssit = c(1)) 
predict.lm(MLRfit.5, newdata24, interval ="confidence") 
 
newdata25 = list (Stall =c(52), Area =c(2), Breed =c(1), FreqAssit = c(3)) 
predict.lm(MLRfit.5, newdata25, interval ="confidence") 
 
newdata26 = list (Stall =c(53), Area =c(2), Breed =c(1), FreqAssit =c(3)) 
predict.lm(MLRfit.5, newdata26, interval ="confidence") 
 
newdata27 = list (Stall =c(54), Area =c(2), Breed =c(1), FreqAssit =c(1)) 
predict.lm(MLRfit.5, newdata27, interval ="confidence") 
 
newdata28 = list (Stall =c(55), Area =c(2), Breed =c(1), FreqAssit =c(1)) 
predict.lm(MLRfit.5, newdata28, interval ="confidence") 
 
newdata29 = list (Stall =c(56), Area =c(2), Breed =c(1), FreqAssit =c(1)) 
predict.lm(MLRfit.5, newdata29, interval ="confidence") 
 
newdata30 = list (Stall =c(57), Area =c(2), Breed =c(3), FreqAssit =c(2)) 
predict.lm(MLRfit.5, newdata30, interval ="confidence") 
 
newdata31 = list (Stall =c(58), Area =c(1), Breed =c(1), FreqAssit =c(3)) 
predict.lm(MLRfit.5, newdata31, interval ="confidence") 
 
newdata32 = list (Stall =c(60), Area =c(1), Breed =c(2), FreqAssit =c(2)) 
predict.lm(MLRfit.5, newdata32, interval ="confidence") 
 
 
__________________________ Survival Analysis ________________________________ 
 
library (MASS) 
library (survival) 
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___________Kaplan Meier-Empirical Survival Function (Churchill Downs) ____________ 
 
Church <-c(1.0,1.3,1.4,1.7,1.8,1.8,2.0,2.1,2.1,2.1,2.2,2.2,2.3,2.5,2.5,2.9,2.9,2.9,3.1,3.4, 
3.6,3.6,3.9,3.9,4.0,5.1,5.2,5.3,5.5,6.5,6.5,6.9,10.8,13.4,14.0,14.0,14.0) 
 
plot(stepfun(c(1.0,1.3,1.4,1.7,1.8,2.0,2.1,2.2,2.3,2.5,2.9,3.1,3.4,3.6,3.9,4.0,5.1,5.2,5.3,5.5,6.
5,6.9,10.8,13.4,14.0), 
c(1,36/37,35/37,34/37,33/37,31/37,30/37,27/37,25/37,24/37,22/37,19/37,18/37,17/37,15/37,
13/37,12/37,11/37,10/37,9/37,8/37,6/37,5/37,4/37,3/37,0)), 
main = "", xlab="Time to Infection (Days)",ylab= "Survival Probability") 
 
Event <-c(1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0, 
0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0) 
 
Time <-c(1.0,1.3,1.4,1.7,1.8,1.8,2.0,2.1,2.1,2.1,2.2,2.2,2.3,2.5,2.5,2.9,2.9,2.9,3.1,3.4, 
3.6,3.6,3.9,3.9,4.0,5.1,5.2,5.3,5.5,6.5,6.5,6.9,10.8,13.4,14.0,14.0,14.0,1.0,3.5,12.6,13.1,14.2,
14.7,15.2,16.2,23.1,23.6,23.7,23.9,24.7,26.7,28.8,29.0,29.8,33.5,35.3,35.8,36.3,37.1,37.4, 
41.8,41.9,43.9,52.1,53.1,55.9,62.0,63.0,63.0,63.0,63.0,63.0) 
 
Status <-c(1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,1,1,1, 
1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0) 
 
summary (Church) 
 
KMfit.C <-survfit(Surv(Time,Status)~Event, subset=Event== 1) 
plot(KMfit.C, conf.int = F, xlab = "Time to Infection (Days)", ylab = "Survival Probability", 
main = "") 
 
 
________ Kaplan Meier-Empirical Survival Function (Murray State University) _________ 
 
Murray <-c(1,3.5,12.6,13.1,14.2,14.7,15.2,16.2,23.1,23,6,23.7,23.9,24.7,26.7,28.8,29.0, 
29.8,33.5,35.3,35.8,36.3,37.1,37.4,41.8,41.9,43.9,52.1,53.1,55.9,62.0,63.0) 
 
plot(stepfun(c(1.0,3.5,12.6,13.1,14.2,14.7,15.2,16.2,23.1,23.6,23.7,23.9,24.7,26.7,28.8,29.0,
29.8,33.5,35.3,35.8,36.3,37.1,37.4,41.8,41.9,43.9,52.1,53.1,55.9,62.0,63.0), c(1,34/35, 
33/35,32/35,31/35,30/35,29/35,28/35,27/35,26/35,25/35,24/35,23/35,22/35,21/35,20/35, 
19/35,18/35,17/35,16/35,15/35,14/35,13/35,12/35,11/35,10/35,9/35,8/35,7/35,6/35,5/35,0)), 
main ="",xlab ="Time to Infection (Days)",ylab ="Survival Probability") 
 
summary (Murray) 
 
-- Kaplan-Meier Estimates of the Survival Functions for Churchill Versus Murray State ----- 
 
Horse <-c(1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29, 
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30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,5
9,60,61,62,63,64,65,66,67,68,69,70,71,72)  
 
Event <-c(1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0, 
0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0) 
 
Churchill <c(125,125,126,127,167,127,128,128,128,130,130,131,132,132,133,126,129,126, 
125,127,167,127,127,129,129,131,132,130,129,128,128,131,167,129,133,139,144) 
 
Murray <-c(24,23,63,35,35,63,37,53,52,13,42,1,62,24,27,44,36,36,25,42,63,13,24,16,56, 
15,14,37,30,3,29,63,63,29) 
 
Time <-c(1.0,1.3,1.4,1.7,1.8,1.8,2.0,2.1,2.1,2.1,2.2,2.2,2.3,2.5,2.5,2.9,2.9,2.9,3.1,3.4,3.6, 
3.6,3.9,3.9,4.0,5.1,5.2,5.3,5.5,6.5,6.5,6.9,10.8,13.4,63.0,63.0,63.0,1.0,3.5,12.6,13.1,14.2,14.
7,15.2,16.2,23.1,23.6,23.7,23.9,24.7,26.7,28.8,29.0,29.8,33.5,35.3,35.8,36.3,37.1,37.4,41.8,
41.9,43.9,52.1,53.1,55.9,62.0,63.0,63.0,63.0,63.0,63.0) 
 
Status <-c(1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,1,1,1,1, 
1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,0,0,0,0,0) 
 
library (MASS) 
library (survival) 
 
________________________ Survival Analysis- Combined _________________________ 
 
KMfit.1 <-survfit(Surv(Time,Status)~Event, subset=Event== 1) 
plot(KMfit.1, conf.int = F, xlab = "Time to Infection (Days)", ylab = "Survival Probability", 
main = "") 
 
summary (KMfit.1) 
 
KMfit.2 <-survfit(Surv(Time,Status)~Event, subset=Event==0) 
plot(KMfit.2, conf.int = F, xlab = "Time to Infection (Days)", ylab = "Survival Probability", 
main = "") 
 
summary (KMfit.2) 
 
KMfit.3 <-survfit(Surv(Time,Status)~Event) 
plot(KMfit.3, conf.int = F, lty =c(1,2), xlab = "Time to Infection (Days)", ylab = "Survival 
Probability", main = "")  
 
summary (KMfit.3) 
survdiff(Surv(Time)~Event, rho=0) 
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II. SAS Code 
 
Churchill Downs 
 
DATA HERPESCASES; 
INPUT OBS HORSE $ 4-22 Stall 23-25 Gender Age GROOM Fever; 
CARDS; 
Proc Freq; 
run; 
Proc REG; 
Model Fever = Stall Groom Age / TOL VIF; 
Run; 
 
Murray State University 
DATA HERPESCASES;_ 
INPUT OBS HORSE $ 4-22 Stall 23-25 Gender Age Area Breed FreqAssit Onset; 
CARDS; 
Proc Freq; 
run; 
Proc REG; 
Model Onset = Stall Area Breed FreqAssit / TOL VIF; 
Run; 
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